<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Reported-in-Senate" bill-type="olc" public-private="public" star-print="no-star-print">
	<form display="yes">
		<distribution-code display="yes">II</distribution-code>
		<calendar>Calendar No. 452</calendar>
		<congress display="yes">109th CONGRESS</congress>
		<session display="yes">2d Session</session>
		<legis-num display="yes">S. 2560</legis-num>
		<current-chamber display="yes">IN THE SENATE OF THE UNITED
		  STATES</current-chamber>
		<action display="yes">
			<action-date date="20060406">April 6, 2006</action-date>
			<action-desc><sponsor name-id="S161">Mr. Specter</sponsor> (for
			 himself, <cosponsor name-id="S010">Mr. Biden</cosponsor>,
			 <cosponsor name-id="S118">Mr. Hatch</cosponsor>, <cosponsor name-id="S153">Mr.
			 Grassley</cosponsor>, and <cosponsor name-id="S131">Mr. Levin</cosponsor>)
			 introduced the following bill; which was read twice and referred to the
			 <committee-name added-display-style="italic" committee-id="SSJU00" deleted-display-style="strikethrough">Committee on the
			 Judiciary</committee-name></action-desc>
		</action>
		<action>
			<action-date date="20060525">May 25, 2006</action-date>
			<action-desc>Reported by <sponsor name-id="S161">Mr. Specter</sponsor>,
			 with an amendment</action-desc>
			<action-instruction>Strike out all after the enacting clause and insert
			 the part printed in italic</action-instruction>
		</action>
		<legis-type display="yes">A BILL</legis-type>
		<official-title display="yes">To reauthorize the Office of National Drug
		  Control Policy.</official-title>
	</form>
	<legis-body display-enacting-clause="yes-display-enacting-clause" style="OLC">
		<section changed="deleted" commented="no" display-inline="no-display-inline" id="id1AB6E49F81CD4CCBA7ADDB767D4231D2" reported-display-style="strikethrough" section-type="section-one"><enum>1.</enum><header>Short title, reference, and
			 table of contents</header>
			<subsection changed="deleted" commented="no" display-inline="no-display-inline" id="id2C299742279045128F48640F1DC46556" reported-display-style="strikethrough"><enum>(a)</enum><header>Short
			 title</header><text display-inline="yes-display-inline">This Act may be cited
			 as the <quote><short-title>Office of National Drug Control
			 Policy Reauthorization Act of 2006</short-title></quote>.</text>
			</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID5592684906EF4F8188401F907B5F8D67" reported-display-style="strikethrough"><enum>(b)</enum><header>Amendment of
			 Office of National Drug Control Policy Reauthorization Act of
			 1998</header><text display-inline="yes-display-inline">Except as otherwise
			 expressly provided, whenever in this Act an amendment or repeal is expressed in
			 terms of an amendment to, or repeal of, a section or other provision, the
			 reference shall be considered to be made to a section or other provision of the
			 Office of National Drug Control Policy Reauthorization Act of 1998 (Public Law
			 105–277; 21 U.S.C. 1701 et seq.).</text>
			</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID30F44B6347FE431BB616C44AD1866575" reported-display-style="strikethrough"><enum>(c)</enum><header>Table of
			 Contents</header><text display-inline="yes-display-inline">The table of
			 contents for this Act is as follows:</text>
				<toc>
					<toc-entry bold="off" changed="deleted" idref="id1AB6E49F81CD4CCBA7ADDB767D4231D2" level="section" reported-display-style="strikethrough">Sec. 1. Short title, reference, and
				table of contents.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID4FA2908AA3B948379C3031DE42DC9328" level="title" reported-display-style="strikethrough">TITLE I—ORGANIZATION OF
				OFFICE OF NATIONAL DRUG CONTROL POLICY AND ROLES AND
				RESPONSIBILITIES</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID3A96DD93BC0B4B29A81A1EE6A0B5AF77" level="section" reported-display-style="strikethrough">Sec. 101. Amendments to
				definitions.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID2A6E92E81A914D3791E6E87654FAB0B1" level="section" reported-display-style="strikethrough">Sec. 102. Establishment of the Office of
				National Drug Control Policy.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID33BD2F52823540BBB622BBB1316F1A7B" level="section" reported-display-style="strikethrough">Sec. 103. Appointment and
				responsibilities of the Director.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="IDAF2192E824C44F0E913433BA4DEE4747" level="section" reported-display-style="strikethrough">Sec. 104. Amendments to ensure
				coordination with other agencies.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID64F55E06EDF447DEBDEE7FA71A529C14" level="title" reported-display-style="strikethrough">TITLE II—THE NATIONAL DRUG
				CONTROL STRATEGY</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID84B9E0EF83E94C3AA856DC6C77DBA1C4" level="section" reported-display-style="strikethrough">Sec. 201. Annual preparation and
				submission of National Drug Control Strategy.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="IDCB1545365E2447388DE25A7390707016" level="section" reported-display-style="strikethrough">Sec. 202. Performance
				measurements.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID9DD2FDB909E04369AC3739BCB27629F4" level="section" reported-display-style="strikethrough">Sec. 203. Annual report
				requirement.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="IDDCCCDCF0BD714472B9C1A21D2D18456E" level="title" reported-display-style="strikethrough">TITLE III—High intensity
				drug trafficking areas </toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID045426EF39B8482E99FFA0691EA33C75" level="section" reported-display-style="strikethrough">Sec. 301. High Intensity Drug
				Trafficking Areas Program.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="IDA00A8188F28F490FB1BF0B523F902349" level="section" reported-display-style="strikethrough">Sec. 302. Funding for certain high
				intensity drug trafficking areas.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID5B94BD41E2BA44D7B5E17AD2CF9EC6A1" level="section" reported-display-style="strikethrough">Sec. 303. Assessment.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="id341C3F6997194589A2D9908F05648616" level="title" reported-display-style="strikethrough">TITLE
				IV—Technology</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="IDCCA08B584F7D47D594E823FE435E58D7" level="section" reported-display-style="strikethrough">Sec. 401. Counterdrug Technology
				Assessment Center.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="IDDF37CABF46E5434BA5EEC48EF5392360" level="title" reported-display-style="strikethrough">TITLE V—REAUTHORIZATION
				AND IMPROVEMENT OF THE NATIONAL ANTI-DRUG MEDIA CAMPAIGN</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID059FE2AC6F714CE5BCB361C07D193CA2" level="section" reported-display-style="strikethrough">Sec. 501. Short title.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID788DC3CCDBB54FE9830D14E46E8BFA0B" level="section" reported-display-style="strikethrough">Sec. 502. Purposes of the National Youth
				Anti-Drug Media Campaign.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID60F61E9B57CC4D14B9617A3FD4A06D31" level="section" reported-display-style="strikethrough">Sec. 503. Roles and responsibilities of
				the Director, the Partnership for a Drug-Free America, and a media buying
				contractor.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="IDFDF0CD38B2FF4EF1BB7A9FC1A1FC5838" level="section" reported-display-style="strikethrough">Sec. 504. Responsible use of Federal
				funds for the National Youth Anti-Drug Media Campaign.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID11A8458174E04C2D9CEB943F4F1F5A53" level="section" reported-display-style="strikethrough">Sec. 505. Authorization for National
				Youth Anti-Drug Media Campaign.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID8565E70265E3480CBC53F22722CD7A0C" level="title" reported-display-style="strikethrough">TITLE VI—AUTHORIZATIONS
				AND EXTENSION OF TERMINATION DATE</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="IDA51BBBB00B814870B2EFA99BD0E92FB3" level="section" reported-display-style="strikethrough">Sec. 601. Authorization of
				appropriations.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="IDEA45D1B97F134692A8EF07302A192D91" level="section" reported-display-style="strikethrough">Sec. 602. Extension of termination
				date.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="id0CAE4A04EAB34A8F9BD538C5668477B4" level="title" reported-display-style="strikethrough">TITLE VII—Anti-Doping
				Agency</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="id2FF6687314614948B617B539B6DBBA91" level="section" reported-display-style="strikethrough">Sec. 701. Designation of United States
				Anti-Doping Agency.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="idC8B41A46E2704D43AE1E65CDF747857F" level="section" reported-display-style="strikethrough">Sec. 702. Records, audit, and
				report.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="IDDD4AE77185DC4FCDBEA19E2566411BB1" level="section" reported-display-style="strikethrough">Sec. 703. Authorization of
				appropriations.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="idC480D564584C418C9F1C741F2BCF423B" level="title" reported-display-style="strikethrough">TITLE VIII—Drug-free
				communities</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="idACB66A3C933542FCA35267B4B42CBA20" level="section" reported-display-style="strikethrough">Sec. 801. Reauthorization.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="idFFFAA02E30AB401798E7245F9671A8AC" level="section" reported-display-style="strikethrough">Sec. 802. Suspension of
				grants.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="id30C1C762CBE14691B98458C0BAA29DCE" level="section" reported-display-style="strikethrough">Sec. 803. Grant award
				increase.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="id1A8171562F79437B8D752E6711F1523B" level="section" reported-display-style="strikethrough">Sec. 804. Prohibition on additional
				eligibility criteria.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="id198497A894EB47548CE83CCAB9F2B77F" level="section" reported-display-style="strikethrough">Sec. 805. Supplemental grants for
				coalitions.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="id5DED049C669A4A3E8FB54A18FB92AD02" level="section" reported-display-style="strikethrough">Sec. 806. National Community Antidrug
				Coalition Institute.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="id6A08F410A5E94F7B8A2A225A9C4358EF" level="section" reported-display-style="strikethrough">Sec. 807. Contracting
				requirement.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID0C78E232DA404824AC746C393D5D14F3" level="title" reported-display-style="strikethrough">TITLE IX—NATIONAL GUARD
				COUNTERDRUG SCHOOLS</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID671FF999C9AD4CB8AB35A7AE5274A159" level="section" reported-display-style="strikethrough">Sec. 901. National Guard Counterdrug
				Schools.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID158C2C906F004FFC985A2E5E743F8375" level="title" reported-display-style="strikethrough">TITLE X—MISCELLANEOUS
				PROVISIONS</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID83BF049EEEE0468E8DF839FAA501A544" level="section" reported-display-style="strikethrough">Sec. 1001. Repeals.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID1AC44FCD66B5430A9C2D9EFE5F1AA895" level="section" reported-display-style="strikethrough">Sec. 1002. <act-name parsable-cite="CSA">Controlled Substances Act</act-name>
				amendments.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="IDF16A8D375B4E4F418B124FC356C71032" level="section" reported-display-style="strikethrough">Sec. 1003. Report on intelligence
				sharing.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="ID293244B5EA5642BBB44718AF2496B247" level="section" reported-display-style="strikethrough">Sec. 1004. Requirement for South
				American heroin strategy.</toc-entry>
					<toc-entry bold="off" changed="deleted" idref="id0DF5AC6C5A004551A5A9CFD143A06DF9" level="section" reported-display-style="strikethrough">Sec. 1005. Model Acts.</toc-entry>
				</toc>
			</subsection></section><title changed="deleted" commented="no" id="ID4FA2908AA3B948379C3031DE42DC9328" reported-display-style="strikethrough" style="OLC"><enum>I</enum><header>ORGANIZATION OF OFFICE OF NATIONAL DRUG
			 CONTROL POLICY AND ROLES AND RESPONSIBILITIES</header>
			<section changed="deleted" commented="no" display-inline="no-display-inline" id="ID3A96DD93BC0B4B29A81A1EE6A0B5AF77" reported-display-style="strikethrough" section-type="subsequent-section"><enum>101.</enum><header>Amendments to
			 definitions</header>
				<subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID1D9BB27DDC13403094F86A6BBE5E6781" reported-display-style="strikethrough"><enum>(a)</enum><header>Demand
			 Reduction</header><text display-inline="yes-display-inline">Section 702(1) is
			 amended—</text>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID79C3943FD3F34C4ABD4D15C3120DAC57" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">in subparagraph (F), by striking
			 <quote>and</quote> after the semicolon; and</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID8AEEDBA75EB646BAAE82EE1EE28B0958" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">in subparagraph (G), by striking the period
			 and inserting <quote>; and</quote>; and</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID18BC55CA68A841A4B54E4FB6C3D1E17E" reported-display-style="strikethrough"><enum>(3)</enum><text display-inline="yes-display-inline">by adding at the end the following:</text>
						<quoted-block changed="deleted" display-inline="no-display-inline" id="IDEEA85D4FC4B94D628051DBA54AD8FF56" reported-display-style="strikethrough" style="OLC">
							<subparagraph commented="no" display-inline="no-display-inline" id="IDCC1EC9CCFC7843159773181F56A9FA73"><enum>(H)</enum><text display-inline="yes-display-inline">international drug abuse education,
				prevention, treatment, research, rehabilitation activities, and interventions
				for drug abuse and
				dependence.</text>
							</subparagraph><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph></subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID43EC801649EA4B21BC9F1B06C3864776" reported-display-style="strikethrough"><enum>(b)</enum><header>Office</header><text display-inline="yes-display-inline">Section 702(9) is amended by striking
			 <quote>implicates</quote> and inserting <quote>indicates</quote>.</text>
				</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID89CECF7665AC4405B231FE4495EB108E" reported-display-style="strikethrough"><enum>(c)</enum><header>State and Local
			 Affairs</header><text display-inline="yes-display-inline">Paragraph (10) of
			 section 702 is amended to read as follows:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="IDA0BB60CC4E3344899C1485496C238B3D" reported-display-style="strikethrough" style="OLC">
						<paragraph commented="no" display-inline="no-display-inline" id="ID14A5337AF7C64537B0001B9A9A79C9E0"><enum>(10)</enum><header>State and local
				affairs</header><text display-inline="yes-display-inline">The term <term>State
				and local affairs</term> means domestic activities conducted by a National Drug
				Control Program agency that are intended to reduce the availability and use of
				illegal drugs, including—</text>
							<subparagraph commented="no" display-inline="no-display-inline" id="IDD3519BAAB9A6421B9BEC99A8E685C99C"><enum>(A)</enum><text display-inline="yes-display-inline">coordination and enhancement of Federal,
				State, and local law enforcement drug control efforts;</text>
							</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID530779F33BD6417CB26027F7FB86C214"><enum>(B)</enum><text display-inline="yes-display-inline">coordination and enhancement of efforts
				among National Drug Control Program agencies and State and local demand
				reduction and supply reduction agencies;</text>
							</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDE794A4E96213419D907E398882F737D1"><enum>(C)</enum><text display-inline="yes-display-inline">coordination and enhancement of Federal,
				State, and local law enforcement initiatives to gather, analyze, and
				disseminate information and intelligence relating to drug control among
				domestic law enforcement agencies; and</text>
							</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDB82EE753046D4818B30488E0C2C0FE2E"><enum>(D)</enum><text display-inline="yes-display-inline">other coordinated and joint initiatives
				among Federal, State, and local agencies to promote comprehensive drug control
				strategies designed to reduce the demand for, and the availability of, illegal
				drugs.</text>
							</subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID8D39B47B4C5B4948B53226DB5AAE714C" reported-display-style="strikethrough"><enum>(d)</enum><header>Supply
			 Reduction</header><text display-inline="yes-display-inline">Section 702(11) is
			 amended to read as follows:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="ID998B76DAA2AB480B8E4794EA1A890E2F" reported-display-style="strikethrough" style="OLC">
						<paragraph commented="no" display-inline="no-display-inline" id="ID87357B4AE0BB4959BB0A01FD51DCEFDD"><enum>(11)</enum><header>Supply
				reduction</header><text display-inline="yes-display-inline">The term
				<term>supply reduction</term> means any activity or program conducted by a
				National Drug Control Program agency that is intended to reduce the
				availability or use of illegal drugs in the United States or abroad,
				including—</text>
							<subparagraph commented="no" display-inline="no-display-inline" id="ID7D878CCC1E574BAEA425B1FAC77789B4"><enum>(A)</enum><text display-inline="yes-display-inline">activities to control international
				trafficking in, and availability of, illegal drugs, including—</text>
								<clause commented="no" display-inline="no-display-inline" id="IDF97A6DCB83EC4779BD91E0FC63A9F2EE"><enum>(i)</enum><text display-inline="yes-display-inline">accurate assessment and monitoring of
				international drug production and interdiction programs and policies;
				and</text>
								</clause><clause commented="no" display-inline="no-display-inline" id="ID8113C851A39449CE8D3118261C75EE9C"><enum>(ii)</enum><text display-inline="yes-display-inline">coordination and promotion of compliance
				with international treaties relating to the production, transportation, or
				interdiction of illegal drugs;</text>
								</clause></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID8DC82FB1931C45E0B432910791D81E09"><enum>(B)</enum><text display-inline="yes-display-inline">activities to conduct and promote
				international law enforcement programs and policies to reduce the supply of
				drugs; and</text>
							</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID8B42F8CCB0864C3F861C25C31429D89C"><enum>(C)</enum><text display-inline="yes-display-inline">activities to facilitate and enhance the
				sharing of domestic and foreign intelligence information among National Drug
				Control Program agencies, relating to the production and trafficking of drugs
				in the United States and in foreign
				countries.</text>
							</subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID89CA64419C1545FE822897816B57C195" reported-display-style="strikethrough"><enum>(e)</enum><header>Definition of
			 Appropriate Congressional Committees</header><text display-inline="yes-display-inline">Section 702 is amended by adding at the end
			 the following:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="ID60FB9BBF782A4AAF9C444BF7EC90B397" reported-display-style="strikethrough" style="OLC">
						<paragraph commented="no" display-inline="no-display-inline" id="ID346035ED9FDA49E5887EE1053307D47C"><enum>(12)</enum><header>Appropriate
				congressional committees</header><text display-inline="yes-display-inline">Except where otherwise provided, the term
				<term>appropriate congressional committees</term> means the Committee on the
				Judiciary, the Committee on Appropriations, and the Caucus on International
				Narcotics Control of the Senate and the Committee on Government Reform, the
				Committee on the Judiciary, and the Committee on Appropriations of the House of
				Representatives.</text>
						</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection></section><section changed="deleted" commented="no" display-inline="no-display-inline" id="ID2A6E92E81A914D3791E6E87654FAB0B1" reported-display-style="strikethrough" section-type="subsequent-section"><enum>102.</enum><header>Establishment of the
			 Office of National Drug Control Policy</header>
				<subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID433EA5976EF040D9A42C7608F37A427A" reported-display-style="strikethrough"><enum>(a)</enum><header>Responsibilities</header><text display-inline="yes-display-inline">Section 703(a) is amended to read as
			 follows:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="IDB7606F82A4794FFE86322DDDC1402A7D" reported-display-style="strikethrough" style="OLC">
						<subsection commented="no" display-inline="no-display-inline" id="ID8DDA7FF8721B4032899F7104EEA63608"><enum>(a)</enum><header>Establishment of
				Office</header><text display-inline="yes-display-inline">There is established
				in the Executive Office of the President an Office of National Drug Control
				Policy, which shall—</text>
							<paragraph commented="no" display-inline="no-display-inline" id="IDFED65B3E8A924AB1A2D51D3657B301EA"><enum>(1)</enum><text display-inline="yes-display-inline">develop national drug control
				policy;</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDC1B5F1A881A149BEACB40A1AF4AC823B"><enum>(2)</enum><text display-inline="yes-display-inline">coordinate and oversee the implementation
				of the national drug control policy;</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID67332E4DE76B440BA8F98D1B3A1EDA38"><enum>(3)</enum><text display-inline="yes-display-inline">assess and certify the adequacy of National
				Drug Control Programs and the budget for those programs;</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID3CFCE128838C464FB083FABF625944DB"><enum>(4)</enum><text display-inline="yes-display-inline">evaluate the effectiveness of National Drug
				Control Program agencies’ programs; and</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID7CB646E6815F4826A378A9830096BDA4"><enum>(5)</enum><text display-inline="yes-display-inline">develop specific goals and performance
				measurements needed to assess the effectiveness of—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="ID34078815B54442B4A61B16E09748B2D1"><enum>(A)</enum><text display-inline="yes-display-inline">the national drug control policy;
				and</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDD01C0A5719474F03B74C2E21827CF37F"><enum>(B)</enum><text display-inline="yes-display-inline">the programs of the National Drug Control
				Program
				agencies.</text>
								</subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="IDD4154551494D470AB622FBB2A1B4E670" reported-display-style="strikethrough"><enum>(b)</enum><header>Positions</header><text display-inline="yes-display-inline">Section 703(b) is amended to read as
			 follows:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="ID5C4DF3982D9146549C867E9038F31506" reported-display-style="strikethrough" style="OLC">
						<subsection commented="no" display-inline="no-display-inline" id="ID2F9A751C88E04DF3A03E2BDE61A41FD1"><enum>(b)</enum><header>Director of
				National Drug Control Policy and Deputy Directors</header>
							<paragraph commented="no" display-inline="no-display-inline" id="ID4BEA4724EA34478883539F9C1BBE7F27"><enum>(1)</enum><header>Director</header><text display-inline="yes-display-inline">There shall be a Director of National Drug
				Control Policy who shall head the Office (referred to in this Act as the
				<quote>Director</quote>).</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID0A60664D6154454AB96D3A10A219764B"><enum>(2)</enum><header>Deputy
				director</header><text display-inline="yes-display-inline">There shall be a
				Deputy Director of National Drug Control Policy who shall report directly to
				the Director (referred to in this Act as the <quote>Deputy
				Director</quote>).</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID27F5E534D77C4FC3AC784798918ED39C"><enum>(3)</enum><header>Other deputy
				directors</header>
								<subparagraph commented="no" display-inline="no-display-inline" id="IDE4B2C5EEE48A4C5097BC69E9B07B0885"><enum>(A)</enum><header>In
				general</header><text display-inline="yes-display-inline">There shall be a
				Deputy Director for Demand Reduction, a Deputy Director for Supply Reduction,
				and a Deputy Director for State and Local Affairs.</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID4D816B67CB0244DEBA4C19904D5BC8A5"><enum>(B)</enum><header>Reporting</header><text display-inline="yes-display-inline">The Deputy Director for Demand Reduction,
				the Deputy Director for Supply Reduction, and the Deputy Director for State and
				Local Affairs shall report directly to the Deputy Director of the Office of
				National Drug Control Policy.</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID1602027603B54F799FB11369FA98600D"><enum>(C)</enum><header>Deputy director
				for demand reduction</header><text display-inline="yes-display-inline">The
				Deputy Director for Demand Reduction shall be responsible for the
				activities—</text>
									<clause commented="no" display-inline="no-display-inline" id="ID906D7A01F86F466999FEA08D38CDFE55"><enum>(i)</enum><text display-inline="yes-display-inline">in subparagraphs (A) through (H) of section
				702(l); and</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="ID0E8FA1D5B99E4351A7A71E00F99D11D4"><enum>(ii)</enum><text display-inline="yes-display-inline">in section 709, the National Youth
				Anti-Drug Media Campaign Act.</text>
									</clause></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID8DB4620DDF724D839313CCE4888310BB"><enum>(D)</enum><header>Deputy director
				for supply reduction</header><text display-inline="yes-display-inline">The
				Deputy Director for Supply Reduction shall be responsible for the activities in
				subparagraphs (A) through (C) in section 702(11).</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID44AE55B260DD4F2A84E2A4D1A76F53A7"><enum>(E)</enum><header>Deputy director
				for state and local affairs</header><text display-inline="yes-display-inline">The Deputy Director for State and Local
				Affairs shall be responsible for the activities—</text>
									<clause commented="no" display-inline="no-display-inline" id="ID491F0A1E4CB545A1AEF69E8DE0F278C8"><enum>(i)</enum><text display-inline="yes-display-inline">in subparagraphs (A) through (D) of section
				702(10);</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="ID4E3899A4E66445F8A76687FCBE51744F"><enum>(ii)</enum><text display-inline="yes-display-inline">in section 707, the High Intensity Drug
				Trafficking Areas Program; and</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="IDF3E4319332654FDABDD740A3DF68727D"><enum>(iii)</enum><text display-inline="yes-display-inline">in section 708, the Counterdrug Technology
				Assessment
				Center.</text>
									</clause></subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection></section><section changed="deleted" commented="no" display-inline="no-display-inline" id="ID33BD2F52823540BBB622BBB1316F1A7B" reported-display-style="strikethrough" section-type="subsequent-section"><enum>103.</enum><header>Appointment and
			 responsibilities of the Director</header>
				<subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID83C4D4917CBE468FA48DF3F30C0625E0" reported-display-style="strikethrough"><enum>(a)</enum><header>Succession</header><text display-inline="yes-display-inline">Section 704(a) is amended by amending
			 paragraph (3) to read as follows:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="ID708B880FE32B4743AB7E55E368EFE218" reported-display-style="strikethrough" style="OLC">
						<paragraph commented="no" display-inline="no-display-inline" id="IDD2658A69A3D34E7B9DA79605520EAC67"><enum>(3)</enum><header>Acting
				director</header><text display-inline="yes-display-inline">If the Director
				dies, resigns, or is otherwise unable to perform the functions and duties of
				the office, the Deputy Director shall perform the functions and duties of the
				Director temporarily in an acting capacity pursuant to subchapter III of
				chapter 33 of title 5, United States
				Code.</text>
						</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID4C413BA633274BE488B8618CBC6FF327" reported-display-style="strikethrough"><enum>(b)</enum><header>Responsibilities</header><text display-inline="yes-display-inline">Section 704(b) is amended—</text>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID2D6616EA95EE4303AF70BA9CC3BBAD94" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">in paragraph (4), by striking
			 <quote>Federal departments and agencies engaged in drug enforcement</quote> and
			 inserting <quote>National Drug Control Program agencies</quote>;</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID669204947AEA4EEDAA1B7C3F061B9698" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">in paragraph (7), by inserting after
			 <quote>President</quote> the following: <quote>and the appropriate
			 congressional committees</quote>;</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID4A8DB59F6F654D98919F7A8DE2FD7B2F" reported-display-style="strikethrough"><enum>(3)</enum><text display-inline="yes-display-inline">in paragraph (13), by striking
			 <quote>(beginning in 1999)</quote>;</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID5497DC215A7E4B33981D7A57D3675272" reported-display-style="strikethrough"><enum>(4)</enum><text display-inline="yes-display-inline">by striking paragraph (14) and inserting
			 the following:</text>
						<quoted-block changed="deleted" display-inline="no-display-inline" id="IDC93C98C1CD9548B294655489D6CFFBE0" reported-display-style="strikethrough" style="OLC">
							<paragraph commented="no" display-inline="no-display-inline" id="ID54E9D806F68E450CB9236D0FFE91CA3D"><enum>(14)</enum><text display-inline="yes-display-inline">shall submit to the appropriate
				congressional committees on an annual basis, not later than 60 days after the
				date of the last day of the applicable period, a summary of—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="IDED610A7700E44264800C3DC7F26123E2"><enum>(A)</enum><text display-inline="yes-display-inline">each of the evaluations received by the
				Director under paragraph (13); and</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID7334515BB3B7456686388D6B54B742D1"><enum>(B)</enum><text display-inline="yes-display-inline">the progress of each National Drug Control
				Program agency toward the drug control program goals of the agency using the
				performance measures for the agency developed under section
				706(c);</text>
								</subparagraph></paragraph><after-quoted-block>;</after-quoted-block></quoted-block>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDE76088F7BB344B0D9F5EDA6FDC7F11BF" reported-display-style="strikethrough"><enum>(5)</enum><text display-inline="yes-display-inline">in paragraph (15), by striking subparagraph
			 (C) and inserting the following:</text>
						<quoted-block changed="deleted" display-inline="no-display-inline" id="IDCFF1809858B84C23A1DD0FA89D24DD19" reported-display-style="strikethrough" style="OLC">
							<subparagraph commented="no" display-inline="no-display-inline" id="IDD7E239B873294BC49676786F0BBC95EC"><enum>(C)</enum><text display-inline="yes-display-inline">supporting the substance abuse information
				clearinghouse administered by the Administrator of the Substance Abuse and
				Mental Health Services Administration and established in section 501(d)(16) of
				the <act-name parsable-cite="PHSA">Public Health Service Act</act-name>
				by—</text>
								<clause commented="no" display-inline="no-display-inline" id="ID1D80CEAE72394234B3C4F58309404EF6"><enum>(i)</enum><text display-inline="yes-display-inline">encouraging all National Drug Control
				Program agencies to provide all appropriate and relevant information;
				and</text>
								</clause><clause commented="no" display-inline="no-display-inline" id="IDAA68EC3D9EA34A0687A899B31DC7835D"><enum>(ii)</enum><text display-inline="yes-display-inline">supporting the dissemination of information
				to all interested entities;</text>
								</clause></subparagraph><after-quoted-block>;
				and</after-quoted-block></quoted-block>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDFFE56FD3BBAB4CCEB6B8BC09E4D09FCC" reported-display-style="strikethrough"><enum>(6)</enum><text display-inline="yes-display-inline">by inserting at the end the
			 following:</text>
						<quoted-block changed="deleted" display-inline="no-display-inline" id="IDB4AE2A743E69447F8ECDA5BF3F808629" reported-display-style="strikethrough" style="OLC">
							<paragraph commented="no" display-inline="no-display-inline" id="IDDDEF6E8B1C134EAAA78752F187F9EBDC"><enum>(16)</enum><text display-inline="yes-display-inline">shall coordinate with the private sector to
				promote private research and development of medications to treat
				addiction;</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID8587BFF634AC4E0D83F7197065882AD2"><enum>(17)</enum><text display-inline="yes-display-inline">shall seek the support and commitment of
				State and local officials in the formulation and implementation of the National
				Drug Control Strategy;</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID2D8A58EE64114BBE8CABCA7B1DD7F046"><enum>(18)</enum><text display-inline="yes-display-inline">shall monitor and evaluate the allocation
				of resources among Federal law enforcement agencies in response to significant
				local and regional drug trafficking and production threats; and</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID8206096B44A44E0CA770BA2CC6C89B7D"><enum>(19)</enum><text display-inline="yes-display-inline">shall submit an annual report to Congress
				detailing how the Office of National Drug Control Policy has consulted with and
				assisted State and local governments with respect to the formulation and
				implementation of the National Drug Control Strategy and other relevant
				issues.</text>
							</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph></subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID90220C95BA43409F8DCCED04C47071E3" reported-display-style="strikethrough"><enum>(c)</enum><header>Review and
			 Certification of National Drug Control Program Budget</header><text display-inline="yes-display-inline">Section 704(c)(3) is amended—</text>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDE5B11D0C266940D399C8DBE22027D852" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">in subparagraph (C)(iii), by inserting
			 <quote>and the appropriate congressional committees,</quote> after <quote>House
			 of Representatives</quote>; and</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID5C6C281C35FC49DEA8DAE0345796F0C5" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">in subparagraph (D)(ii)(II)(bb), by
			 inserting <quote>and the appropriate congressional committees,</quote> after
			 <quote>House of Representatives</quote>.</text>
					</paragraph></subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID1B9791D526AB4DF986B1218F54F433CE" reported-display-style="strikethrough"><enum>(d)</enum><header>Powers of
			 Director</header><text display-inline="yes-display-inline">Section 704(d) is
			 amended—</text>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDEBB17746A42843F3B390C08D3C120E73" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">in paragraph (9)—</text>
						<subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID8AD9CE768B624006A18551D5F7FDA45D" reported-display-style="strikethrough"><enum>(A)</enum><text display-inline="yes-display-inline">by inserting <quote>notwithstanding any
			 other provision of law,</quote> after <quote>(9)</quote>; and</text>
						</subparagraph><subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID5B299059BDB845BDA5DA6482ECDF3D2B" reported-display-style="strikethrough"><enum>(B)</enum><text display-inline="yes-display-inline">by striking <quote>Strategy; and</quote>
			 and inserting <quote>Strategy and notify the appropriate congressional
			 committees of any fund control notice issued in accordance with section
			 704(f)(5);</quote>; and</text>
						</subparagraph></paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID77D2B260862945BE84A33F73E7E2FCBD" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">in paragraph (10), by inserting before the
			 period the following: <quote>and section 706 of the Department of State
			 Authorization Act for Fiscal Year 2003 (22 U.S.C. 229j–1)</quote>.</text>
					</paragraph></subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID47FA8478ABD04484A3AF4D6E935C57BE" reported-display-style="strikethrough"><enum>(e)</enum><header>Fund Control
			 Notices</header><text display-inline="yes-display-inline">Section 704(f) is
			 amended by adding at the end the following:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="IDEFC3EE189AA64259858AFD78133907B8" reported-display-style="strikethrough" style="OLC">
						<paragraph commented="no" display-inline="no-display-inline" id="ID530C973DCD8F4A1BA697AC6A07D58497"><enum>(4)</enum><header>Congressional
				notice</header><text display-inline="yes-display-inline">A copy of each fund
				control notice shall be transmitted to the appropriate congressional
				committees.</text>
						</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDBE06FC395DA543938D464C5B7A7A23DB"><enum>(5)</enum><header>Restrictions</header><text display-inline="yes-display-inline">The Director shall not issue a fund control
				notice to direct that all or part of an amount appropriated to the National
				Drug Control Program agency account be obligated, modified, or altered in any
				manner—</text>
							<subparagraph commented="no" display-inline="no-display-inline" id="ID1A719835C71C4C68853DEA4DA7DF2DB0"><enum>(A)</enum><text display-inline="yes-display-inline">contrary, in whole or in part, to a
				specific appropriation; or</text>
							</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID7464B361239C42728615B32DBF65D9E9"><enum>(B)</enum><text display-inline="yes-display-inline">contrary, in whole or in part, to the
				expressed intent of
				Congress.</text>
							</subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID2647374B071948509370362D57205512" reported-display-style="strikethrough"><enum>(f)</enum><header>United States
			 Interdiction Coordinator</header>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDF4846C0A37264E7C9A43932D9AA9639F" reported-display-style="strikethrough"><enum>(1)</enum><header>In
			 general</header><text display-inline="yes-display-inline">Section 704 is
			 amended by adding at the end the following:</text>
						<quoted-block changed="deleted" display-inline="no-display-inline" id="ID640C5F37260E4B72B3452192DF7FF9E7" reported-display-style="strikethrough" style="OLC">
							<subsection commented="no" display-inline="no-display-inline" id="ID6B13ACBF93014ABC8D5E7A667265C51F"><enum>(i)</enum><header>United States
				Interdiction Coordinator</header>
								<paragraph commented="no" display-inline="no-display-inline" id="IDA4C1DCD2D9784AE5BF655E0DA5CCBF54"><enum>(1)</enum><header>In
				general</header><text display-inline="yes-display-inline">There shall be a
				United States Interdiction Coordinator, who shall be designated by the Director
				and who shall be responsible for the coordination of interdiction operations
				among National Drug Control Program agencies to prevent and reduce the illegal
				importation of drugs into the United States.</text>
								</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDD2ED2F7169DF4FD8B4B9AA4026B7F013"><enum>(2)</enum><header>Responsibilities</header><text display-inline="yes-display-inline">The United States Interdiction Coordinator
				shall be responsible to the Director for—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="ID419A0A46E25E4FE1BA867F41359118DC"><enum>(A)</enum><text display-inline="yes-display-inline">coordinating the interdiction activities of
				the National Drug Control Program agencies to ensure consistency with the
				National Drug Control Strategy;</text>
									</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDA35F766069A44FCDBD4E8C883275D14D"><enum>(B)</enum><text display-inline="yes-display-inline">developing a National Drug Control
				Interdiction plan to ensure consistency with the National Drug Control
				Strategy;</text>
									</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID1B0D869627484589857682C74CDBCDE7"><enum>(C)</enum><text display-inline="yes-display-inline">assessing the sufficiency of assets of the
				National Drug Control Program agencies committed to illicit drug interdiction;
				and</text>
									</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID62893113F9D6463283341FEC4E600365"><enum>(D)</enum><text display-inline="yes-display-inline">advising the Director on the efforts of
				each National Drug Control Program Agency to implement the National Drug
				Control Interdiction
				plan.</text>
									</subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID94DE3EE9551A4504B9AE6FF595DACE45" reported-display-style="strikethrough"><enum>(2)</enum><header>Amendment to
			 homeland security act of 2002</header><text display-inline="yes-display-inline">Section 878 of the Homeland Security Act of
			 2002 (6 U.S.C. 458) is amended by striking <quote>shall—</quote> through
			 paragraph (2) and inserting <quote>shall ensure the adequacy of resources
			 within the Department for illicit drug interdiction.</quote>.</text>
					</paragraph></subsection></section><section changed="deleted" commented="no" display-inline="no-display-inline" id="IDAF2192E824C44F0E913433BA4DEE4747" reported-display-style="strikethrough" section-type="subsequent-section"><enum>104.</enum><header>Amendments to ensure
			 coordination with other agencies</header><text display-inline="no-display-inline">Section 705 is amended—</text>
				<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDB82CDD37FF9744F9BFD79BB47B74FF64" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">in subsection (a)(1)(A), by striking
			 <quote>abuse</quote>;</text>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDE2D743102CC44CA7AD41A30E4FC56137" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">by amending subsection (a)(3) to read as
			 follows:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="ID834E2094C0404B49B062C490AE4501AF" reported-display-style="strikethrough" style="OLC">
						<paragraph commented="no" display-inline="no-display-inline" id="IDAE5100706AD64651B5B32942D97D711E"><enum>(3)</enum><header>Required
				reports</header>
							<subparagraph commented="no" display-inline="no-display-inline" id="ID8248866C64F0475A9157683A4F742357"><enum>(A)</enum><header>Secretaries of
				the interior and agriculture</header><text display-inline="yes-display-inline">Not later than July 1 of each year, the
				Secretaries of Agriculture and the Interior shall jointly submit to the
				Director and the appropriate congressional committees an assessment of the
				quantity of illegal drug cultivation and manufacturing in the United States on
				lands owned or under the jurisdiction of the Federal Government for the
				preceding year.</text>
							</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID6AFB632DD63649AFB3A1F015FC3C7B1D"><enum>(B)</enum><header>Secretary of
				homeland security</header><text display-inline="yes-display-inline">Not later
				than July 1 of each year, the Secretary of Homeland Security shall submit to
				the Director and the appropriate congressional committees information for the
				preceding year regarding—</text>
								<clause commented="no" display-inline="no-display-inline" id="IDF2E9DA816E694ACBAB088A6FA668991E"><enum>(i)</enum><text display-inline="yes-display-inline">the number and type of seizures of drugs by
				each component of the Department of Homeland Security seizing drugs, as well as
				statistical information on the geographic areas of such seizures; and</text>
								</clause><clause commented="no" display-inline="no-display-inline" id="ID626EE444B0AF4934A50F1272521924A1"><enum>(ii)</enum><text display-inline="yes-display-inline">the number of air and maritime patrol hours
				primarily dedicated to drug supply reduction missions undertaken by each
				component of the Department of Homeland Security.</text>
								</clause></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDA566C115785640C89B024D20FEDA9F03"><enum>(C)</enum><header>Secretary of
				defense</header><text display-inline="yes-display-inline">The Secretary of
				Defense shall, by July 1 of each year, submit to the Director and the
				appropriate congressional committees information for the preceding year
				regarding the number of air and maritime patrol hours primarily dedicated to
				drug supply reduction missions undertaken by each component of the Department
				of Defense.</text>
							</subparagraph></paragraph><after-quoted-block>;
				and</after-quoted-block></quoted-block>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID5591E87D516440F08239D02334F35C03" reported-display-style="strikethrough"><enum>(3)</enum><text display-inline="yes-display-inline">in subsection (b)(2)(B), by striking
			 <quote>Program</quote> and inserting <quote>Strategy</quote>.</text>
				</paragraph></section></title><title changed="deleted" commented="no" id="ID64F55E06EDF447DEBDEE7FA71A529C14" reported-display-style="strikethrough" style="OLC"><enum>II</enum><header>THE NATIONAL DRUG CONTROL STRATEGY</header>
			<section changed="deleted" commented="no" display-inline="no-display-inline" id="ID84B9E0EF83E94C3AA856DC6C77DBA1C4" reported-display-style="strikethrough" section-type="subsequent-section"><enum>201.</enum><header>Annual preparation
			 and submission of National Drug Control Strategy</header><text display-inline="no-display-inline">Section 706 is amended to read as
			 follows:</text>
				<quoted-block changed="deleted" display-inline="no-display-inline" id="ID8FB8B35E31474305B935C13AB6505117" reported-display-style="strikethrough" style="OLC">
					<section commented="no" display-inline="no-display-inline" id="ID4107F8BFD82F41D1885C1AF967CBAE42" section-type="subsequent-section"><enum>706.</enum><header>Development,
				submission, implementation, and assessment of National Drug Control
				Strategy</header>
						<subsection commented="no" display-inline="no-display-inline" id="ID58437606449444E2936B4CE82FD7F61A"><enum>(a)</enum><header>Timing,
				Contents, and Process for Development and Submission of National Drug Control
				Strategy</header>
							<paragraph commented="no" display-inline="no-display-inline" id="IDE2B8EE3ACC7543DAA35F2621CD3FD0B3"><enum>(1)</enum><header>Timing</header><text display-inline="yes-display-inline">Not later than February 1 of each year, the
				President shall submit to Congress a National Drug Control Strategy, which
				shall set forth a comprehensive plan for the year to reduce drug abuse and the
				consequences of such drug abuse in the United States by limiting the
				availability of, and reducing the demand for, illegal drugs.</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID9023FE189CF34F9DB7169BA098827371"><enum>(2)</enum><header>Contents</header>
								<subparagraph commented="no" display-inline="no-display-inline" id="ID9FAFAD0DF2534CB0867E977B8AE506E9"><enum>(A)</enum><header>In
				general</header><text display-inline="yes-display-inline">The National Drug
				Control Strategy submitted under paragraph (1) shall include—</text>
									<clause commented="no" display-inline="no-display-inline" id="ID2A874A13321741829E4A33972165240D"><enum>(i)</enum><text display-inline="yes-display-inline">comprehensive, research-based, long-range,
				quantifiable goals for reducing drug abuse and the consequences of drug abuse
				in the United States;</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="IDAC91E8C8B577492090B5354E27DB2892"><enum>(ii)</enum><text display-inline="yes-display-inline">annual quantifiable and measurable
				objectives and specific targets to accomplish long-term quantifiable goals that
				the Director determines may be achieved during each year beginning on the date
				on which the National Drug Control Strategy is submitted;</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="ID81CB5DFB1EC74B5CBB1C628071EE3F77"><enum>(iii)</enum><text display-inline="yes-display-inline">5-year projections for program and budget
				priorities;</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="IDAA7540EB017B419DB1B33E8D6FDB6213"><enum>(iv)</enum><text display-inline="yes-display-inline">a review of international, State, local,
				and private sector drug control activities to ensure that the United States
				pursues coordinated and effective drug control at all levels of
				government;</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="ID80D3BC75E8044246B627C0D497CCA7CA"><enum>(v)</enum><text display-inline="yes-display-inline">an assessment of current illicit drug use
				(including inhalants) and availability, impact of illicit drug use, and
				treatment availability, which assessment shall include—</text>
										<subclause commented="no" display-inline="no-display-inline" id="ID206A6F7B0A8E42A2AE3DC2FE8F3CD330"><enum>(I)</enum><text display-inline="yes-display-inline">estimates of drug prevalence and frequency
				of use as measured by national, State, and local surveys of illicit drug use
				and by other special studies of nondependent and dependent illicit drug
				use;</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="ID38DC92B04C6D407095139CCC85F05EA0"><enum>(II)</enum><text display-inline="yes-display-inline">illicit drug use in the workplace and the
				productivity lost by such use; and</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="ID4290A2DAAE80413A851225D129481F28"><enum>(III)</enum><text display-inline="yes-display-inline">illicit drug use by arrestees,
				probationers, and parolees;</text>
										</subclause></clause><clause commented="no" display-inline="no-display-inline" id="ID79603C75F5E74B889E8B75C33A6EF403"><enum>(vi)</enum><text display-inline="yes-display-inline">an assessment of the reduction of illicit
				drug availability, as measured by—</text>
										<subclause commented="no" display-inline="no-display-inline" id="ID194D9CFF2F434590B415AF31FD4FEA21"><enum>(I)</enum><text display-inline="yes-display-inline">the quantities of cocaine, heroin,
				marijuana, methamphetamine, ecstasy, and other drugs available for consumption
				in the United States;</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="ID6D47120C3EC14B0BB844C504B5AD4153"><enum>(II)</enum><text display-inline="yes-display-inline">the amount of marijuana, cocaine, heroin,
				methamphetamine, ecstasy, and precursor chemicals and other drugs entering the
				United States;</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="ID082CFDB48000441BBB053ED593D6C2BC"><enum>(III)</enum><text display-inline="yes-display-inline">the number of illicit drug manufacturing
				laboratories seized and destroyed and the number of hectares of marijuana,
				poppy, and coca cultivated and destroyed domestically and in other
				countries;</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="ID0971A4E8A67847E09EEA15B1C672A01C"><enum>(IV)</enum><text display-inline="yes-display-inline">the number of metric tons of marijuana,
				heroin, cocaine, and methamphetamine seized and other drugs; and</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="IDA8E71B5195484A86B3F303DAA1C189E9"><enum>(V)</enum><text display-inline="yes-display-inline">changes in the price and purity of heroin,
				methamphetamine, and cocaine, changes in the price of ecstasy, and changes in
				tetrahydrocannabinol level of marijuana and other drugs;</text>
										</subclause></clause><clause commented="no" display-inline="no-display-inline" id="ID6A61EF1949A04A61B3CFD2ED303CF9F2"><enum>(vii)</enum><text display-inline="yes-display-inline">an assessment of the reduction of the
				consequences of illicit drug use and availability, which shall include—</text>
										<subclause commented="no" display-inline="no-display-inline" id="ID345F5D526BDB49CC8A88DA712B6B754F"><enum>(I)</enum><text display-inline="yes-display-inline">the burden illicit drug users placed on
				hospital emergency departments in the United States, such as the quantity of
				illicit drug-related services provided;</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="ID59364B3223584788BC5859360191724B"><enum>(II)</enum><text display-inline="yes-display-inline">the annual national health care cost of
				illicit drug use; and</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="IDA67ABF316B764EFC9A1267B0FE9C9592"><enum>(III)</enum><text display-inline="yes-display-inline">the extent of illicit drug-related crime
				and criminal activity;</text>
										</subclause></clause><clause commented="no" display-inline="no-display-inline" id="ID70EEFBE3FEAB45789AC22F1A405D9AAB"><enum>(viii)</enum><text display-inline="yes-display-inline">a determination of the status of drug
				treatment in the United States, by assessing—</text>
										<subclause commented="no" display-inline="no-display-inline" id="ID2AA313BD6EE74848A5247CF68E52714F"><enum>(I)</enum><text display-inline="yes-display-inline">public and private treatment utilization;
				and</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="ID3BD93EC4EBE04EF9A5278AC469C85D0A"><enum>(II)</enum><text display-inline="yes-display-inline">the number of illicit drug users the
				Director estimates meet diagnostic criteria for treatment;</text>
										</subclause></clause><clause commented="no" display-inline="no-display-inline" id="ID56B5687918D740B5B33BBFB347CBC5F0"><enum>(ix)</enum><text display-inline="yes-display-inline">a review of the research agenda of the
				Counterdrug Technology Assessment Center to reduce the availability and abuse
				of drugs; and</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="ID9FADD134507140549C5EF54F2E8E6ADE"><enum>(x)</enum><text display-inline="yes-display-inline">a summary of the efforts made to coordinate
				with private sector entities to conduct private research and development of
				medications to treat addiction by—</text>
										<subclause commented="no" display-inline="no-display-inline" id="ID465F63273EDE4E8C946FC4AD23891DDF"><enum>(I)</enum><text display-inline="yes-display-inline">screening chemicals for potential
				therapeutic value;</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="ID5F13324B10EF48C5BB3DFB44F478FF8A"><enum>(II)</enum><text display-inline="yes-display-inline">developing promising compounds;</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="IDF24B826508BA4352A84710F3A5C549FA"><enum>(III)</enum><text display-inline="yes-display-inline">conducting clinical trials;</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="IDAD8F6A6EFB3A44A381C33F147C7C276A"><enum>(IV)</enum><text display-inline="yes-display-inline">seeking Food and Drug Administration
				approval for drugs to treat addiction;</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="IDAF7803F00243474FB329D8416F6CFB7E"><enum>(V)</enum><text display-inline="yes-display-inline">marketing the drug for the treatment of
				addiction;</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="IDB528624F5ADA453E92334EFDB50611BE"><enum>(VI)</enum><text display-inline="yes-display-inline">urging physicians to use the drug in the
				treatment of addiction; and</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="IDA8F978CACFEE4F739EF509C02917350A"><enum>(VII)</enum><text display-inline="yes-display-inline">encouraging insurance companies to
				reimburse the cost of the drug for the treatment of addiction.</text>
										</subclause></clause></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID30A668F0772040C5B05CC1913C85E964"><enum>(B)</enum><header>Classified
				information</header><text display-inline="yes-display-inline">Any contents of
				the National Drug Control Strategy that involve information properly classified
				under criteria established by an Executive order shall be presented to Congress
				separately from the rest of the National Drug Control Strategy.</text>
								</subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDE238C02D1BEA4606BFF01A0FF7D4BD19"><enum>(3)</enum><header>Process for
				development and submission</header><text display-inline="yes-display-inline">In
				developing and effectively implementing the National Drug Control Strategy, the
				Director—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="ID251C5125B5444DFCB2A368F6B8DB62D8"><enum>(A)</enum><text display-inline="yes-display-inline">shall consult with—</text>
									<clause commented="no" display-inline="no-display-inline" id="ID6728BC86DCCB4109BCC757E53C976CDB"><enum>(i)</enum><text display-inline="yes-display-inline">the heads of the National Drug Control
				Program agencies;</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="ID4B7C1DB0AA604898B6A6EB7526A9C844"><enum>(ii)</enum><text display-inline="yes-display-inline">Congress;</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="ID8BED2E4BB8554FD69B1FF9000003E1A2"><enum>(iii)</enum><text display-inline="yes-display-inline">State and local officials;</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="ID7547556F6D434F1592A8297C28C569D8"><enum>(iv)</enum><text display-inline="yes-display-inline">private citizens and organizations with
				experience and expertise in demand reduction;</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="ID320115821A984229ACF865A0EF3059B0"><enum>(v)</enum><text display-inline="yes-display-inline">private citizens and organizations with
				experience and expertise in supply reduction; and</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="IDDF08B95469BE4C369BA02403B0B15E07"><enum>(vi)</enum><text display-inline="yes-display-inline">appropriate representatives of foreign
				governments;</text>
									</clause></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDF2BC02363DF643AEB66C57FFD23F0B31"><enum>(B)</enum><text display-inline="yes-display-inline">in satisfying the requirements of
				subparagraph (A), shall ensure, to the maximum extent possible, that State and
				local officials and relevant private organizations commit to support and take
				steps to achieve the goals and objectives of the National Drug Control
				Strategy;</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID592513EFC26E4367B95D193FE2DFA363"><enum>(C)</enum><text display-inline="yes-display-inline">with the concurrence of the Attorney
				General, may require the El Paso Intelligence Center to undertake specific
				tasks or projects to support or implement the National Drug Control Strategy;
				and</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDC67709661414498EB01BDA452783E59C"><enum>(D)</enum><text display-inline="yes-display-inline">with the concurrence of the Director of
				National Intelligence and the Attorney General, may request that the National
				Drug Intelligence Center undertake specific tasks or projects to support or
				implement the National Drug Control Strategy.</text>
								</subparagraph></paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="IDC1472468CD584248B6A85AA10EAF7F56"><enum>(b)</enum><header>Submission of
				Revised Strategy</header><text display-inline="yes-display-inline">The
				President may submit to Congress a revised National Drug Control Strategy that
				meets the requirements of this section—</text>
							<paragraph commented="no" display-inline="no-display-inline" id="IDCA97A2A03D1549B3A976B8C707D3412C"><enum>(1)</enum><text display-inline="yes-display-inline">at any time, upon a determination of the
				President, in consultation with the Director, that the National Drug Control
				Strategy in effect is not sufficiently effective; or</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDAC9D0AF143774616A8E911597A00732E"><enum>(2)</enum><text display-inline="yes-display-inline">if a new President or Director takes
				office.</text>
							</paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
			</section><section changed="deleted" commented="no" display-inline="no-display-inline" id="IDCB1545365E2447388DE25A7390707016" reported-display-style="strikethrough" section-type="subsequent-section"><enum>202.</enum><header>Performance
			 measurements</header><text display-inline="no-display-inline">Section 706 is
			 amended by adding at the end the following:</text>
				<quoted-block changed="deleted" display-inline="no-display-inline" id="IDEFF6BE7DDAE343F1BFE24CA26D033EFF" reported-display-style="strikethrough" style="OLC">
					<subsection commented="no" display-inline="no-display-inline" id="ID20D2B3B505CE47E2907121361F60B9A9"><enum>(c)</enum><header>Performance
				Measurement System</header><text display-inline="yes-display-inline">Not later
				than February 1 of each year, the Director shall submit to Congress as part of
				the National Drug Control Strategy, a description of a national drug control
				performance measurement system, that—</text>
						<paragraph commented="no" display-inline="no-display-inline" id="ID662F95CE5C0B4C6E808C5FD5C91CA0F0"><enum>(1)</enum><text display-inline="yes-display-inline">develops 2-year and 5-year performance
				measures and targets for each National Drug Control Strategy goal and objective
				established for reducing drug use, availability, and the consequences of drug
				use;</text>
						</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDF455B02C6158453892045A7F72258EAC"><enum>(2)</enum><text display-inline="yes-display-inline">describes the sources of information and
				data that will be used for each performance measure incorporated into the
				performance measurement system;</text>
						</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDDEBB9E08477E43B69F38701869C30B10"><enum>(3)</enum><text display-inline="yes-display-inline">identifies major programs and activities of
				the National Drug Control Program agencies that support the goals and annual
				objectives of the National Drug Control Strategy;</text>
						</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID9D5986CAA80A4ED490619688CC59C6D3"><enum>(4)</enum><text display-inline="yes-display-inline">evaluates the contribution of demand
				reduction and supply reduction activities as defined in section 702 implemented
				by each National Drug Control Program agency in support of the National Drug
				Control Strategy;</text>
						</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID93E170BE35784760B5E37E27E4B9E226"><enum>(5)</enum><text display-inline="yes-display-inline">monitors consistency between the
				drug-related goals and objectives of the National Drug Control Program agencies
				and ensures that each agency’s goals and budgets support and are fully
				consistent with the National Drug Control Strategy; and</text>
						</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID9497B74DE3FE4129A06AF41580DC6C82"><enum>(6)</enum><text display-inline="yes-display-inline">coordinates the development and
				implementation of national drug control data collection and reporting systems
				to support policy formulation and performance measurement, including an
				assessment of—</text>
							<subparagraph commented="no" display-inline="no-display-inline" id="ID821DED8D2FA44DA4B2E52BB64EF3F1F6"><enum>(A)</enum><text display-inline="yes-display-inline">the quality of current drug use measurement
				instruments and techniques to measure supply reduction and demand reduction
				activities;</text>
							</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID1321FAE93FE64B4DA09408ED4EFF3300"><enum>(B)</enum><text display-inline="yes-display-inline">the adequacy of the coverage of existing
				national drug use measurement instruments and techniques to measure the casual
				drug use population, the addicted drug user population, and groups that are at
				risk for drug use;</text>
							</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID210B28BEC509407F8AACD2E22F464EFF"><enum>(C)</enum><text display-inline="yes-display-inline">the adequacy of the coverage of existing
				national treatment outcome monitoring systems to measure the effectiveness of
				drug abuse treatment in reducing drug use and criminal behavior during and
				after the completion of substance abuse treatment; and</text>
							</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID58CFE23F9D9D4C86B8A06CD81CA74F8C"><enum>(D)</enum><text display-inline="yes-display-inline">the actions the Director shall take to
				correct any deficiencies and limitations identified pursuant to subparagraphs
				(A) and (B) of this subsection.</text>
							</subparagraph></paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="ID8FE36560BB8C4ED48A33BF4EAC1CDA2C"><enum>(d)</enum><header>Modifications</header><text display-inline="yes-display-inline">A description of any modifications made
				during the preceding year to the national drug performance measurement system
				described in subsection (c) shall be included in each report submitted under
				subsection
				(b).</text>
					</subsection><after-quoted-block>.</after-quoted-block></quoted-block>
			</section><section changed="deleted" commented="no" display-inline="no-display-inline" id="ID9DD2FDB909E04369AC3739BCB27629F4" reported-display-style="strikethrough" section-type="subsequent-section"><enum>203.</enum><header>Annual report
			 requirement</header>
				<subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID8A9D5DD76B66466E862E64016740FB05" reported-display-style="strikethrough"><enum>(a)</enum><header>In
			 General</header><text display-inline="yes-display-inline">On or before February
			 1 of each year, the Director shall submit a report to Congress that
			 describes—</text>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID0BA95DEA07D445AF849CA4F9A47A8962" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">the strategy of the national media campaign
			 and whether specific objectives of the campaign were accomplished;</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID7FBC705BEE634D29A2380D59649DBED6" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">steps taken to ensure that the national
			 media campaign operates in an effective and efficient manner consistent with
			 the overall strategy and focus of the campaign;</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID358908C9380746C19AB6F4F1B21B7905" reported-display-style="strikethrough"><enum>(3)</enum><text display-inline="yes-display-inline">plans to purchase advertising time and
			 space;</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID3292A8EA78DE4CEEB35B5F629731E0B7" reported-display-style="strikethrough"><enum>(4)</enum><text display-inline="yes-display-inline">policies and practices implemented to
			 ensure that Federal funds are used responsibly to purchase advertising time and
			 space and eliminate the potential for waste, fraud, and abuse;</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID7973EADD23184839A97E0D9FDF09B90D" reported-display-style="strikethrough"><enum>(5)</enum><text display-inline="yes-display-inline">all contracts entered into with a
			 corporation, partnership, or individual working on behalf of the national media
			 campaign;</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID4CAB07BC147840F3B5569D8A95997048" reported-display-style="strikethrough"><enum>(6)</enum><text display-inline="yes-display-inline">specific policies and steps implemented to
			 ensure compliance with title IV of this Act;</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID3186801373A342A2B7F336F09AF94F53" reported-display-style="strikethrough"><enum>(7)</enum><text display-inline="yes-display-inline">steps taken to ensure that the national
			 media campaign will secure, to the maximum extent possible, no cost matches of
			 advertising time and space or in-kind contributions that are directly related
			 to the campaign in accordance with title IV of this Act; and</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDD52B0D19236347FBA2A9E5B537398466" reported-display-style="strikethrough"><enum>(8)</enum><text display-inline="yes-display-inline">a review and evaluation of the
			 effectiveness of the national media campaign strategy for the past year.</text>
					</paragraph></subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="IDD2B79D28B2A64F87916F06298FF400ED" reported-display-style="strikethrough"><enum>(b)</enum><header>Audit</header><text display-inline="yes-display-inline">The Government Accountability Office shall,
			 at a frequency of not less than once per year—</text>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDA605D7D26F294DEFB38D92B1D1F0C2D2" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">conduct and supervise an audit and
			 investigation relating to the programs and operations of the—</text>
						<subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID6AEE36F8D2424B6E992BE4F46A939E34" reported-display-style="strikethrough"><enum>(A)</enum><text display-inline="yes-display-inline">Office; or</text>
						</subparagraph><subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID490467E9D9D340DE95C52F64E96661BF" reported-display-style="strikethrough"><enum>(B)</enum><text display-inline="yes-display-inline">certain programs within the Office,
			 including—</text>
							<clause changed="deleted" commented="no" display-inline="no-display-inline" id="IDA7C7DA74F66B432BA013EAC53D18533E" reported-display-style="strikethrough"><enum>(i)</enum><text display-inline="yes-display-inline">the High Intensity Drug Trafficking Areas
			 Program;</text>
							</clause><clause changed="deleted" commented="no" display-inline="no-display-inline" id="IDEE03158F7D8F477CA4AD1F72DC104BA4" reported-display-style="strikethrough"><enum>(ii)</enum><text display-inline="yes-display-inline">the Counterdrug Technology Assessment
			 Center; or</text>
							</clause><clause changed="deleted" commented="no" display-inline="no-display-inline" id="IDAE6C22C8DF064E2CB77D2BC0F02F01AA" reported-display-style="strikethrough"><enum>(iii)</enum><text display-inline="yes-display-inline">the National Youth Anti-drug Media
			 Campaign; and</text>
							</clause></subparagraph></paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID0FAAAEF97C3B40B5865703FBB3A6F99F" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">provide the Director and the appropriate
			 congressional committees with a report containing an evaluation of and
			 recommendations on the—</text>
						<subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID4D2374383F19405EAAAFDA5EE7956B10" reported-display-style="strikethrough"><enum>(A)</enum><text display-inline="yes-display-inline">policies and activities of the programs and
			 operations subject to the audit and investigation;</text>
						</subparagraph><subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID0BEAF8C55B8F43078A16B306904061F4" reported-display-style="strikethrough"><enum>(B)</enum><text display-inline="yes-display-inline">economy, efficiency, and effectiveness in
			 the administration of the reviewed programs and operations; and</text>
						</subparagraph><subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID9C249C3EFEAE46739A152846EB9CF3FE" reported-display-style="strikethrough"><enum>(C)</enum><text display-inline="yes-display-inline">policy or management changes needed to
			 prevent and detect fraud and abuse in such programs and operations.</text>
						</subparagraph></paragraph></subsection></section></title><title changed="deleted" commented="no" id="IDDCCCDCF0BD714472B9C1A21D2D18456E" reported-display-style="strikethrough" style="OLC"><enum>III</enum><header>High intensity drug trafficking areas
			 </header>
			<section changed="deleted" commented="no" display-inline="no-display-inline" id="ID045426EF39B8482E99FFA0691EA33C75" reported-display-style="strikethrough" section-type="subsequent-section"><enum>301.</enum><header>High Intensity Drug
			 Trafficking Areas Program</header><text display-inline="no-display-inline">Section 707 is amended to read as
			 follows:</text>
				<quoted-block changed="deleted" display-inline="no-display-inline" id="ID0A485BBD8DBE46F9AD3CC1CE8F177EF8" reported-display-style="strikethrough" style="OLC">
					<section commented="no" display-inline="no-display-inline" id="ID30856D9CA8DC4FF3B91515AA2F7EDC8F" section-type="subsequent-section"><enum>707.</enum><header>High Intensity
				Drug Trafficking Areas Program</header>
						<subsection commented="no" display-inline="no-display-inline" id="ID55CED14F7E7C4302A6C77C5C80441BD1"><enum>(a)</enum><header>Establishment</header>
							<paragraph commented="no" display-inline="no-display-inline" id="IDBC3B6730071042F697B1D0B594A72E98"><enum>(1)</enum><header>In
				general</header><text display-inline="yes-display-inline">There is established
				in the Office a program to be known as the High Intensity Drug Trafficking
				Areas Program (in this section referred to as the
				<quote>Program</quote>).</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDDA1086F33EE646CD9F3DB0075B3F9C24"><enum>(2)</enum><header>Purpose</header><text display-inline="yes-display-inline">The purpose of the Program is to reduce
				drug trafficking and drug production in the United States by—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="IDBA0A7411176A4E3F90EB4662C4EA3965"><enum>(A)</enum><text display-inline="yes-display-inline">facilitating cooperation among Federal,
				State, and local law enforcement agencies to share information and implement
				coordinated enforcement activities;</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID62D1E49904B941D4BD224DFA16D76434"><enum>(B)</enum><text display-inline="yes-display-inline">enhancing intelligence sharing among
				Federal, State, and local law enforcement agencies;</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDAC73D48CCE974DA3A73B052B811E50EF"><enum>(C)</enum><text display-inline="yes-display-inline">providing reliable intelligence to law
				enforcement agencies needed to design effective enforcement strategies and
				operations; and</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID8044CA9101814555B809AB29C5D2BAB0"><enum>(D)</enum><text display-inline="yes-display-inline">supporting coordinated law enforcement
				strategies which maximize use of available resources to reduce the supply of
				illegal drugs in designated areas and in the United States as a whole.</text>
								</subparagraph></paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="IDF9BDAA7000534BB281F9992DB1E43B9D"><enum>(b)</enum><header>Designation</header>
							<paragraph commented="no" display-inline="no-display-inline" id="id499A54700F894F9CAAB875416B89099F"><enum>(1)</enum><header>In
				general</header><text display-inline="yes-display-inline">The Director, in
				consultation with the Attorney General, the Secretary of the Treasury, the
				Secretary of Homeland Security, heads of the National Drug Control Program
				agencies, and the Governor of each applicable State, may designate any
				specified area of the United States as a high intensity drug trafficking
				area.</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="id76CDCBD809DC49F28FD817B076E3B1DA"><enum>(2)</enum><header>Activities</header><text display-inline="yes-display-inline">After making a designation under paragraph
				(1) and in order to provide Federal assistance to the area so designated, the
				Director may—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="ID8FB82F0E893E47CB91AFD854320B517A"><enum>(A)</enum><text display-inline="yes-display-inline">obligate such sums as are appropriated for
				the Program;</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID2DC69697B6EA42EF84C4F7844EC7032E"><enum>(B)</enum><text display-inline="yes-display-inline">direct the temporary reassignment of
				Federal personnel to such area, subject to the approval of the head of the
				department or agency that employs such personnel;</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID51AA1A98D10F4F339ED73BA528013F8B"><enum>(C)</enum><text display-inline="yes-display-inline">take any other action authorized under
				section 704 to provide increased Federal assistance to those areas; and</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID29553105561549DDBB5BE26BFB49D95F"><enum>(D)</enum><text display-inline="yes-display-inline">coordinate activities under this section
				(specifically administrative, recordkeeping, and funds management activities)
				with State and local officials.</text>
								</subparagraph></paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="ID320EB8E68B9940359FF17C1A5B22873E"><enum>(c)</enum><header>Petitions for
				Designation</header><text display-inline="yes-display-inline">The Director
				shall establish regulations under which a coalition of interested law
				enforcement agencies from an area may petition for designation as a high
				intensity drug trafficking area. Such regulations shall provide for a regular
				review by the Director of the petition, including a recommendation regarding
				the merit of the petition to the Director by a panel of qualified, independent
				experts.</text>
						</subsection><subsection commented="no" display-inline="no-display-inline" id="ID2E67C530BFD54E468D7F348390FA9EA0"><enum>(d)</enum><header>Factors for
				Consideration</header><text display-inline="yes-display-inline">In considering
				whether to designate an area under this section as a high intensity drug
				trafficking area, the Director shall consider, in addition to such other
				criteria as the Director considers to be appropriate, the extent to
				which—</text>
							<paragraph commented="no" display-inline="no-display-inline" id="ID9F477E52CF6443688CDFF62C52025EDF"><enum>(1)</enum><text display-inline="yes-display-inline">the area is a significant center of illegal
				drug production, manufacturing, importation, or distribution;</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID922DF0D779494247B19C73C33F5C144D"><enum>(2)</enum><text display-inline="yes-display-inline">State and local law enforcement agencies
				have committed resources to respond to the drug trafficking problem in the
				area, thereby indicating a determination to respond aggressively to the
				problem;</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID3BC87D144D1640A8BE61F2A5967B39D5"><enum>(3)</enum><text display-inline="yes-display-inline">drug-related activities in the area are
				having a significant harmful impact in the area, and in other areas of the
				country; and</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID340C582E6ABC444AB2A67A631053C70E"><enum>(4)</enum><text display-inline="yes-display-inline">a significant increase in allocation of
				Federal resources is necessary to respond adequately to drug-related activities
				in the area.</text>
							</paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="IDEE800578DC9E4BE9B6A131B94C48B96D"><enum>(e)</enum><header>Organization of
				High Intensity Drug Trafficking Areas</header>
							<paragraph commented="no" display-inline="no-display-inline" id="ID0FE0C354EB584978BA2B8CEF7A1BF88B"><enum>(1)</enum><header>Executive board
				and officers</header><text display-inline="yes-display-inline">To be eligible
				for funds appropriated under this section, each high intensity drug trafficking
				area shall be governed by an Executive Board. The Executive Board shall
				designate a chairman, vice chairman, and any other officers to the Executive
				Board that it determines are necessary.</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDFB7CF78E8F3B45EC947311AC3E29B5F9"><enum>(2)</enum><header>Responsibilities</header><text display-inline="yes-display-inline">The Executive Board of a high intensity
				drug trafficking area shall be responsible for—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="IDAAE9E5F5CD394E0FAD8A3FF130E8A86B"><enum>(A)</enum><text display-inline="yes-display-inline">providing direction and oversight in
				establishing and achieving the goals of the high intensity drug trafficking
				area;</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID213129B810D5447B9E66FE0EE8DD9093"><enum>(B)</enum><text display-inline="yes-display-inline">managing the funds of the high intensity
				drug trafficking area;</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID64762BE32EDF4910BF6965EA355BCB71"><enum>(C)</enum><text display-inline="yes-display-inline">reviewing and approving all funding
				proposals consistent with the overall objective of the high intensity drug
				trafficking area; and</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID994331B0E02947D09E1F1566F21D58B9"><enum>(D)</enum><text display-inline="yes-display-inline">reviewing and approving all reports to the
				Director on the activities of the high intensity drug trafficking area.</text>
								</subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID2231F79DA31440D9B85D46242F9FF0A9"><enum>(3)</enum><header>Board
				representation</header><text display-inline="yes-display-inline">None of the
				funds appropriated under this section may be expended for any high intensity
				drug trafficking area, or for a partnership or region of a high intensity drug
				trafficking area, if the Executive Board for such area, region, or partnership,
				does not apportion an equal number of votes between representatives of
				participating Federal agencies and representatives of participating State and
				local agencies. Where it is impractical for an equal number of representatives
				of Federal agencies and State and local agencies to attend a meeting of an
				Executive Board in person, the Executive Board may use a system of proxy votes
				or weighted votes to achieve the voting balance required by this
				paragraph.</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID594AB37B5D1C4EAD9FA2F43CAE16EB1E"><enum>(4)</enum><header>No agency
				relationship</header><text display-inline="yes-display-inline">The eligibility
				requirements of this section are intended to ensure the responsible use of
				Federal funds. Nothing in this section is intended to create an agency
				relationship between individual high intensity drug trafficking areas and the
				Federal Government.</text>
							</paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="ID3A74129696F34377BF325D3812D0492F"><enum>(f)</enum><header>Use of
				Funds</header><text display-inline="yes-display-inline">The Director shall
				ensure that no Federal funds appropriated for the Program are expended for the
				establishment or expansion of drug treatment programs, and shall ensure that
				not more than 5 percent of the Federal funds appropriated for the Program are
				expended for the establishment of drug prevention programs.</text>
						</subsection><subsection commented="no" display-inline="no-display-inline" id="IDAAD81E2A949443DF8250194F330EF179"><enum>(g)</enum><header>Counterterrorism
				Activities</header>
							<paragraph commented="no" display-inline="no-display-inline" id="ID9B0E83A2B0EA41EA9500280271B9EA80"><enum>(1)</enum><header>Assistance
				authorized</header><text display-inline="yes-display-inline">The Director may
				authorize use of resources available for the Program to assist Federal, State,
				and local law enforcement agencies in investigations and activities related to
				terrorism and prevention of terrorism, especially but not exclusively with
				respect to such investigations and activities that are also related to drug
				trafficking.</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID3945CB8D462E4261BDB42F30A5D165E4"><enum>(2)</enum><header>Limitation</header><text display-inline="yes-display-inline">The Director shall ensure—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="ID4BCDC12B31A54C7DAEA1B9B63AA3D975"><enum>(A)</enum><text display-inline="yes-display-inline">that assistance provided under paragraph
				(1) remains incidental to the purpose of the Program to reduce drug
				availability and carry out drug-related law enforcement activities; and</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID203696C3C9184C0A83C5EF080B6C8921"><enum>(B)</enum><text display-inline="yes-display-inline">that significant resources of the Program
				are not redirected to activities exclusively related to terrorism, except on a
				temporary basis under extraordinary circumstances, as determined by the
				Director.</text>
								</subparagraph></paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="IDDDB98FF3242046A3AD6F5449EB3A4FF8"><enum>(h)</enum><header>Role of Drug
				Enforcement Administration</header><text display-inline="yes-display-inline">The Director, in consultation with the
				Attorney General, shall ensure that a representative of the Drug Enforcement
				Administration is included in the Intelligence Support Center for each high
				intensity drug trafficking area.</text>
						</subsection><subsection commented="no" display-inline="no-display-inline" id="ID6E27FB5BC2B24153AF72C3B9403A14E6"><enum>(i)</enum><header>Annual HIDTA
				Program Budget Submissions</header><text display-inline="yes-display-inline">As
				part of the documentation that supports the President’s annual budget request
				for the Office, the Director shall submit to Congress a budget justification
				that includes—</text>
							<paragraph commented="no" display-inline="no-display-inline" id="ID7210E686C5FF442B8BB228B325215F77"><enum>(1)</enum><text display-inline="yes-display-inline">the amount requested for each high
				intensity drug trafficking area, with supporting narrative descriptions and
				rationale for each request; and</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID55A3AF7917984B348A15055D522F0F32"><enum>(2)</enum><text display-inline="yes-display-inline">a detailed justification for each funding
				request that explains—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="idD666BA17E4B8478FA0DF4B35E2B40721"><enum>(A)</enum><text display-inline="yes-display-inline">the reasons for the requested funding
				level; how such funding level was determined based on a current assessment of
				the drug trafficking threat in each high intensity drug trafficking
				area;</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id5319FF6CF2844BBBB1646AA84485F71E"><enum>(B)</enum><text display-inline="yes-display-inline">how such funding will ensure that the goals
				and objectives of each such area will be achieved; and</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="id5211E7C648134CAF895900D511833843"><enum>(C)</enum><text display-inline="yes-display-inline">how such funding supports the National Drug
				Control Strategy.</text>
								</subparagraph></paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="ID046EC1D17CF34B14BF7A59CB0DEEBE9E"><enum>(j)</enum><header>Emerging Threat
				Response Fund</header>
							<paragraph commented="no" display-inline="no-display-inline" id="ID5769809175B54A26A1FADBD900F77C9B"><enum>(1)</enum><header>In
				general</header><text display-inline="yes-display-inline">Subject to the
				availability of appropriations, the Director may expend up to 10 percent of the
				amounts appropriated under this section on a discretionary basis, to respond to
				any emerging drug trafficking threat in an existing high intensity drug
				trafficking area, or to establish a new high intensity drug trafficking area or
				expand an existing high intensity drug trafficking area, in accordance with the
				criteria established under paragraph (2).</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDCD4B8AB946EB4C33B4F6B337FDC28EC2"><enum>(2)</enum><header>Consideration of
				impact</header><text display-inline="yes-display-inline">In allocating funds
				under this subsection, the Director shall consider—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="IDF13B1E9786AA4A11ABC056EAABB769A2"><enum>(A)</enum><text display-inline="yes-display-inline">the impact of activities funded on reducing
				overall drug traffic in the United States, or minimizing the probability that
				an emerging drug trafficking threat will spread to other areas of the United
				States; and</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDF112406437E34EE89FAAE4232CDFFDFC"><enum>(B)</enum><text display-inline="yes-display-inline">such other criteria as the Director
				considers appropriate.</text>
								</subparagraph></paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="IDA571B4772B5B447F8487696F01FFE613"><enum>(k)</enum><header>Evaluation</header>
							<paragraph commented="no" display-inline="no-display-inline" id="IDD594B4E918E542AEB21C072C5F50AD10"><enum>(1)</enum><header>Initial
				report</header><text display-inline="yes-display-inline">Not later than 90 days
				after the date of the enactment of this section, the Director shall, after
				consulting with the Executive Boards of each designated high intensity drug
				trafficking area, submit a report to Congress that describes, for each
				designated high intensity drug trafficking area—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="ID036FC5505C044175BB638C30E3821016"><enum>(A)</enum><text display-inline="yes-display-inline">the specific purposes for the high
				intensity drug trafficking area;</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDF5B7DF2A8B9744529081E055DF9ADC80"><enum>(B)</enum><text display-inline="yes-display-inline">the specific long-term and short-term goals
				and objectives for the high intensity drug trafficking area;</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDB5A7FB6A7F024B4B8C6BEDF760415E92"><enum>(C)</enum><text display-inline="yes-display-inline">the measurements that will be used to
				evaluate the performance of the high intensity drug trafficking area in
				achieving the long-term and short-term goals; and</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID30D90905360640E18FD246E7390830FE"><enum>(D)</enum><text display-inline="yes-display-inline">the reporting requirements needed to
				evaluate the performance of the high intensity drug trafficking area in
				achieving the long-term and short-term goals.</text>
								</subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDDCB2AF4674B849C896FECB084AF695FD"><enum>(2)</enum><header>Evaluation of
				hidta program as part of national drug control strategy</header><text display-inline="yes-display-inline">For each designated high intensity drug
				trafficking area, the Director shall submit, as part of the annual National
				Drug Control Strategy report, a report that—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="ID91E10853F48347B4A295CC4679A90DFC"><enum>(A)</enum><text display-inline="yes-display-inline">describes—</text>
									<clause commented="no" display-inline="no-display-inline" id="ID7AA257F4A5A24372B8CD60F0D9A83B8C"><enum>(i)</enum><text display-inline="yes-display-inline">the specific purposes for the high
				intensity drug trafficking area; and</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="IDA1ED4957EE3B46BD8E2B09F848C6D9AB"><enum>(ii)</enum><text display-inline="yes-display-inline">the specific long-term and short-term goals
				and objectives for the high intensity drug trafficking area; and</text>
									</clause></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID3F54944C00C84E6289B514F9C026D889"><enum>(B)</enum><text display-inline="yes-display-inline">includes an evaluation of the performance
				of the high intensity drug trafficking area in accomplishing the specific
				long-term and short-term goals and objectives identified under paragraph
				(1)(B).</text>
								</subparagraph></paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="ID0247B94517B64DBEA3A11EB22DD86441"><enum>(l)</enum><header>Assessment of
				Drug Enforcement Task Forces in High Intensity Drug Trafficking
				Areas</header><text display-inline="yes-display-inline">Not later than 180 days
				after the date of enactment of this subsection, and as part of each subsequent
				annual National Drug Control Strategy report, the Director shall submit to
				Congress a report—</text>
							<paragraph commented="no" display-inline="no-display-inline" id="ID72B9688EF07D494894DB23A5EBF06E36"><enum>(1)</enum><text display-inline="yes-display-inline">assessing the number and operation of all
				federally funded drug enforcement task forces within each high intensity drug
				trafficking area; and</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID4DC8484EDA14458D971EC0930104E751"><enum>(2)</enum><text display-inline="yes-display-inline">describing—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="IDAD969ADD28194CDAB0EA42E00BEA0D5F"><enum>(A)</enum><text display-inline="yes-display-inline">each Federal, State, and local drug
				enforcement task force operating in the high intensity drug trafficking
				area;</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDDE4ED3E741E84E36AD687C38F06DE832"><enum>(B)</enum><text display-inline="yes-display-inline">how such task forces coordinate with each
				other, with any high intensity drug trafficking area task force, and with
				investigations receiving funds from the Organized Crime and Drug Enforcement
				Task Force;</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID04308D32154C40D8957FC0831B37AB20"><enum>(C)</enum><text display-inline="yes-display-inline">what steps, if any, each such task force
				takes to share information regarding drug trafficking and drug production with
				other federally funded drug enforcement task forces in the high intensity drug
				trafficking area;</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID2ABCE912329D49419EC4FDE089F669C3"><enum>(D)</enum><text display-inline="yes-display-inline">the role of the high intensity drug
				trafficking area in coordinating the sharing of such information among task
				forces;</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID225F26DFA9F44C179502A66E03E4D58B"><enum>(E)</enum><text display-inline="yes-display-inline">the nature and extent of cooperation by
				each Federal, State, and local participant in ensuring that such information is
				shared among law enforcement agencies and with the high intensity drug
				trafficking area;</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDA5FE3AE43A884768B92360FC5B4B3299"><enum>(F)</enum><text display-inline="yes-display-inline">the nature and extent to which information
				sharing and enforcement activities are coordinated with joint terrorism task
				forces in the high intensity drug trafficking area; and</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDE41CAE50CC0743B4A18BF22D2C4B803A"><enum>(G)</enum><text display-inline="yes-display-inline">any recommendations for measures needed to
				ensure that task force resources are utilized efficiently and effectively to
				reduce the availability of illegal drugs in the high intensity drug trafficking
				areas.</text>
								</subparagraph></paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="ID0907ED95095C4D25A27393D982C6C359"><enum>(m)</enum><header>Assessment of
				Intelligence Sharing in High Intensity Drug Trafficking Areas
				program</header><text display-inline="yes-display-inline">Not later than 180
				days after the date of the enactment of this section, and as part of each
				subsequent annual National Drug Control Strategy report, the Director, in
				consultation with the Director of National Intelligence, shall submit to
				Congress a report—</text>
							<paragraph commented="no" display-inline="no-display-inline" id="IDB40374EAE44C4CF8A2517AC23663CF02"><enum>(1)</enum><text display-inline="yes-display-inline">evaluating existing and planned
				intelligence systems supported by each high intensity drug trafficking area, or
				utilized by task forces receiving any funding under the Program, including the
				extent to which such systems ensure access and availability of intelligence to
				Federal, State, and local law enforcement agencies within the high intensity
				drug trafficking area and outside of it;</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID97A40B650F2E4CDE8E3B9AA5FC2169B8"><enum>(2)</enum><text display-inline="yes-display-inline">the extent to which Federal, State, and
				local law enforcement agencies participating in each high intensity drug
				trafficking area are sharing intelligence information to assess current drug
				trafficking threats and design appropriate enforcement strategies; and</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDF14E0416E09443419675B5EACAC4FE43"><enum>(3)</enum><text display-inline="yes-display-inline">the measures needed to improve effective
				sharing of information and intelligence regarding drug trafficking and drug
				production among Federal, State, and local law enforcement participating in a
				high intensity drug trafficking area, and between such agencies and similar
				agencies outside the high intensity drug trafficking area.</text>
							</paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="ID7019BF604E734CD6A9703E83EB7FF151"><enum>(n)</enum><header>Coordination of
				Intelligence Sharing With Organized Crime Drug Enforcement Task Force
				Program</header><text display-inline="yes-display-inline">The Director, in
				consultation with the Attorney General, shall ensure that any drug enforcement
				intelligence obtained by the Intelligence Support Center for each high
				intensity drug trafficking area is shared, on a timely basis, with the drug
				intelligence fusion center operated by the Organized Crime Drug Enforcement
				Task Force of the Department of Justice.</text>
						</subsection><subsection commented="no" display-inline="no-display-inline" id="IDCEAA893D606F478A8F3C2D6B7AFC99B1"><enum>(o)</enum><header>Use of Funds to
				Combat Methamphetamine Trafficking</header>
							<paragraph commented="no" display-inline="no-display-inline" id="IDE6B364AC25754C2C9E7BD515A3EB0BB1"><enum>(1)</enum><header>In
				general</header>
								<subparagraph commented="no" display-inline="no-display-inline" id="IDB91BD893231B4E19A854A3B8D095FF93"><enum>(A)</enum><header>Requirement</header><text display-inline="yes-display-inline">The Director shall ensure that, of the
				amounts appropriated for a fiscal year for the Program, at least $15,000,000 is
				allocated to combat the trafficking of methamphetamine in areas designated by
				the Director as high intensity drug trafficking areas.</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDB3B011204C814CDEA7837FC431496337"><enum>(B)</enum><header>Activities</header><text display-inline="yes-display-inline">In meeting the requirement in subparagraph
				(A), the Director shall transfer funds to appropriate Federal, State, and local
				governmental agencies for employing additional Federal law enforcement
				personnel, or facilitating the employment of additional State and local law
				enforcement personnel, including agents, investigators, prosecutors, laboratory
				technicians, chemists, investigative assistants, and drug prevention
				specialists.</text>
								</subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID72F52C23B37048ED8FA9BEA5BA4014D1"><enum>(2)</enum><header>Apportionment of
				funds</header>
								<subparagraph commented="no" display-inline="no-display-inline" id="ID141658384FA4454BA123A63682BF78C3"><enum>(A)</enum><header>Factors in
				apportionment</header><text display-inline="yes-display-inline">The Director
				shall apportion amounts allocated under paragraph (1) among areas designated by
				the Director as high intensity drug trafficking areas based on the following
				factors:</text>
									<clause commented="no" display-inline="no-display-inline" id="ID2447AFB625714FF8A535A2294410E7C1"><enum>(i)</enum><text display-inline="yes-display-inline">The number of methamphetamine manufacturing
				facilities discovered by Federal, State, or local law enforcement officials in
				the area during the previous fiscal year.</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="ID86A04BFBC154499DAC7FA049B9057F48"><enum>(ii)</enum><text display-inline="yes-display-inline">The number of methamphetamine prosecutions
				in Federal, State, or local courts in the area during the previous fiscal
				year.</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="ID32CB9B0F5D4A4A1F8779662059484B3F"><enum>(iii)</enum><text display-inline="yes-display-inline">The number of methamphetamine arrests by
				Federal, State, or local law enforcement officials in the area during the
				previous fiscal year.</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="ID14CF4C2242C14109B53F87BB26A8ECFA"><enum>(iv)</enum><text display-inline="yes-display-inline">The amounts of methamphetamine or listed
				chemicals (as that term is defined in section 102(33) of the
				<act-name parsable-cite="CSA">Controlled Substances Act</act-name> (21 U.S.C.
				802(33)) seized by Federal, State, or local law enforcement officials in the
				area during the previous fiscal year.</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="ID60398F45528540E88B176C2779482DF5"><enum>(v)</enum><text display-inline="yes-display-inline">Intelligence and predictive data from the
				Drug Enforcement Administration showing patterns and trends in abuse,
				trafficking, and transportation in methamphetamine and listed chemicals (as
				that term is so defined).</text>
									</clause></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDDE895E73268F41668E7FA4B410D7DBA5"><enum>(B)</enum><header>Certification</header><text display-inline="yes-display-inline">Before the Director apportions any funds
				under this paragraph to a high intensity drug trafficking area, the Director
				shall certify that the law enforcement entities responsible for clandestine
				methamphetamine laboratory seizures in that area are providing laboratory
				seizure data to the national clandestine laboratory database at the El Paso
				Intelligence Center.</text>
								</subparagraph></paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="IDCDB8CA568E6446968CAD9CA9E0BB223B"><enum>(p)</enum><header>Authorization of
				Appropriations</header><text display-inline="yes-display-inline">There is
				authorized to be appropriated to the Office of National Drug Control Policy to
				carry out this section—</text>
							<paragraph commented="no" display-inline="no-display-inline" id="ID36321688261F4A109C7863B712155450"><enum>(1)</enum><text display-inline="yes-display-inline">$280,000,000 for fiscal year 2007;</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID06A7BDCF16F440D6BDE47DCC0B827FF5"><enum>(2)</enum><text display-inline="yes-display-inline">$290,000,000 for each of fiscal years 2008
				and 2009; and</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID83F2B739BE0E4027B17E1157993C3DAA"><enum>(3)</enum><text display-inline="yes-display-inline">$300,000,000 for each of fiscal years 2010
				and
				2011.</text>
							</paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
			</section><section changed="deleted" commented="no" display-inline="no-display-inline" id="IDA00A8188F28F490FB1BF0B523F902349" reported-display-style="strikethrough" section-type="subsequent-section"><enum>302.</enum><header>Funding for certain
			 High Intensity Drug Trafficking Areas</header>
				<subsection changed="deleted" commented="no" display-inline="no-display-inline" id="IDA2829360DD9242CC9BA3AF3A69C13CAD" reported-display-style="strikethrough"><enum>(a)</enum><header>Short
			 Title</header><text display-inline="yes-display-inline">This section may be
			 cited as the <quote>Dawson Family Community Protection Act</quote>.</text>
				</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="IDB2199D42EDA34D17A153CCE89AD54CAE" reported-display-style="strikethrough"><enum>(b)</enum><header>Findings</header><text display-inline="yes-display-inline">Congress finds the following:</text>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDAF8D39D609444ABE875C5040191C068A" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">In the early morning hours of October 16,
			 2002, the home of Carnell and Angela Dawson was firebombed in apparent
			 retaliation for Mrs. Dawson’s notification to police about persistent drug
			 distribution activity in their East Baltimore City neighborhood.</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDAC7620F6D80742D18921D103A67CC32B" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">The arson claimed the lives of Mr. and Mrs.
			 Dawson and their 5 young children, aged 9 to 14.</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDE6E213391C6C41E9A6892EE9A8CA4105" reported-display-style="strikethrough"><enum>(3)</enum><text display-inline="yes-display-inline">The horrific murder of the Dawson family is
			 a stark example of domestic narco-terrorism.</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDE30ADABA5D004ADF83AE65F7EFC42ADC" reported-display-style="strikethrough"><enum>(4)</enum><text display-inline="yes-display-inline">In all phases of counternarcotics law
			 enforcement—from prevention to investigation to prosecution to reentry—the
			 voluntary cooperation of ordinary citizens is a critical component.</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDD2F706BFC85C45899A01A627DB7C0FA7" reported-display-style="strikethrough"><enum>(5)</enum><text display-inline="yes-display-inline">Voluntary cooperation is difficult for law
			 enforcement officials to obtain when citizens feel that cooperation carries the
			 risk of violent retaliation by illegal drug trafficking organizations and their
			 affiliates.</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID3450DDCD5F6245D7AEBF9BBD12802564" reported-display-style="strikethrough"><enum>(6)</enum><text display-inline="yes-display-inline">Public confidence that law enforcement is
			 doing all it can to make communities safe is a prerequisite for voluntary
			 cooperation among people who may be subject to intimidation or reprisal (or
			 both).</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDF2337390F1D943D680B0551A8E473E17" reported-display-style="strikethrough"><enum>(7)</enum><text display-inline="yes-display-inline">Witness protection programs are
			 insufficient on their own to provide security because many individuals and
			 families who strive every day to make distressed neighborhoods livable for
			 their children, other relatives, and neighbors will resist or refuse offers of
			 relocation by local, State, and Federal prosecutorial agencies and because,
			 moreover, the continued presence of strong individuals and families is critical
			 to preserving and strengthening the social fabric in such communities.</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID0808F0696B7A4E46BE6C89BFCD05F3DE" reported-display-style="strikethrough"><enum>(8)</enum><text display-inline="yes-display-inline">Where (as in certain sections of Baltimore
			 City) interstate trafficking of illegal drugs has severe ancillary local
			 consequences within areas designated as high intensity drug trafficking areas,
			 it is important that supplementary High Intensity Drug Trafficking Areas
			 Program funds be committed to support initiatives aimed at making the affected
			 communities safe for the residents of those communities and encouraging their
			 cooperation with local, State, and Federal law enforcement efforts to combat
			 illegal drug trafficking.</text>
					</paragraph></subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID716B526A85AA43329A74AC7783E0F4A9" reported-display-style="strikethrough"><enum>(c)</enum><header>Funding for
			 Certain High Intensity Drug Trafficking Areas</header><text display-inline="yes-display-inline">Section 707, as amended by section 301, is
			 amended by adding at the end the following:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="ID87304D9496F64AE6B153D5E0F5CAAB66" reported-display-style="strikethrough" style="OLC">
						<subsection commented="no" display-inline="no-display-inline" id="IDF9A490CD297B423794E50833BCCCEFEB"><enum>(q)</enum><header>Specific
				Purposes</header>
							<paragraph commented="no" display-inline="no-display-inline" id="ID362EC18F091E4887BFAC97927FE7BEF5"><enum>(1)</enum><header>In
				general</header><text display-inline="yes-display-inline">The Director shall
				ensure that, of the amounts appropriated for a fiscal year for the Program, at
				least $7,000,000 is used in high intensity drug trafficking areas with severe
				neighborhood safety and illegal drug distribution problems.</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID18388453FC354F48B15DC6F3423CC635"><enum>(2)</enum><header>Required
				uses</header><text display-inline="yes-display-inline">The funds used under
				paragraph (1) shall be used—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="ID6C1BFD2FB1DF4674B8B7FC7B0EB8FF0E"><enum>(A)</enum><text display-inline="yes-display-inline">to ensure the safety of neighborhoods and
				the protection of communities, including the prevention of the intimidation of
				potential witnesses of illegal drug distribution and related activities;
				and</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDA8C692343F8142508D7BD97CDAEFA223"><enum>(B)</enum><text display-inline="yes-display-inline">to combat illegal drug trafficking through
				such methods as the Director considers appropriate, such as establishing or
				operating (or both) a toll-free telephone hotline for use by the public to
				provide information about illegal drug-related
				activities.</text>
								</subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection></section><section changed="deleted" commented="no" display-inline="no-display-inline" id="ID5B94BD41E2BA44D7B5E17AD2CF9EC6A1" reported-display-style="strikethrough" section-type="subsequent-section"><enum>303.</enum><header>Assessment</header><text display-inline="no-display-inline">The Director shall assess the ability of the
			 HIDTA Program to respond to the so-called <quote>balloon effect</quote>,
			 whereby urban drug traffickers facing intensive law enforcement efforts expand
			 and spread their trafficking and distribution into rural, suburban, and smaller
			 urban areas by conducting a demonstration project examining the ability of the
			 New York/New Jersey HIDTA, with its new single colocated Organized Crime and
			 Drug Enforcement Task Force/High Intensity Drug Trafficking Area Strike Force
			 and HIDTA Regional Intelligence Center, to address the movement of drug
			 traffickers into the more rural, suburban, and smaller areas encompassed by the
			 counties of Albany, Onondaga, Monroe, and Erie in New York State and by
			 annexing these counties into the existing New York/New Jersey HIDTA.</text>
			</section></title><title changed="deleted" commented="no" id="id341C3F6997194589A2D9908F05648616" reported-display-style="strikethrough" style="OLC"><enum>IV</enum><header>Technology</header>
			<section changed="deleted" commented="no" display-inline="no-display-inline" id="IDCCA08B584F7D47D594E823FE435E58D7" reported-display-style="strikethrough" section-type="subsequent-section"><enum>401.</enum><header>Counterdrug
			 Technology Assessment Center</header>
				<subsection changed="deleted" commented="no" display-inline="no-display-inline" id="IDACC34D5F7C2144E3BF6190800B2D627C" reported-display-style="strikethrough"><enum>(a)</enum><header>Chief
			 Scientist</header><text display-inline="yes-display-inline">Section 708(b) is
			 amended to read as follows:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="ID536BFE64450A4628ACBD7084AD7F5E16" reported-display-style="strikethrough" style="OLC">
						<subsection commented="no" display-inline="no-display-inline" id="ID3FEDF419DB3A476390E80D72DA825ED2"><enum>(b)</enum><header>Chief
				Scientist</header><text display-inline="yes-display-inline">There shall be at
				the head of the Center the Chief Scientist, who shall be appointed by the
				Director from among individuals qualified and distinguished in the area of
				science, medicine, engineering, or
				technology.</text>
						</subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID331EE338E69B4FAC981F468D376B6334" reported-display-style="strikethrough"><enum>(b)</enum><header>Responsibilities</header>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDB654EBB0F4C34CF7A0F88497F9997085" reported-display-style="strikethrough"><enum>(1)</enum><header>Research and
			 development</header><text display-inline="yes-display-inline">Section 708 is
			 amended by—</text>
						<subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID5C5FF1FF57B940A4A45B3897F18B18A5" reported-display-style="strikethrough"><enum>(A)</enum><text display-inline="yes-display-inline">redesignating subsection (d) as subsection
			 (e); and</text>
						</subparagraph><subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID9F09D7A28B564C61BDB9AAE63BDEA528" reported-display-style="strikethrough"><enum>(B)</enum><text display-inline="yes-display-inline">striking subsection (c) and inserting the
			 following:</text>
							<quoted-block changed="deleted" display-inline="no-display-inline" id="ID86C62E7C9E4544219B0CC49182E6E670" reported-display-style="strikethrough" style="OLC">
								<subsection commented="no" display-inline="no-display-inline" id="ID03D0D5CF865C4E1999F396E46D53BBE0"><enum>(c)</enum><header>Research and
				Development Responsibilities</header><text display-inline="yes-display-inline">The Chief Scientist shall be responsible to
				the Director for—</text>
									<paragraph commented="no" display-inline="no-display-inline" id="ID5C726C303B824DC79AA290E349F78476"><enum>(1)</enum><text display-inline="yes-display-inline">identifying and defining the short-,
				medium-, and long-term scientific and technological needs of Federal, State,
				and local drug supply reduction agencies, including—</text>
										<subparagraph commented="no" display-inline="no-display-inline" id="IDDEE3D0228E3A47D08DA45FF33EBCA516"><enum>(A)</enum><text display-inline="yes-display-inline">advanced surveillance, tracking, and radar
				imaging;</text>
										</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID294875FB64E4456CB3F80AE4CAD601BB"><enum>(B)</enum><text display-inline="yes-display-inline">electronic support measures;</text>
										</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID62EBFF37CF7745C6AA8BADFE4B71889C"><enum>(C)</enum><text display-inline="yes-display-inline">communications;</text>
										</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID0615FB4329164CCBB8A2D2D87700B48A"><enum>(D)</enum><text display-inline="yes-display-inline">data fusion, advanced computer systems, and
				artificial intelligence; and</text>
										</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID105690453E5E43C3B6F30C87467B9888"><enum>(E)</enum><text display-inline="yes-display-inline">chemical, biological, radiological
				(including neutron and electron), and other means of detection;</text>
										</subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID28C11220528C4CA49C54BB05C22A2299"><enum>(2)</enum><text display-inline="yes-display-inline">identifying demand reduction basic and
				applied research needs and initiatives, in consultation with affected National
				Drug Control Program agencies, including—</text>
										<subparagraph commented="no" display-inline="no-display-inline" id="ID5CF18D3F88974908BD62117585EAC3F3"><enum>(A)</enum><text display-inline="yes-display-inline">improving treatment through neuroscientific
				advances;</text>
										</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID96342B38E20B46B4A2BF3A676CFD1501"><enum>(B)</enum><text display-inline="yes-display-inline">improving the transfer of biomedical
				research to the clinical setting; and</text>
										</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID35F6EFB0D4574546A37A9BD9ACBBEDF0"><enum>(C)</enum><text display-inline="yes-display-inline">in consultation with the National Institute
				of Drug Abuse, and through interagency agreements or grants, examining
				addiction and rehabilitation research and the application of technology to
				expanding the effectiveness and availability of drug treatment;</text>
										</subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID13B639EE06FF48178B89FAB580C29CCB"><enum>(3)</enum><text display-inline="yes-display-inline">making a priority ranking of such needs
				identified in paragraphs (1) and (2) according to fiscal and technological
				feasibility, as part of a National Counterdrug Research and Development
				Program;</text>
									</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID387DB4BAD0A8459D812FB6A240521196"><enum>(4)</enum><text display-inline="yes-display-inline">overseeing and coordinating counterdrug
				technology initiatives with related activities of other Federal civilian and
				military departments;</text>
									</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID151203CE727F479EBEBEA8AEA6A1ED24"><enum>(5)</enum><text display-inline="yes-display-inline">providing support to the development and
				implementation of the national drug control performance measurement system
				established under subsection (c) of section 706; and</text>
									</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDBD94DCF3D7C540969E7418546928B6F1"><enum>(6)</enum><text display-inline="yes-display-inline">transferring funds made available to a
				National Drug Control Program Agency for counterdrug technology research and
				development to another account within such agency or to another National Drug
				Control Program Agency for counterdrug technology research and development,
				pursuant to the authority of the Director under section 704.</text>
									</paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="IDACA8835256DB4CDAB7DBAA59C9E64347"><enum>(d)</enum><header>Limitation on
				Authority</header><text display-inline="yes-display-inline">The authority
				granted to the Director under this section shall not extend to the awarding of
				contracts, management of individual projects, or other operational
				activities.</text>
								</subsection><after-quoted-block>.</after-quoted-block></quoted-block>
						</subparagraph></paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID7D26A36521004A8487F0287EC3C0E3EE" reported-display-style="strikethrough"><enum>(2)</enum><header>Assistance and
			 support</header><text display-inline="yes-display-inline">Subsection (e) of
			 section 708, as redesignated by this section, is amended to read as
			 follows:</text>
						<quoted-block changed="deleted" display-inline="no-display-inline" id="IDBF8D4A4508F042CA92B39FC261910EB8" reported-display-style="strikethrough" style="OLC">
							<subsection commented="no" display-inline="no-display-inline" id="ID6C443AD5F8EE4640B799C5954CCFF036"><enum>(e)</enum><header>Assistance and
				Support to the Office of National Drug Control Policy</header><text display-inline="yes-display-inline">The Secretary of Defense, the Secretary of
				Homeland Security, and the Secretary of Health and Human Services shall, to the
				maximum extent practicable, render assistance and support to the Office and to
				the Director in the conduct of counterdrug technology
				assessment.</text>
							</subsection><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID57458BAB63584E4DBF42ED340D8DD8A2" reported-display-style="strikethrough"><enum>(3)</enum><header>Technology
			 transfer program</header><text display-inline="yes-display-inline">Section 708
			 is amended by adding at the end the following:</text>
						<quoted-block changed="deleted" display-inline="no-display-inline" id="ID91CC9C01DB744207AEEF3ACF1499B307" reported-display-style="strikethrough" style="OLC">
							<subsection commented="no" display-inline="no-display-inline" id="ID6DE494120A834EE7BAA65C203F2530E0"><enum>(f)</enum><header>Technology
				Transfer Program</header>
								<paragraph commented="no" display-inline="no-display-inline" id="IDC7ECAA82F2D840D38441441A31688AE2"><enum>(1)</enum><header>Program</header><text display-inline="yes-display-inline">The Chief Scientist, with the advice and
				counsel of experts from State and local law enforcement agencies, shall be
				responsible to the Director for coordination and implementation of a
				counterdrug technology transfer program.</text>
								</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDFE6F0C08C294412CB0D1DF22F0E1A9B7"><enum>(2)</enum><header>Purpose</header><text display-inline="yes-display-inline">The purpose of the Technology Transfer
				Program shall be for the Counterdrug Technology Assessment Center to transfer
				technology and associated training directly to State and local law enforcement
				agencies.</text>
								</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID54E37765C6A44E80AB062A8FC688D862"><enum>(3)</enum><header>Priority of
				receipts</header><text display-inline="yes-display-inline">Transfers shall be
				made in priority order based on—</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="ID95A849D1EA764133B3517AE55137DDE4"><enum>(A)</enum><text display-inline="yes-display-inline">the need of potential recipients for such
				technology;</text>
									</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDF9C55044798D4B3CBE1A1AAEFA3B4229"><enum>(B)</enum><text display-inline="yes-display-inline">the effectiveness of the technology to
				enhance current counterdrug activities of potential recipients; and</text>
									</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID5C945BEC8FA546DDB767B52C675F6C61"><enum>(C)</enum><text display-inline="yes-display-inline">the ability and willingness of potential
				recipients to evaluate transferred technology.</text>
									</subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID887FF7FDA9B045019AF2379D6E150165"><enum>(4)</enum><header>Agreement
				authority</header><text display-inline="yes-display-inline">The Director may
				enter into an agreement with the Secretary of Homeland Security to transfer
				technology with both counterdrug and homeland security applications to State
				and local law enforcement agencies on a reimbursable basis.</text>
								</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID23BEFD9C6A5148E9A780A97B247AAB0D"><enum>(5)</enum><header>Report</header><text display-inline="yes-display-inline">On or before July 1 of each year, the
				Director shall submit a report to the appropriate congressional committees
				which addresses the following:</text>
									<subparagraph commented="no" display-inline="no-display-inline" id="IDDDF028B449A149CE958D67437D005E22"><enum>(A)</enum><text display-inline="yes-display-inline">The number of requests received during the
				previous 12 months.</text>
									</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID3BFE551259DE42D891CB8E40A1A4F08B"><enum>(B)</enum><text display-inline="yes-display-inline">The number of requests fulfilled during the
				previous 12 months.</text>
									</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID19D9DB3FD9FD4EF1905CEE69DFCDDBCC"><enum>(C)</enum><text display-inline="yes-display-inline">A summary of the criteria used in making
				the determination on what requests were funded and what requests were not
				funded.</text>
									</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID54F78D32BF1447FDB0B54D0707B3DD37"><enum>(D)</enum><text display-inline="yes-display-inline">A general assessment of the future needs of
				the program, based on expected changes in threats, expected technologies, and
				likely need from potential recipients.</text>
									</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID9717C36DC06549D890FA4314ED319C01"><enum>(E)</enum><text display-inline="yes-display-inline">An assessment of the effectiveness of the
				technologies transferred, based in part on the evaluations provided by the
				recipients, with a recommendation whether the technology should continue to be
				offered through the
				program.</text>
									</subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph></subsection></section></title><title changed="deleted" commented="no" id="IDDF37CABF46E5434BA5EEC48EF5392360" reported-display-style="strikethrough" style="OLC"><enum>V</enum><header>REAUTHORIZATION AND IMPROVEMENT OF THE
			 NATIONAL ANTI-DRUG MEDIA CAMPAIGN</header>
			<section changed="deleted" commented="no" display-inline="no-display-inline" id="ID059FE2AC6F714CE5BCB361C07D193CA2" reported-display-style="strikethrough" section-type="subsequent-section"><enum>501.</enum><header>Short
			 title</header><text display-inline="no-display-inline">This title may be cited
			 as the <quote><short-title>National Youth Anti-Drug Media
			 Campaign Reauthorization Act of 2006</short-title></quote>.</text>
			</section><section changed="deleted" commented="no" display-inline="no-display-inline" id="ID788DC3CCDBB54FE9830D14E46E8BFA0B" reported-display-style="strikethrough" section-type="subsequent-section"><enum>502.</enum><header>Purposes of the
			 National Youth Anti-Drug Media Campaign</header><text display-inline="no-display-inline">The Drug-Free Media Campaign Act of 1998 (21
			 U.S.C. 1801 et seq.) is amended—</text>
				<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDAFDEADCD64864912B035DEF9F1DF30AB" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">in section 101, by striking
			 <quote>Drug-Free Media Campaign Act of 1998</quote> and inserting
			 <quote>National Youth Anti-Drug Media Campaign Act</quote>; and</text>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID1ED12723F6E1413286F797A12D637BD4" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">in section 102—</text>
					<subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID4D6AAD2C17C94AA9A2315640FC74ACF3" reported-display-style="strikethrough"><enum>(A)</enum><text display-inline="yes-display-inline">in subsection (a), by striking “national
			 media campaign” and all that follows through the period and inserting the
			 following: “national youth anti-drug media campaign (referred to in this
			 subtitle as the ‘national media campaign’) in accordance with this subtitle for
			 the purposes of—</text>
						<quoted-block changed="deleted" display-inline="no-display-inline" id="ID29AAD5C27DAE466EA59B4FC5E4F8093D" reported-display-style="strikethrough" style="OLC">
							<paragraph commented="no" display-inline="no-display-inline" id="ID71FA484B7BE94682A00AC09F4B9A3EC8"><enum>(1)</enum><text display-inline="yes-display-inline">preventing drug abuse among young people in
				the United States;</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDAB7C63B91D484E6DA79992182D55D3B5"><enum>(2)</enum><text display-inline="yes-display-inline">increasing awareness of adults of the
				impact of drug abuse on young people; and</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID13D2978A22AB409C868E57F224C752C2"><enum>(3)</enum><text display-inline="yes-display-inline">encouraging parents and other interested
				adults to discuss with young people the dangers of illegal drug
				use.</text>
							</paragraph><after-quoted-block>;
				and</after-quoted-block></quoted-block>
					</subparagraph><subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDF309BDAF6A7B459480881DA92011ED7A" reported-display-style="strikethrough"><enum>(B)</enum><text display-inline="yes-display-inline">in subsection (b), by striking
			 <quote>105</quote> and inserting <quote>104</quote>.</text>
					</subparagraph></paragraph></section><section changed="deleted" commented="no" display-inline="no-display-inline" id="ID60F61E9B57CC4D14B9617A3FD4A06D31" reported-display-style="strikethrough" section-type="subsequent-section"><enum>503.</enum><header>Roles and
			 responsibilities of the Director, the Partnership for a Drug-Free America, and
			 a media buying contractor</header><text display-inline="no-display-inline">The
			 Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 et seq.) is
			 amended—</text>
				<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDF57831402BE94E3E970E6125CD0899C7" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">by adding at the end the following:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="IDFD4C9FCB83A74D638243786E1531B6FB" reported-display-style="strikethrough" style="OLC">
						<subsection commented="no" display-inline="no-display-inline" id="ID63C003BB14BB45CFB3D9034C091C9EF2"><enum>(c)</enum><header>Division of
				Responsibilities and Functions Under the Program</header>
							<paragraph commented="no" display-inline="no-display-inline" id="IDF4377CA3550046FEA95FDA9864BA1F38"><enum>(1)</enum><header>In
				general</header><text display-inline="yes-display-inline">The Director, in
				consultation with the Partnership for a Drug-Free America, shall determine the
				overall purposes and strategy of the national media campaign.</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDF9557FBF10D349D0A2C45D35ED9B5843"><enum>(2)</enum><header>Responsibilities</header>
								<subparagraph commented="no" display-inline="no-display-inline" id="IDAC059C5AA28D418A8C3C4A83AB6F34AF"><enum>(A)</enum><header>Director</header><text display-inline="yes-display-inline">The Director shall be responsible for
				implementing a focused national media campaign to meet the purposes set forth
				in section 102(a), and shall approve—</text>
									<clause commented="no" display-inline="no-display-inline" id="ID6D8F5EA076254F148369E50B7AA01440"><enum>(i)</enum><text display-inline="yes-display-inline">the strategy of the national media
				campaign;</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="IDE2595ED788654DAA86C230E2940B49A3"><enum>(ii)</enum><text display-inline="yes-display-inline">all advertising and promotional material
				used in the national media campaign; and</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="ID27FDB4043BB24B7783818E209C3E5473"><enum>(iii)</enum><text display-inline="yes-display-inline">the plan for the purchase of advertising
				time and space for the national media campaign.</text>
									</clause></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDA0FA4A3BE2B64FF19E30DA0D8BF50DAE"><enum>(B)</enum><header>The partnership
				for a drug-free america</header><text display-inline="yes-display-inline">The
				Director shall request that the Partnership for a Drug-Free America—</text>
									<clause commented="no" display-inline="no-display-inline" id="ID84195B9749514C36B86B34B4C5687BCF"><enum>(i)</enum><text display-inline="yes-display-inline">develop and recommend strategies to achieve
				the goals of the national media campaign, including addressing national and
				local drug threats in specific regions or States, such as methamphetamine and
				ecstasy;</text>
									</clause><clause commented="no" display-inline="no-display-inline" id="IDE6C70386046B4948AC6B18BE1BA09C2D"><enum>(ii)</enum><text display-inline="yes-display-inline">create all advertising to be used in the
				national media campaign, except advertisements that are—</text>
										<subclause commented="no" display-inline="no-display-inline" id="IDD1742537B642480EA59D64F4180EEBF4"><enum>(I)</enum><text display-inline="yes-display-inline">provided by other nonprofit entities
				pursuant to section 103(c);</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="IDFCB92B84236542CA9305AE5AEF5C4D12"><enum>(II)</enum><text display-inline="yes-display-inline">intended to reach a minority, ethnic, or
				other special audience that cannot be obtained at no cost (not including
				production costs and talent reuse payments), provided that any such advertising
				material is reviewed by the Partnership for a Drug-Free America; or</text>
										</subclause><subclause commented="no" display-inline="no-display-inline" id="ID8E0C23B9E1FE45FCB0B7FCF8B323A000"><enum>(III)</enum><text display-inline="yes-display-inline">any other advertisements that the
				Partnership for a Drug-Free America determines it is unable to provide.</text>
										</subclause></clause></subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID61CB0CB495424E13B3EBE4408EC14F4A"><enum>(C)</enum><header>Media buying
				contractor</header><text display-inline="yes-display-inline">The Director shall
				enter into a contract with a media buying contractor to plan and purchase
				advertising time and space for the national media campaign. The media buying
				contractor shall not provide any service or material, or conduct any function
				or activity which can be provided by the Partnership for a Drug-Free America,
				as defined in section 403(2)(B)</text>
								</subparagraph></paragraph></subsection><after-quoted-block>;
				and</after-quoted-block></quoted-block>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID5DDC02AB10144FA2B5AF57F65FDFA84B" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">in section 103—</text>
					<subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID258E0CFDD11445008B76F0B2B855A67F" reported-display-style="strikethrough"><enum>(A)</enum><text display-inline="yes-display-inline">in subparagraph (A), by inserting <quote>,
			 including the strategic planning for, and accounting of, such purchases</quote>
			 after <quote>space</quote>;</text>
					</subparagraph><subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID6C7D82F54E054F1CAACB2DB9E584F421" reported-display-style="strikethrough"><enum>(B)</enum><text display-inline="yes-display-inline">in subparagraph (C), by striking
			 <quote>out-of-pocket</quote>; and</text>
					</subparagraph><subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDFAFDF6DB26814882A4845D4F213E15FE" reported-display-style="strikethrough"><enum>(C)</enum><text display-inline="yes-display-inline">in subparagraph (F), by striking <quote>the
			 Office of National Drug Control Policy</quote> and inserting <quote>either the
			 Office of National Drug Control Policy or the designee of the
			 Office</quote>.</text>
					</subparagraph></paragraph></section><section changed="deleted" commented="no" display-inline="no-display-inline" id="IDFDF0CD38B2FF4EF1BB7A9FC1A1FC5838" reported-display-style="strikethrough" section-type="subsequent-section"><enum>504.</enum><header>Responsible use of
			 Federal funds for the National Youth Anti-Drug Media Campaign</header><text display-inline="no-display-inline">The Drug-Free Media Campaign Act of 1998 (21
			 U.S.C. 1801 et seq.) is amended—</text>
				<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID0ED3CFB2A6F94A088F882E964BEE8472" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">in section 103, by striking paragraph (2)
			 and inserting the following:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="ID1E527ED546D8429FA4DA83220F42E5C9" reported-display-style="strikethrough" style="OLC">
						<paragraph commented="no" display-inline="no-display-inline" id="ID7389F7DC128D40EC94C427CE7706B1C2"><enum>(2)</enum><header>Advertising</header>
							<subparagraph commented="no" display-inline="no-display-inline" id="ID6B2DB17BE47143468A51209A11509270"><enum>(A)</enum><header>In
				general</header><text display-inline="yes-display-inline">Except as provided in
				subparagraph (B), in carrying out this subtitle, the Director shall ensure that
				sufficient funds are allocated to meet the stated goals of the national media
				campaign.</text>
							</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDF1DF0601AD88412D91896FF7EF600682"><enum>(B)</enum><header>Exception</header><text display-inline="yes-display-inline">No funds shall be used for the creative
				development of advertisements (not including out-of-pocket production costs and
				talent reuse payments) except when—</text>
								<clause commented="no" display-inline="no-display-inline" id="IDFFA15BC53D164E9796FCD60A3DE92F02"><enum>(i)</enum><text display-inline="yes-display-inline">the advertisements are intended to reach a
				minority, ethnic, or other special audience that cannot be obtained at no cost
				(not including production costs and talent reuse payments); or</text>
								</clause><clause commented="no" display-inline="no-display-inline" id="ID89A4DF0A86E74C8F97653302AB4B1624"><enum>(ii)</enum><text display-inline="yes-display-inline">the Partnership for a Drug-Free America,
				determines that it is unable to provide such
				advertisements.</text>
								</clause></subparagraph></paragraph><after-quoted-block>;</after-quoted-block></quoted-block>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDA65DB3F917134272AFB3E0F50AEFB64E" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">in subsection (b), by striking
			 <quote>105</quote> and inserting <quote>104</quote>;</text>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDDF4F7AF40F6A45898F9FC59812727F7C" reported-display-style="strikethrough"><enum>(3)</enum><text display-inline="yes-display-inline">by striking subsection (c) and inserting
			 the following:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="ID627968725BAA4275AF4B6EF431EB744B" reported-display-style="strikethrough" style="OLC">
						<subsection commented="no" display-inline="no-display-inline" id="IDE92F35FABA034D81986B9645F4768ACF"><enum>(c)</enum><header>Matching
				Requirement</header>
							<paragraph commented="no" display-inline="no-display-inline" id="IDD4322ADBADFA4FDA92846D39E9B89D54"><enum>(1)</enum><header>No cost
				match</header>
								<subparagraph commented="no" display-inline="no-display-inline" id="IDB81743CF67AF4213828DC749AC7F1F3E"><enum>(A)</enum><header>In
				general</header><text display-inline="yes-display-inline">Except as provided in
				subparagraph (B), amounts made available for the national media campaign under
				section 106 shall be used to require a no cost match of equivalent value of
				advertising broadcast time, print space, or in-kind contributions to the
				national media campaign.</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID58B8E7CD74044FDFA8DE95ED5684799A"><enum>(B)</enum><header>Exception</header><text display-inline="yes-display-inline">The Director shall ensure that all no cost
				matches of advertising material, time, space, or in-kind contributions provided
				pursuant to subparagraph (A) directly relate to substance abuse prevention and
				specifically promote 1 or more of the specific purposes set forth in section
				102(a). This may include antismoking messages that are produced by nonprofit
				organizations and are targeted toward minors.</text>
								</subparagraph></paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID8035C4F66DAA4661A96CA94086C0902D"><enum>(2)</enum><header>Sponsorship
				identification</header><text display-inline="yes-display-inline">Any
				advertising material donated to the national media campaign at no cost shall
				not be subject to the sponsorship identification provisions in section 317 of
				the <act-name parsable-cite="CA34">Communications Act of 1934</act-name> (47
				U.S.C.
				317).</text>
							</paragraph></subsection><after-quoted-block>;</after-quoted-block></quoted-block>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDB001A99F346D457EB9F545325E462332" reported-display-style="strikethrough"><enum>(4)</enum><text display-inline="yes-display-inline">by adding at the end the following:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="id2B81ABE43B8041B199F2A13B9FE5A650" reported-display-style="strikethrough" style="OLC">
						<subsection commented="no" display-inline="no-display-inline" id="IDDCFC22E95F80405584C4888D343B5ED6"><enum>(d)</enum><header>Responsible Use
				of Federal Funds</header>
							<paragraph commented="no" display-inline="no-display-inline" id="ID8C195CA84CE74A37AEAAA4244A6FF246"><enum>(1)</enum><header>In
				general</header><text display-inline="yes-display-inline">The Director shall
				ensure that—</text>
								<subparagraph commented="no" display-inline="no-display-inline" id="ID4A17A024FD09406A90E48E8EA04F29DE"><enum>(A)</enum><text display-inline="yes-display-inline">for each fiscal year, not less than 77
				percent of the amounts appropriated under this subtitle shall be used for the
				activities allowed under section 103(a)(1)(A);</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="ID6FECC35B20044BABB2251EB97FFD0E42"><enum>(B)</enum><text display-inline="yes-display-inline">no Federal funds provided under this
				subtitle are used to pay any entity for any activity or service that
				duplicates, in whole or in part, any material, function, activity, or service
				provided by the Partnership for a Drug-Free America, as defined in section
				403(2)(B); and</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="IDF7AFE899E23F433895A06DB6443CCBF9"><enum>(C)</enum><text display-inline="yes-display-inline">no more than $5,000,000 is used in each
				fiscal year to develop advertising material pursuant to subsection
				(a)(2)(B)(ii).</text>
								</subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</paragraph></section><section changed="deleted" commented="no" display-inline="no-display-inline" id="ID11A8458174E04C2D9CEB943F4F1F5A53" reported-display-style="strikethrough" section-type="subsequent-section"><enum>505.</enum><header>Authorization for
			 National Youth Anti-Drug Media Campaign</header><text display-inline="no-display-inline">The Drug-Free Media Campaign Act of 1998 (21
			 U.S.C. 1801 et seq.) is amended by striking sections 104 and 105 and inserting
			 the following:</text>
				<quoted-block changed="deleted" display-inline="no-display-inline" id="id47D1BA6C84F44C009AB25554BB91E2FC" reported-display-style="strikethrough" style="OLC">
					<section commented="no" display-inline="no-display-inline" id="ID947E78E7B6534782B3764C8DE9B488E9" section-type="subsequent-section"><enum>104.</enum><header>Authorization
				of appropriations</header><text display-inline="no-display-inline">There is
				authorized to be appropriated to the Office of National Drug Control Policy to
				carry out this subtitle, $195,000,000 for each of the fiscal years 2006 through
				2010.</text>
					</section><after-quoted-block>.</after-quoted-block></quoted-block>
			</section></title><title changed="deleted" commented="no" id="ID8565E70265E3480CBC53F22722CD7A0C" reported-display-style="strikethrough" style="OLC"><enum>VI</enum><header>AUTHORIZATIONS AND EXTENSION OF TERMINATION
			 DATE</header>
			<section changed="deleted" commented="no" display-inline="no-display-inline" id="IDA51BBBB00B814870B2EFA99BD0E92FB3" reported-display-style="strikethrough" section-type="subsequent-section"><enum>601.</enum><header>Authorization of
			 appropriations</header><text display-inline="no-display-inline">Section 714 is
			 amended—</text>
				<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDAA9DC18AC91E4467A5E6509BD4B604FC" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">by striking <quote>title,</quote> and
			 inserting <quote>title except activities otherwise specified,</quote>;
			 and</text>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDABC0A1548D45406E96D11795EC430C4B" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">by striking <quote>1999 through
			 2003</quote> and inserting <quote>2006 through 2010</quote>.</text>
				</paragraph></section><section changed="deleted" commented="no" display-inline="no-display-inline" id="IDEA45D1B97F134692A8EF07302A192D91" reported-display-style="strikethrough" section-type="subsequent-section"><enum>602.</enum><header>Extension of
			 termination date</header><text display-inline="no-display-inline">Section
			 715(a) is amended by striking <quote>September 30, 2003, this title and the
			 amendments made by this title</quote> and inserting <quote>September 30, 2008,
			 this title and the amendments made to this title</quote>.</text>
			</section></title><title changed="deleted" commented="no" id="id0CAE4A04EAB34A8F9BD538C5668477B4" reported-display-style="strikethrough" style="OLC"><enum>VII</enum><header>Anti-Doping Agency</header>
			<section changed="deleted" commented="no" display-inline="no-display-inline" id="id2FF6687314614948B617B539B6DBBA91" reported-display-style="strikethrough" section-type="subsequent-section"><enum>701.</enum><header>Designation of
			 United States Anti-Doping Agency</header>
				<subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID370688ACA6B440C5BBB0836D928E009B" reported-display-style="strikethrough"><enum>(a)</enum><header>Definitions</header><text display-inline="yes-display-inline">In this title:</text>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDD6F49C90713244EA00F9A334008D313C" reported-display-style="strikethrough"><enum>(1)</enum><header>United States
			 Olympic Committee</header><text display-inline="yes-display-inline">The term
			 <term>United States Olympic Committee</term> means the organization established
			 by the <quote>Ted Stevens Olympic and Amateur Sports Act</quote> (36 U.S.C.
			 220501 et seq.).</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID821E1DC45A434A970086F19C01F979C8" reported-display-style="strikethrough"><enum>(2)</enum><header>Amateur athletic
			 competition</header><text display-inline="yes-display-inline">The term
			 <term>amateur athletic competition</term> means a contest, game, meet, match,
			 tournament, regatta, or other event in which amateur athletes compete (36
			 U.S.C. 220501(b)(2)).</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDD10F1E2A9AA5442E8BB93262FE3D38F4" reported-display-style="strikethrough"><enum>(3)</enum><header>Amateur
			 athlete</header><text display-inline="yes-display-inline">The term
			 <term>amateur athlete</term> means an athlete who meets the eligibility
			 standards established by the national governing body or paralympic sports
			 organization for the sport in which the athlete competes (36 U.S.C.
			 22501(b)(1)).</text>
					</paragraph></subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="IDEC774593C7AA42A1A1DC82DA94780085" reported-display-style="strikethrough"><enum>(b)</enum><header>In
			 general</header><text display-inline="yes-display-inline">The United States
			 Anti-Doping Agency shall—</text>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDC6EC281CB4AF41C7B77255DB1028C23B" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">serve as the independent anti-doping
			 organization for the amateur athletic competitions recognized by the United
			 States Olympic Committee;</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID7C173BD6AB554C710003ED4FE2CA691B" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">ensure that athletes participating in
			 amateur athletic activities recognized by the United States Olympic Committee
			 are prevented from using performance-enhancing drugs;</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID8614BE9F02BE41D2BF00343E8DC1CB90" reported-display-style="strikethrough"><enum>(3)</enum><text display-inline="yes-display-inline">implement anti-doping education, research,
			 testing, and adjudication programs to prevent United States Amateur Athletes
			 participating in any activity recognized by the United States Olympic Committee
			 from using performance-enhancing drugs; and</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID2B988437742947D98EA03102FE66DB32" reported-display-style="strikethrough"><enum>(4)</enum><text display-inline="yes-display-inline">serve as the United States representative
			 responsible for coordination with other anti-doping organizations coordinating
			 amateur athletic competitions recognized by the United States Olympic Committee
			 to ensure the integrity of athletic competition, the health of the athletes and
			 the prevention of use of performance-enhancing drugs by United States amateur
			 athletes.</text>
					</paragraph></subsection></section><section changed="deleted" commented="no" display-inline="no-display-inline" id="idC8B41A46E2704D43AE1E65CDF747857F" reported-display-style="strikethrough" section-type="subsequent-section"><enum>702.</enum><header>Records, audit, and
			 report</header>
				<subsection changed="deleted" commented="no" display-inline="no-display-inline" id="id5302E6350E5C4154811B3253B6E0A829" reported-display-style="strikethrough"><enum>(a)</enum><header>Records</header><text display-inline="yes-display-inline">The United States Anti-Doping Agency shall
			 keep correct and complete records of account.</text>
				</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="id1A77A00666F14890B34590BEA4E3FCA6" reported-display-style="strikethrough"><enum>(b)</enum><header>Report</header><text display-inline="yes-display-inline">The United States Anti-Doping Agency shall
			 submit an annual report to Congress which shall include—</text>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="idEC45E8C5BC724249BF48CDCD3058E6B3" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">an audit conducted and submitted in
			 accordance with section 10101 of title 36, United States Code; and</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="id78D121D057FA4EB7942CB1FCF06AC9B8" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">a description of the activities of the
			 agency.</text>
					</paragraph></subsection></section><section changed="deleted" commented="no" display-inline="no-display-inline" id="IDDD4AE77185DC4FCDBEA19E2566411BB1" reported-display-style="strikethrough" section-type="subsequent-section"><enum>703.</enum><header>Authorization of
			 appropriations</header><text display-inline="no-display-inline">There are
			 authorized to be appropriated to the United States Anti-Doping Agency—</text>
				<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDA3F1CC98CF4348BAB4F65D79C6203832" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">for fiscal year 2007, $9,700,000;</text>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDC06B4CE1C7384DE3A69F566752003670" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">for fiscal year 2008, $10,300,000;</text>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="idEDFB86186AE2482CA36C035AC46C91A3" reported-display-style="strikethrough"><enum>(3)</enum><text display-inline="yes-display-inline">for fiscal year 2009, $10,600,000;</text>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="idBF1827FD689D494E93A551E387AFCD2D" reported-display-style="strikethrough"><enum>(4)</enum><text display-inline="yes-display-inline">for fiscal year 2010, $11,000,000;
			 and</text>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="id323FF65ACD154C6A9B6D44DFC897ACF3" reported-display-style="strikethrough"><enum>(5)</enum><text display-inline="yes-display-inline">for fiscal year 2011, $11,500,000.</text>
				</paragraph></section></title><title changed="deleted" commented="no" id="idC480D564584C418C9F1C741F2BCF423B" reported-display-style="strikethrough" style="OLC"><enum>VIII</enum><header>Drug-free communities</header>
			<section changed="deleted" commented="no" display-inline="no-display-inline" id="idACB66A3C933542FCA35267B4B42CBA20" reported-display-style="strikethrough" section-type="subsequent-section"><enum>801.</enum><header>Reauthorization</header><text display-inline="no-display-inline">Section 1024(a) of the Drug-Free Communities
			 Act of 1997 (21 U.S.C. 1524(a)) is amended—</text>
				<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="id142AD24D4FE64003AF97000D3F490A0A" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">in paragraph (9), by striking
			 <quote>and</quote> after the semicolon;</text>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="idC9E77B8DF1B648C2921A3632127BCFB9" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">in paragraph (10), by striking the period
			 and inserting a semicolon; and</text>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="id75D93030EC1F4773891A087EFE781598" reported-display-style="strikethrough"><enum>(3)</enum><text display-inline="yes-display-inline">by adding at the end the following:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="id9CE2ADD439384811993AB692A4260A51" reported-display-style="strikethrough" style="OLC">
						<paragraph commented="no" display-inline="no-display-inline" id="id82B06B771D184C5FAC77FA68335F54C3"><enum>(11)</enum><text display-inline="yes-display-inline">$109,000,000 for fiscal year 2008;</text>
						</paragraph><paragraph commented="no" display-inline="no-display-inline" id="idCA14C626034D4A569BEC46F0C8FA39DF"><enum>(12)</enum><text display-inline="yes-display-inline">$119,000,000 for fiscal year 2009;</text>
						</paragraph><paragraph commented="no" display-inline="no-display-inline" id="id34B0346F45F44088B62DFD1CCCEC3F9C"><enum>(13)</enum><text display-inline="yes-display-inline">$129,000,000 for fiscal year 2010;</text>
						</paragraph><paragraph commented="no" display-inline="no-display-inline" id="id60CA1987D19147628BD0A89E2E696000"><enum>(14)</enum><text display-inline="yes-display-inline">$139,000,000 for fiscal year 2011;
				and</text>
						</paragraph><paragraph commented="no" display-inline="no-display-inline" id="idA5E7D58E504B4B8688429FD2D6F00907"><enum>(15)</enum><text display-inline="yes-display-inline">$149,000,000 for fiscal year
				2012.</text>
						</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</paragraph></section><section changed="deleted" commented="no" display-inline="no-display-inline" id="idFFFAA02E30AB401798E7245F9671A8AC" reported-display-style="strikethrough" section-type="subsequent-section"><enum>802.</enum><header>Suspension of
			 grants</header>
				<subsection changed="deleted" commented="no" display-inline="no-display-inline" id="id58C915EE4E954664A3E57C8E9EE6BC90" reported-display-style="strikethrough"><enum>(a)</enum><header>In
			 general</header><text display-inline="yes-display-inline">Section 1032(b) of
			 the Drug-Free Communities Act of 1997 (21 U.S.C. 1532(b)) is amended by adding
			 at the end the following:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="id67359FB73A6842E09CBBAAF225A5B83D" reported-display-style="strikethrough" style="OLC">
						<paragraph commented="no" display-inline="no-display-inline" id="idF3ECB977B9CE47738ED80F49BF75C496"><enum>(4)</enum><header>Process for
				suspension</header><text display-inline="yes-display-inline">A grantee shall
				not be suspended or terminated under paragraph (1)(A)(ii), (2)(A)(iii), or
				(3)(E) unless that grantee is afforded a fair, timely, and independent appeal
				prior to such suspension or
				termination.</text>
						</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="idBEA20258863A4DF6BA4592AFB1459ACD" reported-display-style="strikethrough"><enum>(b)</enum><header>Report to
			 Congress</header><text display-inline="yes-display-inline">Not later than 60
			 days after the date of enactment of this Act, the Director of the Office of
			 National Drug Control Policy shall submit to Congress a report detailing the
			 appeals process required by section 1032 (b)(4) of the Drug-Free Communities
			 Act of 1997, as added by subsection (a).</text>
				</subsection></section><section changed="deleted" commented="no" display-inline="no-display-inline" id="id30C1C762CBE14691B98458C0BAA29DCE" reported-display-style="strikethrough" section-type="subsequent-section"><enum>803.</enum><header>Grant award
			 increase</header><text display-inline="no-display-inline">Subsections
			 (b)(1)(A)(iv), (b)(2)(C)(i), and (b)(3)(F) of section 1032 of the Drug-Free
			 Communities Act of 1997 (21 U.S.C. 1532) are amended by striking
			 <quote>$100,000</quote> and inserting <quote>$125,000</quote>.</text>
			</section><section changed="deleted" commented="no" display-inline="no-display-inline" id="id1A8171562F79437B8D752E6711F1523B" reported-display-style="strikethrough" section-type="subsequent-section"><enum>804.</enum><header>Prohibition on
			 additional eligibility criteria</header><text display-inline="no-display-inline">Section 1032(a) of the Drug-Free Communities
			 Act of 1997 (21 U.S.C. 1532(a)) is amended by adding at the end the
			 following:</text>
				<quoted-block changed="deleted" display-inline="no-display-inline" id="id273FBE5988A046EDA3297489B163D6E5" reported-display-style="strikethrough" style="OLC">
					<paragraph commented="no" display-inline="no-display-inline" id="idF441F3041E9F477F970A3942B417FE2E"><enum>(7)</enum><header>Additional
				criteria</header><text display-inline="yes-display-inline">The Director shall
				not impose any eligibility criteria on new applicants or renewal grantees not
				provided in this
				chapter.</text>
					</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
			</section><section changed="deleted" commented="no" display-inline="no-display-inline" id="id198497A894EB47548CE83CCAB9F2B77F" reported-display-style="strikethrough" section-type="subsequent-section"><enum>805.</enum><header>Supplemental grants
			 for coalitions</header><text display-inline="no-display-inline">The Drug-Free
			 Communities Act of 1997 (21 U.S.C. 1521 et seq.) is amended by inserting after
			 section 1035 the following:</text>
				<quoted-block changed="deleted" display-inline="no-display-inline" id="idA765CE87F7EE4303A25D52909D0EADF3" reported-display-style="strikethrough" style="OLC">
					<section commented="no" display-inline="no-display-inline" id="ID1c2eb0a94bb245baaf22f625a25154b6" section-type="subsequent-section"><enum>1036.</enum><header>Supplemental
				grants for coalitions with a major local drug crisis</header>
						<subsection commented="no" display-inline="no-display-inline" id="ID8a0518c0ccc84472af26471ab3e8d1d9"><enum>(a)</enum><header>Authority to
				make grants</header><text display-inline="yes-display-inline">As part of the
				program established under section 1031, the Director may award an initial grant
				under this subsection, and renewal grants under subsection (f), to any
				coalition awarded a grant under section 1032 that meets the criteria specified
				in subsection (d) in order to fund a coalition dealing with a major local drug
				crisis.</text>
						</subsection><subsection commented="no" display-inline="no-display-inline" id="ID6d07263fa45643bb877ff1504d955160"><enum>(b)</enum><header>Treatment with
				other grants</header>
							<paragraph commented="no" display-inline="no-display-inline" id="ID497a0ca8a35c4648a51fa61388ad5846"><enum>(1)</enum><header>Supplement</header><text display-inline="yes-display-inline">A grant awarded to a coalition under this
				section is in addition to any grant awarded to the coalition under section
				1032.</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID125eef6ffa55437bbc4d988f947d5da8"><enum>(2)</enum><header>Requirement for
				basic grant</header><text display-inline="yes-display-inline">A coalition may
				not be awarded a grant under this section for a fiscal year unless the
				coalition was awarded a grant or renewal grant under section 1032(b) for that
				fiscal year.</text>
							</paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="IDd8804216134b45a0819b077c9319caa7"><enum>(c)</enum><header>Application</header><text display-inline="yes-display-inline">A coalition seeking a grant under this
				section shall submit to the Administrator an application for the grant in such
				form and manner as the Administrator may require.</text>
						</subsection><subsection commented="no" display-inline="no-display-inline" id="IDb56e8d87cd1548f7909201bbd2a8c190"><enum>(d)</enum><header>Criteria</header><text display-inline="yes-display-inline">A coalition meets the criteria specified in
				this subsection if the coalition—</text>
							<paragraph commented="no" display-inline="no-display-inline" id="ID99d7536c439c4454804d44f54ccdb0d8"><enum>(1)</enum><text display-inline="yes-display-inline">has achieved by or through it’s own efforts
				measurable results in the prevention and reduction of substance use among youth
				generally;</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDf18bfba35f054c50a18ec25a8b03777e"><enum>(2)</enum><text display-inline="yes-display-inline">has documented a highly, statistically
				significant increase in a specific drug, from a baseline determined by locally
				collected data, that can be defined as a local drug crisis; and</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="IDc510e0d90e724538abced2d7e599035f"><enum>(3)</enum><text display-inline="yes-display-inline">submits to the Administrator a detailed
				plan for addressing the specific local drug crisis.</text>
							</paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="IDbf313a40131f4177a06a1d249d776bcc"><enum>(e)</enum><header>Use of grant
				funds</header><text display-inline="yes-display-inline">A coalition awarded a
				grant under this section shall use the grant amount for implementing
				comprehensive, community-wide strategies that address their local drug crises
				in accordance with the detailed plan submitted to the Administrator under
				subsection (d)(3).</text>
						</subsection><subsection commented="no" display-inline="no-display-inline" id="ID37829b8f18cd47e98c748a6812243418"><enum>(f)</enum><header>Renewal
				grants</header><text display-inline="yes-display-inline">The Administrator may
				make a renewal grant to any coalition awarded a grant under subsection (a), or
				a previous renewal grant under this subsection, if the coalition at the time of
				the application for such renewal grant—</text>
							<paragraph commented="no" display-inline="no-display-inline" id="IDc2f97d394aa94a81bfdb1331f48fe4df"><enum>(1)</enum><text display-inline="yes-display-inline">continues to meet the criteria specified in
				subsection (d); and</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID56b78eb5760d478097f47b7039965bd0"><enum>(2)</enum><text display-inline="yes-display-inline">has made demonstrable progress in
				addressing the specific local drug crisis.</text>
							</paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="ID005b8173b2e2457786c095d933804e1a"><enum>(g)</enum><header>Grant
				amounts</header>
							<paragraph commented="no" display-inline="no-display-inline" id="ID83349913e47c4da2ae33bae494dd3d86"><enum>(1)</enum><header>In
				general</header><text display-inline="yes-display-inline">Subject to paragraphs
				(2) and (3) the total amount of grants awarded to a coalition under this
				section for a fiscal year may not exceed the amount of non-Federal funds raised
				by the coalition, including in kind contributions, for that fiscal year.</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID9a88be2f45bc41f2ba430fa6390bbc8c"><enum>(2)</enum><header>Initial
				grants</header><text display-inline="yes-display-inline">The amount of the
				initial grant awarded to a coalition under subsection (a) may not exceed
				$50,000.</text>
							</paragraph><paragraph commented="no" display-inline="no-display-inline" id="ID28fcaa880d4f47f595c521a2f204a228"><enum>(3)</enum><header>Renewal
				grants</header><text display-inline="yes-display-inline">The total amount of
				renewal grants awarded to a coalition under subsection (f) for any fiscal year
				may not exceed $50,000.</text>
							</paragraph></subsection><subsection commented="no" display-inline="no-display-inline" id="ID07f133f9aba448dea9101ff0c3e9bbc7"><enum>(h)</enum><header>Fiscal year
				limitation on the amount available for grants</header><text display-inline="yes-display-inline">The total amount available for grants under
				this section, including renewal grants under subsection (f), in any fiscal year
				may not exceed the amount equal to 5 percent of the actual amount appropriated
				for that fiscal
				year.</text>
						</subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
			</section><section changed="deleted" commented="no" display-inline="no-display-inline" id="id5DED049C669A4A3E8FB54A18FB92AD02" reported-display-style="strikethrough" section-type="subsequent-section"><enum>806.</enum><header>National Community
			 Antidrug Coalition Institute</header><text display-inline="no-display-inline">Section 4 of Public Law 107–82 (21 U.S.C.
			 1521 note), reauthorizing the Drug-Free Communities Support Program, is
			 amended—</text>
				<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="id7DF9C785CC14409D91725CF7048CEE69" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">by amending subsection (a) to read as
			 follows:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="id9E760FE7753E405292DEE55F8814608A" reported-display-style="strikethrough" style="OLC">
						<subsection commented="no" display-inline="no-display-inline" id="idFB28B289E00E4DC3A503EA840789B154"><enum>(a)</enum><header>In
				general</header><text display-inline="yes-display-inline">The Director of the
				Office of National Drug Control Policy shall, using amounts authorized to be
				appropriated by subsection (d), make a directed grant to Community Anti-Drug
				Coalitions of America to provide for the continuation of the National Community
				Antidrug Coalition
				Institute.</text>
						</subsection><after-quoted-block>;</after-quoted-block></quoted-block>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="idF64282AD80904F61803AB734C386A3B3" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">by striking subsection (b) and
			 redesignating subsections (c) and (d) as (b) and (c), respectively; and</text>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="id93C76AB94B4A452FA1011AF33C553782" reported-display-style="strikethrough"><enum>(3)</enum><text display-inline="yes-display-inline">in subsection (c), as redesignated by
			 paragraph (2), by adding at the end the following:</text>
					<quoted-block changed="deleted" display-inline="no-display-inline" id="id04C72C8F95294D27808EA9E15302B253" reported-display-style="strikethrough" style="OLC">
						<paragraph commented="no" display-inline="no-display-inline" id="idDDDEC5873B2140C384C642355EDEE3E5"><enum>(4)</enum><text display-inline="yes-display-inline">For each of the fiscal years 2008 through
				2012,
				$2,000,000.</text>
						</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</paragraph></section><section changed="deleted" commented="no" display-inline="no-display-inline" id="id6A08F410A5E94F7B8A2A225A9C4358EF" reported-display-style="strikethrough" section-type="subsequent-section"><enum>807.</enum><header>Contracting
			 requirement</header><text display-inline="no-display-inline">Section 1031(d) of
			 the Drug-Free Communities Act of 1997 (21 U.S.C. 1531(d)) is amended by adding
			 at the end the following: <quote>The Director shall delegate all authority for
			 grant eligibility determinations, review, selection, management, and appeals to
			 another qualified national drug control agency.</quote>.</text>
			</section></title><title changed="deleted" commented="no" id="ID0C78E232DA404824AC746C393D5D14F3" reported-display-style="strikethrough" style="OLC"><enum>IX</enum><header>NATIONAL GUARD COUNTERDRUG SCHOOLS</header>
			<section changed="deleted" commented="no" display-inline="no-display-inline" id="ID671FF999C9AD4CB8AB35A7AE5274A159" reported-display-style="strikethrough" section-type="subsequent-section"><enum>901.</enum><header>National Guard
			 Counterdrug Schools</header>
				<subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID6C0BB2A5832246A1BB54ECDB42C19EE4" reported-display-style="strikethrough"><enum>(a)</enum><header>Authority To
			 Operate</header><text display-inline="yes-display-inline">Under such
			 regulations as the Secretary of Defense may prescribe, the Chief of the
			 National Guard Bureau may establish and operate, or provide financial
			 assistance to the States to establish and operate, not more than five schools
			 (to be known generally as <quote>National Guard counterdrug
			 schools</quote>).</text>
				</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID477A397EE0B145FA9A8359BB6CFEB585" reported-display-style="strikethrough"><enum>(b)</enum><header>Purpose</header><text display-inline="yes-display-inline">The purpose of the National Guard
			 counterdrug schools shall be the provision by the National Guard of training in
			 drug interdiction and counterdrug activities and drug demand reduction
			 activities to personnel of the following:</text>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID911EAB6E25574330AB8246E6EDED7AB8" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">Federal agencies.</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID51FFBD2E9DC441DB9E55CB14F0FC9BE5" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">State and local law enforcement
			 agencies.</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID5615C7BC1026406EB075F455DB6AB5C6" reported-display-style="strikethrough"><enum>(3)</enum><text display-inline="yes-display-inline">Community-based organizations engaged in
			 such activities.</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID8AE14674A9E348F38EBA90B0A4CAFCD0" reported-display-style="strikethrough"><enum>(4)</enum><text display-inline="yes-display-inline">Other non-Federal governmental and private
			 entities and organizations engaged in such activities.</text>
					</paragraph></subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID70C3B4A15D75448185B5FDE4297477E9" reported-display-style="strikethrough"><enum>(c)</enum><header>Counterdrug
			 Schools Specified</header><text display-inline="yes-display-inline">The
			 National Guard counterdrug schools operated under the authority in subsection
			 (a) are as follows:</text>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDCA7A706C652F49E5ABCD996AE6887FFA" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">The National Interagency Civil-Military
			 Institute (NICI), San Luis Obispo, California.</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID6C6FE0D12ADC479CA1F190D3983357DD" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">The Multi-Jurisdictional Counterdrug Task
			 Force Training (MCTFT), St. Petersburg, Florida.</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDD7590A1505F74A66A277B3A4871EA055" reported-display-style="strikethrough"><enum>(3)</enum><text display-inline="yes-display-inline">The Midwest Counterdrug Training Center
			 (MCTC), Johnston, Iowa.</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID88CE52CBDCFC4E2CA35B78E95BC17C0C" reported-display-style="strikethrough"><enum>(4)</enum><text display-inline="yes-display-inline">The Regional Counterdrug Training Academy
			 (RCTA), Meridian, Mississippi.</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDBCBAB258B953462D9090985441D4D0CF" reported-display-style="strikethrough"><enum>(5)</enum><text display-inline="yes-display-inline">The Northeast Regional Counterdrug Training
			 Center (NCTC), Fort Indiantown Gap, Pennsylvania.</text>
					</paragraph></subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="IDB31630BD5808464EB8F2D8B01345695D" reported-display-style="strikethrough"><enum>(d)</enum><header>Use of National
			 Guard Personnel</header>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="id30C800D531174002BC151C764816C0D5" reported-display-style="strikethrough"><enum>(1)</enum><header>In
			 general</header><text display-inline="yes-display-inline">To the extent
			 provided for in the State drug interdiction and counterdrug activities plan of
			 a State in which a National Guard counterdrug school is located, personnel of
			 the National Guard of that State who are ordered to perform full-time National
			 Guard duty authorized under section 112(b) of that title 32, United States
			 Code, may provide training referred to in subsection (b) at that school.</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID478714D5FED34371962FC2E3770B8831" reported-display-style="strikethrough"><enum>(2)</enum><header>Definition</header><text display-inline="yes-display-inline">In this subsection, the term <term>State
			 drug interdiction and counterdrug activities plan</term>, in the case of a
			 State, means the current plan submitted by the Governor of the State to the
			 Secretary of Defense under section 112 of title 32, United States Code.</text>
					</paragraph></subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID0950772AD5EB4DDD9CE463FCFFBD72DF" reported-display-style="strikethrough"><enum>(e)</enum><header>Treatment Under
			 Authority To Provide Counterdrug Support</header><text display-inline="yes-display-inline">The provisions of section 1004 of the
			 National Defense Authorization Act for Fiscal Year 1991 (Public Law 101–510; 10
			 U.S.C. 374 note) shall apply to any activities of a National Guard counterdrug
			 school under this section that are for an agency referred to in subsection (a)
			 of such section 1004 and for a purpose set forth in subsection (b) of such
			 section 1004.</text>
				</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID5F3C8845C3DA49B2B93BB68257174F8B" reported-display-style="strikethrough"><enum>(f)</enum><header>Annual Reports
			 on Activities</header>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="id118E3700A95C42F5B29DBB95099B0752" reported-display-style="strikethrough"><enum>(1)</enum><header>In
			 general</header><text display-inline="yes-display-inline">Not later than
			 February 1 each year, the Secretary of Defense shall submit to Congress a
			 report on the activities of the National Guard counterdrug schools during the
			 preceding year.</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDD98B82B9AB054910BB97B7076E1C9221" reported-display-style="strikethrough"><enum>(2)</enum><header>Contents</header><text display-inline="yes-display-inline">Each report under paragraph (1) shall set
			 forth the following:</text>
						<subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID884F3C77B8F947AA88091C418F6474C5" reported-display-style="strikethrough"><enum>(A)</enum><header>Funding</header><text display-inline="yes-display-inline">The amount made available for each National
			 Guard counterdrug school during the fiscal year ending in the year preceding
			 the year in which such report is submitted.</text>
						</subparagraph><subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDA2E83C31612A4FD493D2DBF12F06D05E" reported-display-style="strikethrough"><enum>(B)</enum><header>Activities</header><text display-inline="yes-display-inline">A description of the activities of each
			 National Guard counterdrug school during the year preceding the year in which
			 such report is submitted.</text>
						</subparagraph></paragraph></subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="IDA40BC1EA0295485DB5556F33B1779A85" reported-display-style="strikethrough"><enum>(g)</enum><header>Authorization of
			 Appropriations</header>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="idC6C366435E1246EAB3A20A71A68B05DD" reported-display-style="strikethrough"><enum>(1)</enum><header>In
			 general</header><text display-inline="yes-display-inline">There is hereby
			 authorized to be appropriated for the Department of Defense for the National
			 Guard for each of fiscal years 2006 through 2010, $30,000,000 for purposes of
			 the National Guard counterdrug schools in such fiscal year.</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID10E3A22A516C4B439CA35C8A43F1B6F3" reported-display-style="strikethrough"><enum>(2)</enum><header>Construction</header><text display-inline="yes-display-inline">The amount authorized to be appropriated by
			 paragraph (1) for a fiscal year is in addition to any other amount authorized
			 to be appropriated for the Department of Defense for the National Guard for
			 such fiscal year.</text>
					</paragraph></subsection></section></title><title changed="deleted" commented="no" id="ID158C2C906F004FFC985A2E5E743F8375" reported-display-style="strikethrough" style="OLC"><enum>X</enum><header>MISCELLANEOUS PROVISIONS</header>
			<section changed="deleted" commented="no" display-inline="no-display-inline" id="ID83BF049EEEE0468E8DF839FAA501A544" reported-display-style="strikethrough" section-type="subsequent-section"><enum>1001.</enum><header>Repeals</header>
				<subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID8C24E66F974C4049A7CD54375C471CD1" reported-display-style="strikethrough"><enum>(a)</enum><header>Act</header><text display-inline="yes-display-inline">Sections 709, 710, and 711 are
			 repealed.</text>
				</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="IDCA3224ACC308450C82E8EC7A69894E36" reported-display-style="strikethrough"><enum>(b)</enum><header>Forfeiture
			 Assets</header><text display-inline="yes-display-inline">Section 6073 of the
			 Assets Forfeiture Amendments Act of 1988 (21 U.S.C. 1509) is repealed.</text>
				</subsection></section><section changed="deleted" commented="no" display-inline="no-display-inline" id="ID1AC44FCD66B5430A9C2D9EFE5F1AA895" reported-display-style="strikethrough" section-type="subsequent-section"><enum>1002.</enum><header><act-name parsable-cite="CSA">Controlled Substances Act</act-name>
			 amendments</header><text display-inline="no-display-inline">Section
			 303(g)(2)(B)(iii) of the Controlled Substances Act (21 U.S.C.
			 823(g)(2)(B)(iii)) is amended by striking <quote>except that the
			 Secretary</quote> and inserting the following: <quote>unless, not sooner than 1
			 year after the date on which the practitioner submitted the initial
			 notification, the practitioner submits a second notification to the Secretary
			 of the need and intent of the practitioner to treat more than such applicable
			 number of patients. A second notification under this clause shall contain the
			 certifications required by clauses (i) and (ii) of this subparagraph. The
			 Secretary</quote>.</text>
			</section><section changed="deleted" commented="no" display-inline="no-display-inline" id="IDF16A8D375B4E4F418B124FC356C71032" reported-display-style="strikethrough" section-type="subsequent-section"><enum>1003.</enum><header>Report on
			 intelligence sharing</header><text display-inline="no-display-inline">Not later
			 than 180 days after the date of enactment of this Act, the Director shall
			 submit to Congress a report—</text>
				<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDBAF9239AAB8B4815B808C78FEE798FB5" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">evaluating existing and planned
			 intelligence systems used by Federal, State, and local law enforcement agencies
			 responsible for drug trafficking and drug production enforcement; and</text>
				</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID9E2711BCE65345538F8FB47A1C68A205" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">addressing—</text>
					<subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID643CAA9D7819472E90BB9C37FDE1D629" reported-display-style="strikethrough"><enum>(A)</enum><text display-inline="yes-display-inline">the current intelligence systems used by
			 Federal, State, and local law enforcement agencies;</text>
					</subparagraph><subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDD5ADEFC386FD4F16B23FD271DCF9B1BD" reported-display-style="strikethrough"><enum>(B)</enum><text display-inline="yes-display-inline">the compatibility of such systems in
			 ensuring access and availability of intelligence to Federal, State, and local
			 law enforcement;</text>
					</subparagraph><subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDBEF8EDDB0AA042EEBF733DD64F0FB945" reported-display-style="strikethrough"><enum>(C)</enum><text display-inline="yes-display-inline">the extent to which Federal, State, and
			 local law enforcement are sharing intelligence information to assess current
			 threats and design appropriate enforcement strategies; and</text>
					</subparagraph><subparagraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID96A3A845789742C8B76A5280420F78A0" reported-display-style="strikethrough"><enum>(D)</enum><text display-inline="yes-display-inline">the measures needed to ensure and to
			 promote effective information sharing among intelligence systems operated by
			 Federal, State, and local law enforcement agencies responsible for drug
			 trafficking and drug production enforcement.</text>
					</subparagraph></paragraph></section><section changed="deleted" commented="no" display-inline="no-display-inline" id="ID293244B5EA5642BBB44718AF2496B247" reported-display-style="strikethrough" section-type="subsequent-section"><enum>1004.</enum><header>Requirement for
			 South American heroin strategy</header>
				<subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID6C2E711A63EF44DEB558AC96FA2CC889" reported-display-style="strikethrough"><enum>(a)</enum><header>In
			 General</header><text display-inline="yes-display-inline">Not later than 90
			 days after the date of enactment of this Act, the Director shall submit to
			 Congress a comprehensive strategy that addresses the increased threat from
			 South American heroin, and in particular Colombian heroin, and the emerging
			 threat from opium poppy grown in Peru and often intended for transit to
			 Columbia for processing into heroin.</text>
				</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="ID1736F070C7904D7FB7D924846300BEDC" reported-display-style="strikethrough"><enum>(b)</enum><header>Contents</header><text display-inline="yes-display-inline">The strategy submitted under subsection (a)
			 shall include—</text>
					<paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="IDFA78020C038A4F9CA2D336CFA77410FA" reported-display-style="strikethrough"><enum>(1)</enum><text display-inline="yes-display-inline">opium eradication efforts to eliminate the
			 problem at the source to prevent heroin from entering the stream of
			 commerce;</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID95214343AB24475F9FFA3D9CBA9F26F2" reported-display-style="strikethrough"><enum>(2)</enum><text display-inline="yes-display-inline">interdiction and precursor chemical
			 controls;</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID844D07D517F04FE284FE38B5BA28507C" reported-display-style="strikethrough"><enum>(3)</enum><text display-inline="yes-display-inline">demand reduction and treatment;</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="id0B953995CFED4AB495C7711E14E2EE76" reported-display-style="strikethrough"><enum>(4)</enum><text display-inline="yes-display-inline">alternative development programs, including
			 direct assistance to regional governments to demobilize and provide alternative
			 livelihoods to former members of insurgent or other groups engaged in heroin,
			 cocoa, or other illicit drug production or trafficking;</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="idCCBE4B92F3DA421CA750BD2AAF1B15EB" reported-display-style="strikethrough"><enum>(5)</enum><text display-inline="yes-display-inline">efforts to inform and involve local
			 citizens in the programs described in paragraphs (1) through (4), such as
			 through leaflets advertising rewards for information;</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID536C82B6B8614A20B315D6F6EDD60434" reported-display-style="strikethrough"><enum>(6)</enum><text display-inline="yes-display-inline">provisions that ensure the maintenance at
			 current levels of efforts to eradicate coca in Colombia; and</text>
					</paragraph><paragraph changed="deleted" commented="no" display-inline="no-display-inline" id="ID016C64F851E1467EADCFA8722ADD4180" reported-display-style="strikethrough"><enum>(7)</enum><text display-inline="yes-display-inline">an assessment of the specific level of
			 funding and resources necessary to simultaneously address the threat from South
			 American heroin and the threat from Colombian and Peruvian coca.</text>
					</paragraph></subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="id9D5F0A9D3F8347A4B7C8F5E5BBC4C764" reported-display-style="strikethrough"><enum>(c)</enum><header>Treatment of
			 Classified or Law Enforcement Sensitive Information</header><text display-inline="yes-display-inline">Any content of the strategy submitted under
			 subsection (a) that involves information classified under criteria established
			 by an Executive order, or whose public disclosure, as determined by the
			 Director or the head of any relevant Federal agency, would be detrimental to
			 the law enforcement of national security activities of any Federal, foreign, or
			 international agency, shall be presented to Congress separately from the rest
			 of the strategy.</text>
				</subsection></section><section changed="deleted" commented="no" display-inline="no-display-inline" id="id0DF5AC6C5A004551A5A9CFD143A06DF9" reported-display-style="strikethrough" section-type="subsequent-section"><enum>1005.</enum><header>Model Acts</header>
				<subsection changed="deleted" commented="no" display-inline="no-display-inline" id="id9C54B934784D4142B800C2C98654F0A6" reported-display-style="strikethrough"><enum>(a)</enum><header>In
			 general</header><text display-inline="yes-display-inline">The Director shall
			 enter into an agreement with a nonprofit corporation that works with States on
			 laws and policies to address alcohol and other drug issues, under which the
			 corporation shall revise the model State drug laws developed by the President's
			 Commission on Model State Drug Laws and draft supplementary model acts to meet
			 changes in States' substance abuse issues.</text>
				</subsection><subsection changed="deleted" commented="no" display-inline="no-display-inline" id="id22D9498A39194DF98F4859A6DAE0C44C" reported-display-style="strikethrough"><enum>(b)</enum><header>Authorization of
			 appropriations</header><text display-inline="yes-display-inline">There are
			 authorized to be appropriated $1,500,000 to carry out this section.</text>
				</subsection></section></title></legis-body>
	<legis-body display-enacting-clause="no-display-enacting-clause">
		<section changed="added" id="id45CE9DD5D666447DA3C770FF8DA48749" reported-display-style="italic" section-type="section-one"><enum>1.</enum><header>Short title, reference, and
			 table of contents</header>
			<subsection changed="added" id="idBC2DBFF44D434F9C8140688AC8FEA39E" reported-display-style="italic"><enum>(a)</enum><header>Short
			 title</header><text>This Act may be cited as the <quote><short-title>Office of National Drug Control Policy Reauthorization Act
			 of 2006</short-title></quote>.</text>
			</subsection><subsection changed="added" id="id89EC22309D8D4822BA71B3A44E06D8AD" reported-display-style="italic"><enum>(b)</enum><header>Amendment of Office of
			 National Drug Control Policy Reauthorization Act of 1998</header><text>Except
			 as otherwise expressly provided, whenever in this Act an amendment or repeal is
			 expressed in terms of an amendment to, or repeal of, a section or other
			 provision, the reference shall be considered to be made to a section or other
			 provision of the Office of National Drug Control Policy Reauthorization Act of
			 1998 (Public Law 105–277; 21 U.S.C. 1701 et seq.).</text>
			</subsection><subsection changed="added" id="idF9FCFBDDD3234F96858ADDEDEB04594E" reported-display-style="italic"><enum>(c)</enum><header>Table of
			 Contents</header><text>The table of contents for this Act is as follows:</text>
				<toc>
					<toc-entry changed="added" idref="id1AB6E49F81CD4CCBA7ADDB767D4231D2" level="section" reported-display-style="italic">Sec. 1. Short title, reference,
				and table of contents.</toc-entry>
					<toc-entry changed="added" idref="ID4FA2908AA3B948379C3031DE42DC9328" level="title" reported-display-style="italic">TITLE I—Organization of Office of
				National Drug Control Policy and roles and responsibilities</toc-entry>
					<toc-entry changed="added" idref="ID3A96DD93BC0B4B29A81A1EE6A0B5AF77" level="section" reported-display-style="italic">Sec. 101. Amendments to
				definitions.</toc-entry>
					<toc-entry changed="added" idref="ID2A6E92E81A914D3791E6E87654FAB0B1" level="section" reported-display-style="italic">Sec. 102. Establishment of the
				Office of National Drug Control Policy.</toc-entry>
					<toc-entry changed="added" idref="ID33BD2F52823540BBB622BBB1316F1A7B" level="section" reported-display-style="italic">Sec. 103. Appointment and
				responsibilities of the Director.</toc-entry>
					<toc-entry changed="added" idref="IDAF2192E824C44F0E913433BA4DEE4747" level="section" reported-display-style="italic">Sec. 104. Amendments to ensure
				coordination with other agencies.</toc-entry>
					<toc-entry changed="added" idref="idE3E75228D58C4BDBBCA1E08E6DA20AD5" level="section" reported-display-style="italic">Sec. 105. Budgetary
				matters.</toc-entry>
					<toc-entry changed="added" idref="ID64F55E06EDF447DEBDEE7FA71A529C14" level="title" reported-display-style="italic">TITLE II—The National Drug
				Control Strategy</toc-entry>
					<toc-entry changed="added" idref="ID84B9E0EF83E94C3AA856DC6C77DBA1C4" level="section" reported-display-style="italic">Sec. 201. Annual preparation
				and submission of National Drug Control Strategy.</toc-entry>
					<toc-entry changed="added" idref="IDCB1545365E2447388DE25A7390707016" level="section" reported-display-style="italic">Sec. 202. Performance
				measurements.</toc-entry>
					<toc-entry changed="added" idref="ID9DD2FDB909E04369AC3739BCB27629F4" level="section" reported-display-style="italic">Sec. 203. Annual report
				requirement.</toc-entry>
					<toc-entry changed="added" idref="IDDCCCDCF0BD714472B9C1A21D2D18456E" level="title" reported-display-style="italic">TITLE III—High intensity drug
				trafficking areas </toc-entry>
					<toc-entry changed="added" idref="ID045426EF39B8482E99FFA0691EA33C75" level="section" reported-display-style="italic">Sec. 301. High Intensity Drug
				Trafficking Areas Program.</toc-entry>
					<toc-entry changed="added" idref="IDA00A8188F28F490FB1BF0B523F902349" level="section" reported-display-style="italic">Sec. 302. Funding for certain
				high intensity drug trafficking areas.</toc-entry>
					<toc-entry changed="added" idref="ID5B94BD41E2BA44D7B5E17AD2CF9EC6A1" level="section" reported-display-style="italic">Sec. 303.
				Assessment.</toc-entry>
					<toc-entry changed="added" idref="id341C3F6997194589A2D9908F05648616" level="title" reported-display-style="italic">TITLE IV—Technology</toc-entry>
					<toc-entry changed="added" idref="IDCCA08B584F7D47D594E823FE435E58D7" level="section" reported-display-style="italic">Sec. 401. Counterdrug
				Technology Assessment Center.</toc-entry>
					<toc-entry changed="added" idref="IDDF37CABF46E5434BA5EEC48EF5392360" level="title" reported-display-style="italic">TITLE V—Reauthorization and
				improvement of the National Anti-Drug Media Campaign</toc-entry>
					<toc-entry changed="added" idref="ID059FE2AC6F714CE5BCB361C07D193CA2" level="section" reported-display-style="italic">Sec. 501. Short
				title.</toc-entry>
					<toc-entry changed="added" idref="ID788DC3CCDBB54FE9830D14E46E8BFA0B" level="section" reported-display-style="italic">Sec. 502. Purposes of the
				National Youth Anti-Drug Media Campaign.</toc-entry>
					<toc-entry changed="added" idref="ID60F61E9B57CC4D14B9617A3FD4A06D31" level="section" reported-display-style="italic">Sec. 503. Roles and
				responsibilities of the Director, the Partnership for a Drug-Free America, and
				a media buying contractor.</toc-entry>
					<toc-entry changed="added" idref="IDFDF0CD38B2FF4EF1BB7A9FC1A1FC5838" level="section" reported-display-style="italic">Sec. 504. Responsible use of
				Federal funds for the National Youth Anti-Drug Media Campaign.</toc-entry>
					<toc-entry changed="added" idref="ID11A8458174E04C2D9CEB943F4F1F5A53" level="section" reported-display-style="italic">Sec. 505. Authorization for
				National Youth Anti-Drug Media Campaign.</toc-entry>
					<toc-entry changed="added" idref="ID8565E70265E3480CBC53F22722CD7A0C" level="title" reported-display-style="italic">TITLE VI—Authorizations and
				extension of termination date</toc-entry>
					<toc-entry changed="added" idref="IDA51BBBB00B814870B2EFA99BD0E92FB3" level="section" reported-display-style="italic">Sec. 601. Authorization of
				appropriations.</toc-entry>
					<toc-entry changed="added" idref="IDEA45D1B97F134692A8EF07302A192D91" level="section" reported-display-style="italic">Sec. 602. Extension of
				termination date.</toc-entry>
					<toc-entry changed="added" idref="id0CAE4A04EAB34A8F9BD538C5668477B4" level="title" reported-display-style="italic">TITLE VII—Anti-Doping
				Agency</toc-entry>
					<toc-entry changed="added" idref="id2FF6687314614948B617B539B6DBBA91" level="section" reported-display-style="italic">Sec. 701. Designation of United
				States Anti-Doping Agency.</toc-entry>
					<toc-entry changed="added" idref="idC8B41A46E2704D43AE1E65CDF747857F" level="section" reported-display-style="italic">Sec. 702. Records, audit, and
				report.</toc-entry>
					<toc-entry changed="added" idref="IDDD4AE77185DC4FCDBEA19E2566411BB1" level="section" reported-display-style="italic">Sec. 703. Authorization of
				appropriations.</toc-entry>
					<toc-entry changed="added" idref="idC480D564584C418C9F1C741F2BCF423B" level="title" reported-display-style="italic">TITLE VIII—Drug-free
				communities</toc-entry>
					<toc-entry changed="added" idref="idACB66A3C933542FCA35267B4B42CBA20" level="section" reported-display-style="italic">Sec. 801.
				Reauthorization.</toc-entry>
					<toc-entry changed="added" idref="idFFFAA02E30AB401798E7245F9671A8AC" level="section" reported-display-style="italic">Sec. 802. Suspension of
				grants.</toc-entry>
					<toc-entry changed="added" idref="id30C1C762CBE14691B98458C0BAA29DCE" level="section" reported-display-style="italic">Sec. 803. Grant award
				increase.</toc-entry>
					<toc-entry changed="added" idref="id1A8171562F79437B8D752E6711F1523B" level="section" reported-display-style="italic">Sec. 804. Prohibition on
				additional eligibility criteria.</toc-entry>
					<toc-entry changed="added" idref="id198497A894EB47548CE83CCAB9F2B77F" level="section" reported-display-style="italic">Sec. 805. Supplemental grants
				for coalitions.</toc-entry>
					<toc-entry changed="added" idref="id5DED049C669A4A3E8FB54A18FB92AD02" level="section" reported-display-style="italic">Sec. 806. National Community
				Anti-Drug Coalition Institute.</toc-entry>
					<toc-entry changed="added" idref="id6A08F410A5E94F7B8A2A225A9C4358EF" level="section" reported-display-style="italic">Sec. 807. Contracting
				requirement.</toc-entry>
					<toc-entry changed="added" idref="ID0C78E232DA404824AC746C393D5D14F3" level="title" reported-display-style="italic">TITLE IX—National Guard
				counterdrug schools</toc-entry>
					<toc-entry changed="added" idref="ID671FF999C9AD4CB8AB35A7AE5274A159" level="section" reported-display-style="italic">Sec. 901. National Guard
				counterdrug schools.</toc-entry>
					<toc-entry changed="added" idref="idEA3FD7EFC244473E95F64CA211C922DB" level="title" reported-display-style="italic">TITLE X—National Methamphetamine
				Information Clearinghouse Act of 2006</toc-entry>
					<toc-entry changed="added" idref="S1" level="section" reported-display-style="italic">Sec. 1001. Short title.</toc-entry>
					<toc-entry changed="added" idref="id4259A57EE59645AFAE08C8FD7E0162A8" level="section" reported-display-style="italic">Sec. 1002.
				Definitions.</toc-entry>
					<toc-entry changed="added" idref="id1C8EAE147902412AA42977231EA5FB9B" level="section" reported-display-style="italic">Sec. 1003. Establishment of
				clearinghouse and advisory council.</toc-entry>
					<toc-entry changed="added" idref="idAF750BD07433427EAD5C1F07B8F0B88D" level="section" reported-display-style="italic">Sec. 1004. NMIC requirements
				and review.</toc-entry>
					<toc-entry changed="added" idref="id10275FE4DCA64BCDB56DA7C796E89150" level="section" reported-display-style="italic">Sec. 1005. Authorization of
				appropriations.</toc-entry>
					<toc-entry changed="added" idref="ID158C2C906F004FFC985A2E5E743F8375" level="title" reported-display-style="italic">TITLE XI—Miscellaneous
				provisions</toc-entry>
					<toc-entry changed="added" idref="ID83BF049EEEE0468E8DF839FAA501A544" level="section" reported-display-style="italic">Sec. 1101. Repeals.</toc-entry>
					<toc-entry changed="added" idref="ID1AC44FCD66B5430A9C2D9EFE5F1AA895" level="section" reported-display-style="italic">Sec. 1102.
				<act-name parsable-cite="CSA">Controlled Substances Act</act-name>
				amendments.</toc-entry>
					<toc-entry changed="added" idref="IDF16A8D375B4E4F418B124FC356C71032" level="section" reported-display-style="italic">Sec. 1103. Report on
				intelligence sharing.</toc-entry>
					<toc-entry changed="added" idref="ID293244B5EA5642BBB44718AF2496B247" level="section" reported-display-style="italic">Sec. 1104. Requirement for
				South American heroin strategy.</toc-entry>
					<toc-entry changed="added" idref="id0DF5AC6C5A004551A5A9CFD143A06DF9" level="section" reported-display-style="italic">Sec. 1105. Model
				acts.</toc-entry>
					<toc-entry changed="added" idref="id67ABAEF699CA41E4B7285D97E6312628" level="section" reported-display-style="italic">Sec. 1106. Study on iatrogenic
				addiction associated with prescription opioid analgesic drugs.</toc-entry>
					<toc-entry changed="added" idref="IDa69bb8530f9f46ed8d8ab1bcdc5463ec" level="section" reported-display-style="italic">Sec. 1107. Requirement for
				strategy to stop Internet advertising of prescription medicines without a
				prescription.</toc-entry>
					<toc-entry changed="added" idref="ID8d0c950d6a224e2eafdd3474a3a0bb38" level="section" reported-display-style="italic">Sec. 1108. Requirement for
				study on diversion and inappropriate uses of prescription drugs.</toc-entry>
				</toc>
			</subsection></section><title changed="added" id="idA503C3799A9B486B8DF032A0E9066D1D" reported-display-style="italic"><enum>I</enum><header>Organization of Office of
			 National Drug Control Policy and roles and responsibilities</header>
			<section changed="added" id="id53B65B6CCB6940638F4FC47A4064EE26" reported-display-style="italic"><enum>101.</enum><header>Amendments to
			 definitions</header>
				<subsection changed="added" id="id97854A38608448A5A084733DC68DE9B4" reported-display-style="italic"><enum>(a)</enum><header>Demand
			 reduction</header><text>Section 702(1) is amended—</text>
					<paragraph changed="added" id="idB3E57B06A99E426C8E14CDDDA999B1AC" reported-display-style="italic"><enum>(1)</enum><text>in subparagraph (F), by
			 striking <quote>and</quote> after the semicolon; and</text>
					</paragraph><paragraph changed="added" id="idF3B3A66AECC64C55BB70FA03EE7A367C" reported-display-style="italic"><enum>(2)</enum><text>in subparagraph (G), by
			 striking the period and inserting <quote>; and</quote>; and</text>
					</paragraph><paragraph changed="added" id="id1FBB51A6147847C8B7B635AED8FE9ECE" reported-display-style="italic"><enum>(3)</enum><text>by adding at the end the
			 following:</text>
						<quoted-block changed="added" id="id69F3BA6AB0CA4FE3A301B6924164CA27" reported-display-style="italic" style="OLC">
							<subparagraph id="id2CCEA0F3E5C446FAA1FD3D907CFC235E"><enum>(H)</enum><text>international drug abuse
				education, prevention, treatment, research, rehabilitation activities, and
				interventions for drug abuse and
				dependence.</text>
							</subparagraph><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph></subsection><subsection changed="added" id="id36D9D6C16EB445CAB67583E122731A07" reported-display-style="italic"><enum>(b)</enum><header>National Drug Control
			 Program</header><text>Section 702(6) is amended by adding before the period the
			 following: <quote>, including any activities involving supply reduction, demand
			 reduction, or State and local affairs</quote>.</text>
				</subsection><subsection changed="added" id="idDEB638171490445397C962FF76EE4CF1" reported-display-style="italic"><enum>(c)</enum><header>Office</header><text>Section
			 702(9) is amended by striking <quote>implicates</quote> and inserting
			 <quote>indicates</quote>.</text>
				</subsection><subsection changed="added" id="id0D10BA17E83A4FD98A00C38612791340" reported-display-style="italic"><enum>(d)</enum><header>State and local
			 affairs</header><text>Paragraph (10) of section 702 is amended to read as
			 follows:</text>
					<quoted-block changed="added" id="id315D500F7E674D3BA816FF2DB9CA5A8F" reported-display-style="italic" style="OLC">
						<paragraph id="idCDFC753D7490448CAFDDC8FD1D0FE46E"><enum>(10)</enum><header>State and local
				affairs</header><text>The term <term>State and local affairs</term> means
				domestic activities conducted by a National Drug Control Program agency that
				are intended to reduce the availability and use of illegal drugs,
				including—</text>
							<subparagraph id="id626D6C8F79AC40D4A290B3D03C951580"><enum>(A)</enum><text>coordination and
				enhancement of Federal, State, and local law enforcement drug control
				efforts;</text>
							</subparagraph><subparagraph id="id77B575E2F6054677812F8FB1B664AD02"><enum>(B)</enum><text>coordination and
				enhancement of efforts among National Drug Control Program agencies and State
				and local demand reduction and supply reduction agencies;</text>
							</subparagraph><subparagraph id="id6BB5F21F73C945AE8D608DBDFFF6C435"><enum>(C)</enum><text>coordination and
				enhancement of Federal, State, and local law enforcement initiatives to gather,
				analyze, and disseminate information and intelligence relating to drug control
				among domestic law enforcement agencies; and</text>
							</subparagraph><subparagraph id="id9D8622F274B2494EBD2B0E60F594DFEE"><enum>(D)</enum><text>other coordinated and
				joint initiatives among Federal, State, and local agencies to promote
				comprehensive drug control strategies designed to reduce the demand for, and
				the availability of, illegal
				drugs.</text>
							</subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection><subsection changed="added" id="id84F551837902457FA17CB878CDC4C123" reported-display-style="italic"><enum>(e)</enum><header>Supply
			 reduction</header><text>Section 702(11) is amended to read as follows:</text>
					<quoted-block changed="added" id="id3F2A0D06DD6D4AAB8150E159B5815E44" reported-display-style="italic" style="OLC">
						<paragraph id="idE55CF0C8459F4C58BB6DC346EC69556C"><enum>(11)</enum><header>Supply
				reduction</header><text>The term <term>supply reduction</term> means any
				activity or program conducted by a National Drug Control Program agency that is
				intended to reduce the availability or use of illegal drugs in the United
				States or abroad, including—</text>
							<subparagraph id="idFAE7BB2FCA9C4ABCBC7E0F74674BAE82"><enum>(A)</enum><text>law enforcement outside
				the United States;</text>
							</subparagraph><subparagraph id="id6CD55C79FF0A49FBA7B5B8043A8EAFC3"><enum>(B)</enum><text>source country programs,
				including economic development programs primarily intended to reduce the
				production or trafficking of illicit drugs;</text>
							</subparagraph><subparagraph id="id203AD239D0454A63A3229D6059220A91"><enum>(C)</enum><text>activities to control
				international trafficking in, and availability of, illegal drugs,
				including—</text>
								<clause id="id2A6F4DF76B45475F8F1E8467A79326D1"><enum>(i)</enum><text>accurate assessment and
				monitoring of international drug production and interdiction programs and
				policies; and</text>
								</clause><clause id="idB792D3CB623A463EA53B2AE2EC045E43"><enum>(ii)</enum><text>coordination and
				promotion of compliance with international treaties relating to the production,
				transportation, or interdiction of illegal drugs;</text>
								</clause></subparagraph><subparagraph id="id0DB64A257D314C8EA3F1A0C361846825"><enum>(D)</enum><text>activities to conduct and
				promote international law enforcement programs and policies to reduce the
				supply of drugs; and</text>
							</subparagraph><subparagraph id="id7A900244C6484F43B7574E2CB574EC4A"><enum>(E)</enum><text>activities to facilitate
				and enhance the sharing of domestic and foreign intelligence information among
				National Drug Control Program agencies, relating to the production and
				trafficking of drugs in the United States and in foreign
				countries.</text>
							</subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection><subsection changed="added" id="id0609294BDB77413FBCA2246675DC3B2E" reported-display-style="italic"><enum>(f)</enum><header>Definitions of
			 appropriate congressional committees and law enforcement</header><text>Section
			 702 is amended by adding at the end the following:</text>
					<quoted-block changed="added" display-inline="no-display-inline" id="idA9B2CA3CBB684EC8970CD4B2F7BAAE71" reported-display-style="italic" style="OLC">
						<paragraph id="id7BB3E60B42EE4E3B9DD5D6150427BA34"><enum>(12)</enum><header>Appropriate
				congressional committees</header><text>Except where otherwise provided, the
				term <term>appropriate congressional committees</term> means the Committee on
				the Judiciary, the Committee on Appropriations, and the Caucus on International
				Narcotics Control of the Senate and the Committee on Government Reform, the
				Committee on the Judiciary, and the Committee on Appropriations of the House of
				Representatives.</text>
						</paragraph><paragraph id="idD049698FA3974EDC948B8C91CC6270AE"><enum>(13)</enum><header>Law
				enforcement</header><text>The term <term>law enforcement</term> or <term>drug
				law enforcement</term> means all efforts by a Federal, State, or local
				government agency to enforce the drug laws of the United States or any State,
				including investigation, arrest, prosecution, and incarceration or other
				punishments or
				penalities.</text>
						</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection></section><section changed="added" id="id75419ECC67C94517868F29AD2DCA0B3F" reported-display-style="italic"><enum>102.</enum><header>Establishment of the
			 Office of National Drug Control Policy</header>
				<subsection changed="added" id="idAB5397E8FF704F669185EDA4B5754209" reported-display-style="italic"><enum>(a)</enum><header>Responsibilities</header><text>Section
			 703(a) is amended to read as follows:</text>
					<quoted-block changed="added" id="id34EA78A5DD85436D9431FC7CDF8F3EAE" reported-display-style="italic" style="OLC">
						<subsection id="idDEA2407EC4894BC6A25742B67BF2D54F"><enum>(a)</enum><header>Establishment of
				Office</header><text>There is established in the Executive Office of the
				President an Office of National Drug Control Policy, which shall—</text>
							<paragraph id="id59511A345A224C2E86A863332EB26DB1"><enum>(1)</enum><text>develop national drug
				control policy;</text>
							</paragraph><paragraph id="id067B14C76F9F4206A577B58F6767039E"><enum>(2)</enum><text>coordinate and oversee
				the implementation of the national drug control policy;</text>
							</paragraph><paragraph id="id22309ADDC6884B4C935B389E9171146C"><enum>(3)</enum><text>assess and certify the
				adequacy of National Drug Control Programs and the budget for those
				programs;</text>
							</paragraph><paragraph id="id24D570477C484AD5B124AD2DC1E697C8"><enum>(4)</enum><text>evaluate the
				effectiveness of National Drug Control Program agencies’ programs; and</text>
							</paragraph><paragraph id="id770D4100DB5A4BBF967B0DE517A7737C"><enum>(5)</enum><text>develop specific goals
				and performance measurements needed to assess the effectiveness of—</text>
								<subparagraph id="id2888791DC4B442FDA5B731B8B6B848D3"><enum>(A)</enum><text>the national drug control
				policy; and</text>
								</subparagraph><subparagraph id="id66F38BFEB2A54974AA1955D1950B28E7"><enum>(B)</enum><text>the programs of the
				National Drug Control Program
				agencies.</text>
								</subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection><subsection changed="added" id="idFDDB211712EC46F0A558B0CBFBBFDCA6" reported-display-style="italic"><enum>(b)</enum><header>Positions</header><text>Section
			 703(b) is amended to read as follows:</text>
					<quoted-block changed="added" id="id6FA043FBB96C43C998C3A8AFAE2B63A3" reported-display-style="italic" style="OLC">
						<subsection id="id2850FCD553C8473B9D97364E7F635B32"><enum>(b)</enum><header>Director of National
				Drug Control Policy and Deputy Directors</header>
							<paragraph id="id50033D36BF524639A4E2A28611B24675"><enum>(1)</enum><header>Director</header><text>There
				shall be a Director of National Drug Control Policy who shall head the Office
				(referred to in this Act as the <quote>Director</quote>).</text>
							</paragraph><paragraph id="id5A4ECAA81917484FB29BB8F4BF3BD891"><enum>(2)</enum><header>Deputy
				director</header><text>There shall be a Deputy Director of National Drug
				Control Policy who shall report directly to the Director (referred to in this
				Act as the <quote>Deputy Director</quote>).</text>
							</paragraph><paragraph id="id81671244ECBB43A7AF95D75D09D176B2"><enum>(3)</enum><header>Other deputy
				directors</header>
								<subparagraph id="idBDDABEEBFCED4A4D8F223150074B43B9"><enum>(A)</enum><header>In
				general</header><text>There shall be a Deputy Director for Demand Reduction, a
				Deputy Director for Supply Reduction, and a Deputy Director for State and Local
				Affairs.</text>
								</subparagraph><subparagraph id="id7CFE0D90AE0943D59C1503125AFCE389"><enum>(B)</enum><header>Reporting</header><text>The
				Deputy Director for Demand Reduction, the Deputy Director for Supply Reduction,
				and the Deputy Director for State and Local Affairs shall report directly to
				the Deputy Director of the Office of National Drug Control Policy.</text>
								</subparagraph><subparagraph id="id7E7E21DF9E244437903C572056C69064"><enum>(C)</enum><header>Deputy director for
				demand reduction</header><text>The Deputy Director for Demand Reduction shall
				be responsible for the activities—</text>
									<clause id="idD74BD256F6B542529384BEFC71B62035"><enum>(i)</enum><text>in subparagraphs (A)
				through (H) of section 702(l); and</text>
									</clause><clause id="id48D1D8B30E8144E0A73ABA319E0C2B57"><enum>(ii)</enum><text>in section 709, the
				National Youth Anti-Drug Media Campaign Act.</text>
									</clause></subparagraph><subparagraph id="id9DDF843A26AB43E797A84F24504F0EA5"><enum>(D)</enum><header>Deputy director for
				supply reduction</header><text>The Deputy Director for Supply Reduction shall
				be responsible for the activities in subparagraphs (A) through (C) in section
				702(11).</text>
								</subparagraph><subparagraph id="id961254B219ED4742B8C0CEB6F9368568"><enum>(E)</enum><header>Deputy director for
				state and local affairs</header><text>The Deputy Director for State and Local
				Affairs shall be responsible for the activities—</text>
									<clause id="id14FB477C87DC4054BF5DFD505938ADEA"><enum>(i)</enum><text>in subparagraphs (A)
				through (D) of section 702(10);</text>
									</clause><clause id="id0BD7A6FD354D49C881B5B79C223D6E38"><enum>(ii)</enum><text>in section 707, the High
				Intensity Drug Trafficking Areas Program; and</text>
									</clause><clause id="idCAE24E0AF3404EBC80D5FEA10582F65C"><enum>(iii)</enum><text>in section 708, the
				Counterdrug Technology Assessment
				Center.</text>
									</clause></subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection></section><section changed="added" id="id61B8A726F465406CA5A38C77BC759B96" reported-display-style="italic"><enum>103.</enum><header>Appointment and
			 responsibilities of the Director</header>
				<subsection changed="added" id="id40412F29332E4DF3BA5C0BA25C1B757C" reported-display-style="italic"><enum>(a)</enum><header>Succession</header><text>Section
			 704(a) is amended by amending paragraph (3) to read as follows:</text>
					<quoted-block changed="added" id="id62CEB2B85ECE401CBD5DF499E1BFAFC8" reported-display-style="italic" style="OLC">
						<paragraph id="id6BF70ED7110C4A4485C65B14B82B0C40"><enum>(3)</enum><header>Acting
				director</header><text>If the Director dies, resigns, or is otherwise unable to
				perform the functions and duties of the office, the Deputy Director shall
				perform the functions and duties of the Director temporarily in an acting
				capacity pursuant to subchapter III of chapter 33 of title 5, United States
				Code.</text>
						</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection><subsection changed="added" id="id939D359ED9254DF6980A92911137B477" reported-display-style="italic"><enum>(b)</enum><header>Responsibilities</header><text>Section
			 704(b) is amended—</text>
					<paragraph changed="added" id="id83A0EB72600D4F568FBD3F2327FCE128" reported-display-style="italic"><enum>(1)</enum><text>in paragraph (4), by
			 striking <quote>Federal departments and agencies engaged in drug
			 enforcement</quote> and inserting <quote>National Drug Control Program
			 agencies</quote>;</text>
					</paragraph><paragraph changed="added" id="idBEA13301365B481BBEB3D6C0B4F96323" reported-display-style="italic"><enum>(2)</enum><text>in paragraph (7), by
			 inserting after <quote>President</quote> the following: <quote>and the
			 appropriate congressional committees</quote>;</text>
					</paragraph><paragraph changed="added" id="idE799E1C26D9B46B2BA9F50CCAD71EA69" reported-display-style="italic"><enum>(3)</enum><text>in paragraph (13), by
			 striking <quote>(beginning in 1999)</quote>;</text>
					</paragraph><paragraph changed="added" id="idF027E8A178124992B632E895EDFA6E46" reported-display-style="italic"><enum>(4)</enum><text>by striking paragraph
			 (14) and inserting the following:</text>
						<quoted-block changed="added" id="id11F34488CE7C4A1CBC71D9AD364E25D1" reported-display-style="italic" style="OLC">
							<paragraph id="id9B6B7ED5E1E2448D8A2DB7A6E430342E"><enum>(14)</enum><text>shall submit to the
				appropriate congressional committees on an annual basis, not later than 60 days
				after the date of the last day of the applicable period, a summary of—</text>
								<subparagraph id="id2047D6D93D274C84B9D925B16FF3A082"><enum>(A)</enum><text>each of the evaluations
				received by the Director under paragraph (13); and</text>
								</subparagraph><subparagraph id="id30B1735CCEA0456E93C9E2AED1E89511"><enum>(B)</enum><text>the progress of each
				National Drug Control Program agency toward the drug control program goals of
				the agency using the performance measures for the agency developed under
				section
				706(c);</text>
								</subparagraph></paragraph><after-quoted-block>;</after-quoted-block></quoted-block>
					</paragraph><paragraph changed="added" id="idE2A470D1BED54CA791560A86FFDE5309" reported-display-style="italic"><enum>(5)</enum><text>in paragraph (15), by
			 striking subparagraph (C) and inserting the following:</text>
						<quoted-block changed="added" id="id677875DC10DB4F6C9B597DCEF3CBC7FF" reported-display-style="italic" style="OLC">
							<subparagraph id="idFF0AF0823DB740A99D71B280EDA45C0B"><enum>(C)</enum><text>supporting the substance
				abuse information clearinghouse administered by the Administrator of the
				Substance Abuse and Mental Health Services Administration and established in
				section 501(d)(16) of the <act-name parsable-cite="PHSA">Public Health Service
				Act</act-name> by—</text>
								<clause id="idB00D239DBDE74E9D8688BEDFDAE1B720"><enum>(i)</enum><text>encouraging all National
				Drug Control Program agencies to provide all appropriate and relevant
				information; and</text>
								</clause><clause id="id5DF33BA174C940B4AB5D480B6C364735"><enum>(ii)</enum><text>supporting the
				dissemination of information to all interested
				entities;</text>
								</clause></subparagraph><after-quoted-block>;
				and</after-quoted-block></quoted-block>
					</paragraph><paragraph changed="added" id="idA04753FF9BCD4FD6A8C0294D0C622AAE" reported-display-style="italic"><enum>(6)</enum><text>by inserting at the end
			 the following:</text>
						<quoted-block changed="added" id="id3CAFE190D4254388A998E2D4CC5E3A6D" reported-display-style="italic" style="OLC">
							<paragraph id="id2233E2F9A31149128A49552B5C1499F6"><enum>(16)</enum><text>shall coordinate with
				the private sector to promote private research and development of medications
				to treat addiction;</text>
							</paragraph><paragraph id="id84B26D629D3E4F5D8ECF472A5825ADFF"><enum>(17)</enum><text>shall seek the support
				and commitment of State and local officials in the formulation and
				implementation of the National Drug Control Strategy;</text>
							</paragraph><paragraph id="id96DEEF78EFE14820A8FB6D45CDE56F8A"><enum>(18)</enum><text>shall monitor and
				evaluate the allocation of resources among Federal law enforcement agencies in
				response to significant local and regional drug trafficking and production
				threats; and</text>
							</paragraph><paragraph id="id60DAA3E28C9B43F4AC18B758A719BE97"><enum>(19)</enum><text>shall submit an annual
				report to Congress detailing how the Office of National Drug Control Policy has
				consulted with and assisted State and local governments with respect to the
				formulation and implementation of the National Drug Control Strategy and other
				relevant
				issues.</text>
							</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph></subsection><subsection changed="added" id="id2C1A9ED7892148B5A01AE30663DF724E" reported-display-style="italic"><enum>(c)</enum><header>Review and
			 certification of National Drug Control Program budget</header><text>Section
			 704(c)(3) is amended—</text>
					<paragraph changed="added" id="id9469B1F44D684C08B9278010BBDCF1C3" reported-display-style="italic"><enum>(1)</enum><text>in subparagraph (C)(iii),
			 by inserting <quote>and the appropriate congressional committees,</quote> after
			 <quote>House of Representatives</quote>; and</text>
					</paragraph><paragraph changed="added" id="id9A212F223CE8484FA86D6E70E4D032BB" reported-display-style="italic"><enum>(2)</enum><text>in subparagraph
			 (D)(ii)(II)(bb), by inserting <quote>and the appropriate congressional
			 committees,</quote> after <quote>House of Representatives</quote>.</text>
					</paragraph></subsection><subsection changed="added" id="id50D19B2CBA7F4220967A8480A9D3AD4E" reported-display-style="italic"><enum>(d)</enum><header>Powers of
			 Director</header><text>Section 704(d) is amended—</text>
					<paragraph changed="added" id="id79E96CFFED90467EACE541B4419A2B9E" reported-display-style="italic"><enum>(1)</enum><text>in paragraph (9)—</text>
						<subparagraph changed="added" id="id090EB2543CB043A0899426E8B9D819EF" reported-display-style="italic"><enum>(A)</enum><text>by inserting
			 <quote>notwithstanding any other provision of law,</quote> after
			 <quote>(9)</quote>; and</text>
						</subparagraph><subparagraph changed="added" id="idF4BE51246F84425BB8FDDFD14A40DA55" reported-display-style="italic"><enum>(B)</enum><text>by striking
			 <quote>Strategy; and</quote> and inserting <quote>Strategy and notify the
			 appropriate congressional committees of any fund control notice issued in
			 accordance with section 704(f)(5);</quote>; and</text>
						</subparagraph></paragraph><paragraph changed="added" id="id2B46B8B2A4FB424597AE2FFF84F39E4E" reported-display-style="italic"><enum>(2)</enum><text>in paragraph (10), by
			 inserting before the period the following: <quote>and section 706 of the
			 Department of State Authorization Act for Fiscal Year 2003 (22 U.S.C.
			 229j–1)</quote>.</text>
					</paragraph></subsection><subsection changed="added" id="id570F846A2168492DB86A1807EE0B7261" reported-display-style="italic"><enum>(e)</enum><header>Fund control
			 notices</header><text>Section 704(f) is amended by adding at the end the
			 following:</text>
					<quoted-block changed="added" id="id0B291872EF03457089CECEE4076075AC" reported-display-style="italic" style="OLC">
						<paragraph id="id9914374A797D406B9550BF458FC53620"><enum>(4)</enum><header>Congressional
				notice</header><text>A copy of each fund control notice shall be transmitted to
				the appropriate congressional committees.</text>
						</paragraph><paragraph id="id4F931C64DF514CCD8046E3E4DF88BBA6"><enum>(5)</enum><header>Restrictions</header><text>The
				Director shall not issue a fund control notice to direct that all or part of an
				amount appropriated to the National Drug Control Program agency account be
				obligated, modified, or altered in any manner—</text>
							<subparagraph id="id8118E7AC503849769AEEB4F367BA40CA"><enum>(A)</enum><text>contrary, in whole or in
				part, to a specific appropriation; or</text>
							</subparagraph><subparagraph id="id66BA8CCF349C48E6B5A9B75E4FE4B2F8"><enum>(B)</enum><text>contrary, in whole or in
				part, to the expressed intent of
				Congress.</text>
							</subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection><subsection changed="added" id="idFC3D1C9449BA4F3BB51323F3216DC114" reported-display-style="italic"><enum>(f)</enum><header>United States
			 Interdiction Coordinator</header>
					<paragraph changed="added" id="idB3128E9D65E64D659B8ACABFCB760EF5" reported-display-style="italic"><enum>(1)</enum><header>In
			 general</header><text>Section 704 is amended by adding at the end the
			 following:</text>
						<quoted-block changed="added" id="id9E75E824E7AB4D21BD4B77DB4D980040" reported-display-style="italic" style="OLC">
							<subsection id="idD9324A254A764436A4705D651C0AF6FE"><enum>(i)</enum><header>United States
				Interdiction Coordinator</header>
								<paragraph id="id507D793112D549B597B9337BBFCADCDF"><enum>(1)</enum><header>In
				general</header><text>There shall be a United States Interdiction Coordinator,
				who shall be designated by the Director and who shall be responsible for the
				coordination of interdiction operations among National Drug Control Program
				agencies to prevent and reduce the illegal importation of drugs into the United
				States.</text>
								</paragraph><paragraph id="idD907CD421F224E67BBB51F908997266D"><enum>(2)</enum><header>Responsibilities</header><text>The
				United States Interdiction Coordinator shall be responsible to the Director
				for—</text>
									<subparagraph id="id19B0A8B8D21F4CB5A0430846EBE9AB17"><enum>(A)</enum><text>coordinating the
				interdiction activities of the National Drug Control Program agencies to ensure
				consistency with the National Drug Control Strategy;</text>
									</subparagraph><subparagraph id="idD6CCE3FE6AD447F7B8FF884C47B9BA89"><enum>(B)</enum><text>developing a National
				Drug Control Interdiction plan to ensure consistency with the National Drug
				Control Strategy;</text>
									</subparagraph><subparagraph id="id560906F3178C417296CD751F323341C1"><enum>(C)</enum><text>assessing the sufficiency
				of assets of the National Drug Control Program agencies committed to illicit
				drug interdiction; and</text>
									</subparagraph><subparagraph id="idA1384FF5856F40D8BA69816B7C42A333"><enum>(D)</enum><text>advising the Director on
				the efforts of each National Drug Control Program Agency to implement the
				National Drug Control Interdiction
				plan.</text>
									</subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph><paragraph changed="added" id="idD8C64C213513497BBCC30971503E8C12" reported-display-style="italic"><enum>(2)</enum><header>Amendment to homeland
			 security act of 2002</header><text>Section 878 of the Homeland Security Act of
			 2002 (6 U.S.C. 458) is amended by striking <quote>shall—</quote> through
			 paragraph (2) and inserting <quote>shall ensure the adequacy of resources
			 within the Department for illicit drug interdiction.</quote>.</text>
					</paragraph></subsection></section><section changed="added" id="id99559CBB3E2941178FF8108B6FACC85C" reported-display-style="italic"><enum>104.</enum><header>Amendments to ensure
			 coordination with other agencies</header><text display-inline="no-display-inline">Section 705 is amended—</text>
				<paragraph changed="added" id="id5906C6237F634E82BE590B58323A6D59" reported-display-style="italic"><enum>(1)</enum><text>in subsection (a)(1)(A),
			 by striking <quote>abuse</quote>;</text>
				</paragraph><paragraph changed="added" id="idFFD58806679649E99828666CA27C5A77" reported-display-style="italic"><enum>(2)</enum><text>by amending subsection
			 (a)(3) to read as follows:</text>
					<quoted-block changed="added" id="id1FE2AA5DA6AE4B0B9ACD9AC91FC7511B" reported-display-style="italic" style="OLC">
						<paragraph id="id59A3043CCC504C398628199F047009CD"><enum>(3)</enum><header>Required
				reports</header>
							<subparagraph id="id09015F254E4647A38F8FAD35054260F1"><enum>(A)</enum><header>Secretaries of the
				Interior and Agriculture</header><text>Not later than July 1 of each year, the
				Secretaries of Agriculture and the Interior shall jointly submit to the
				Director and the appropriate congressional committees an assessment of the
				quantity of illegal drug cultivation and manufacturing in the United States on
				lands owned or under the jurisdiction of the Federal Government for the
				preceding year.</text>
							</subparagraph><subparagraph id="idCAA6B001A2BA41A8ABF80D48CC5D827B"><enum>(B)</enum><header>Secretary of Homeland
				Security</header><text>Not later than July 1 of each year, the Secretary of
				Homeland Security shall submit to the Director and the appropriate
				congressional committees information for the preceding year regarding—</text>
								<clause id="id3809CAE03AF64DA2975D38AF0F02D331"><enum>(i)</enum><text>the number and type of
				seizures of drugs by each component of the Department of Homeland Security
				seizing drugs, as well as statistical information on the geographic areas of
				such seizures; and</text>
								</clause><clause id="idF324F2A843304380A2C47EAB60762381"><enum>(ii)</enum><text>the number of air and
				maritime patrol hours primarily dedicated to drug supply reduction missions
				undertaken by each component of the Department of Homeland Security.</text>
								</clause></subparagraph><subparagraph id="id81B59F88DDB249E8877AD2B088FD6A23"><enum>(C)</enum><header>Secretary of
				Defense</header><text>The Secretary of Defense shall, by July 1 of each year,
				submit to the Director and the appropriate congressional committees information
				for the preceding year regarding the number of air and maritime patrol hours
				primarily dedicated to drug supply reduction missions undertaken by each
				component of the Department of Defense.</text>
							</subparagraph></paragraph><after-quoted-block>;
				and</after-quoted-block></quoted-block>
				</paragraph><paragraph changed="added" id="idBD1D82E6B95F4C9BB9E370CA550EA3F0" reported-display-style="italic"><enum>(3)</enum><text>in subsection (b)(2)(B),
			 by striking <quote>Program</quote> and inserting
			 <quote>Strategy</quote>.</text>
				</paragraph></section><section changed="added" id="idE3E75228D58C4BDBBCA1E08E6DA20AD5" reported-display-style="italic"><enum>105.</enum><header>Budgetary
			 matters</header>
				<subsection changed="added" id="id2AF0BA20A2894AFBB4FEAA7A2BFAF7FD" reported-display-style="italic"><enum>(a)</enum><header>Submission of drug
			 control budget requests</header><text>Section 704(c)(1) is amended by adding at
			 the end the following:</text>
					<quoted-block changed="added" display-inline="no-display-inline" id="idFB518ACAF491489EACCB54FC6B8CC336" reported-display-style="italic" style="OLC">
						<subparagraph id="id6399B2416EF440408122470030C28075"><enum>(C)</enum><header>Content of drug control
				budget requests</header><text>A drug control budget request submitted by a
				department, agency, or program under this paragraph shall include all requests
				for funds for any drug control activity undertaken by that department, agency,
				or program, including demand reduction, supply reduction, and State and local
				affairs, including any drug law enforcement activities. If an activity has both
				drug control and nondrug control purposes or applications, the department,
				agency, or program shall estimate by a documented calculation the total funds
				requested for that activity that would be used for drug control, and shall set
				forth in its request the basis and method for making the
				estimate.</text>
						</subparagraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection><subsection changed="added" id="idFC62224FABCF485EA33D8C530A76BB24" reported-display-style="italic"><enum>(b)</enum><header>National drug control
			 budget proposal</header>
					<paragraph changed="added" id="idFB68E27B9F9E4F0FA1CE7BEABD46DB46" reported-display-style="italic"><enum>(1)</enum><header>National
			 organizations</header><text>Section 704(c)(2) is amended by inserting
			 <quote>and the head of each major national organization that represents law
			 enforcement officers, agencies, or associations</quote> after
			 <quote>agency</quote>.</text>
					</paragraph><paragraph changed="added" id="id15F706DD3A7A48A89210EFDDB329F0C0" reported-display-style="italic"><enum>(2)</enum><header>Total
			 budget</header><text>Section 704(c)(2)(A) is amended by inserting before the
			 semicolon: <quote>and to inform Congress and the public about the total amount
			 proposed to be spent on all supply reduction, demand reduction, State and local
			 affairs, including any drug law enforcement, and other drug control activities
			 by the Federal Government, which shall conform to the content requirements set
			 forth in paragraph (1)(C)</quote>.</text>
					</paragraph></subsection><subsection changed="added" id="idF910FD970A7E4B2AAE6A7D12E41447D1" reported-display-style="italic"><enum>(c)</enum><header>Review and
			 certification of National Drug Control Program budget</header><text>Section
			 704(c)(3) is amended—</text>
					<paragraph changed="added" id="ID965c3f4cc5cc48ad9f6c085319802985" reported-display-style="italic"><enum>(1)</enum><text>by redesignating
			 subparagraphs (C) and (D) as subparagraphs (D) and (E), respectively;</text>
					</paragraph><paragraph changed="added" id="IDa5825edca1764939980e83e50a5d2ed5" reported-display-style="italic"><enum>(2)</enum><text>by inserting after
			 subparagraph (B) the following new subparagraph:</text>
						<quoted-block changed="added" display-inline="no-display-inline" id="id4BBBADBE88DE40B88C90247DFEC391BB" reported-display-style="italic" style="OLC">
							<subparagraph id="ID5623cbf1871b46979da495a05c07fd29"><enum>(C)</enum><header>Specific
				requests</header><text>The Director shall not confirm the adequacy of any
				budget request that—</text>
								<clause id="ID347205529ab348129b66658e2ac17703"><enum>(i)</enum><text>requests funding for
				Federal law enforcement activities that do not adequately compensate for
				transfers of drug enforcement resources and personnel to law enforcement and
				investigation activities;</text>
								</clause><clause id="ID9132d50cd62d4c52848d678a83820e1d"><enum>(ii)</enum><text>requests funding for law
				enforcement activities on the borders of the United States that do not
				adequately direct resources to drug interdiction and enforcement;</text>
								</clause><clause id="ID6045108ecaa047a0b93fb3be185c2725"><enum>(iii)</enum><text>requests funding for
				drug treatment activities that do not provide adequate results and
				accountability measures;</text>
								</clause><clause id="ID97614963ae0949b6bbdabe1916f7529b"><enum>(iv)</enum><text>requests funding for any
				activities of the Safe and Drug-Free Schools Program that do not include a
				clear antidrug message or purpose intended to reduce drug use;</text>
								</clause><clause id="IDdc6939d40e4c4d72ad7998f12f92e65e"><enum>(v)</enum><text>requests funding for drug
				treatment activities that do not adequately support and enhance Federal drug
				treatment programs and capacity;</text>
								</clause><clause id="IDb34d7c7922e84572a8d3ae97a51a1394"><enum>(vi)</enum><text>requests funding for
				fiscal year 2007 for activities of the Department of Education, unless it is
				accompanied by a report setting forth a plan for providing expedited
				consideration of student loan applications for all individuals who submitted an
				application for any Federal grant, loan, or work assistance that was rejected
				or denied pursuant to 484(r)(1) of the Higher Education Act of 1965 (20 U.S.C.
				1091(r)(1)) by reason of a conviction for a drug-related offense not occurring
				during a period of enrollment for which the individual was receiving any
				Federal grant, loan, or work assistance; and</text>
								</clause><clause id="ID6b368904b76349c5950b724451a433cb"><enum>(vii)</enum><text>requests funding for
				the operations and management of the Department of Homeland Security that does
				not include a specific request for funds for the Office of Counternarcotics
				Enforcement to carry out its responsibilities under section 878 of the Homeland
				Security Act of 2002 (6 U.S.C.
				458).</text>
								</clause></subparagraph><after-quoted-block>;</after-quoted-block></quoted-block>
					</paragraph><paragraph changed="added" id="ID4fdfa5b9ae6c4eceb6ba6787bc4a617d" reported-display-style="italic"><enum>(3)</enum><text>in subparagraph (D)(iii),
			 as so redesignated, by inserting <quote>and the appropriate congressional
			 committees</quote> after <quote>House of Representatives</quote>; and</text>
					</paragraph><paragraph changed="added" id="ID1ccff4f9bb3f409d9918933d0916e138" reported-display-style="italic"><enum>(4)</enum><text>in subparagraph
			 (E)(ii)(II)(bb), as so redesignated, by inserting <quote>and the appropriate
			 congressional committees</quote> after <quote>House of
			 Representatives</quote>.</text>
					</paragraph></subsection><subsection changed="added" id="idF9FF7907C0A4410C96832129596B2759" reported-display-style="italic"><enum>(d)</enum><header>Powers of
			 Director</header><text>Section 704(d) is amended—</text>
					<paragraph changed="added" id="ID1292790cfcca441faf59b73f071440f2" reported-display-style="italic"><enum>(1)</enum><text>in paragraph (8)(D), by
			 striking <quote>have been authorized by Congress;</quote> and inserting
			 <quote>authorized by law;</quote>;</text>
					</paragraph><paragraph changed="added" id="IDd6b8ab24bc274f30a57c333f92f3d8e5" reported-display-style="italic"><enum>(2)</enum><text>in paragraph (9)—</text>
						<subparagraph changed="added" id="IDfdf8a70d3aa44410b837fef2331295f6" reported-display-style="italic"><enum>(A)</enum><text>by inserting
			 <quote>notwithstanding any other provision of law,</quote> after
			 <quote>(9)</quote>; and</text>
						</subparagraph><subparagraph changed="added" id="ID0d47614c0a7e4fb5a3f0376c59963c5e" reported-display-style="italic"><enum>(B)</enum><text>by striking
			 <quote>Strategy; and</quote> and inserting <quote>Strategy and notify the
			 appropriate congressional committees of any fund control notice
			 issued;</quote>;</text>
						</subparagraph></paragraph><paragraph changed="added" id="IDd02ab892017c4860a65c6204eaf4d30b" reported-display-style="italic"><enum>(3)</enum><text>in paragraph (10), by
			 striking <quote>(22 U.S.C. 2291j).</quote> and inserting <quote>(22 U.S.C.
			 2291j) and section 706 of the Foreign Relations Authorization Act, Fiscal Year
			 2003 (22 U.S.C. 2291j–1); and</quote>; and</text>
					</paragraph><paragraph changed="added" id="IDa1caa01eddc04dc68898a66e38de0048" reported-display-style="italic"><enum>(4)</enum><text>by adding at the end the
			 following new paragraph:</text>
						<quoted-block changed="added" display-inline="no-display-inline" id="id69E54D3DF2D54AC1BA8B7CC209C5A79B" reported-display-style="italic" style="OLC">
							<paragraph id="ID77dec449a1384bfa9a39b9ed8b03c577"><enum>(11)</enum><text>not later than August 1
				of each year, submit to the President a report, and transmit copies of the
				report to the Secretary of State and the appropriate congressional committees,
				that—</text>
								<subparagraph id="IDa35ccbed874f4ec0af7e605c1cba91f3"><enum>(A)</enum><text>provides the Director's
				assessment of which countries are major drug transit countries or major illicit
				drug producing countries as defined in section 481(e) of the Foreign Assistance
				Act of 1961 (22 U.S.C. 2291(e));</text>
								</subparagraph><subparagraph id="IDbb5ead6a24c14dc380dba8e1d24f5b0a"><enum>(B)</enum><text>provides the Director's
				assessment of whether each country identified under subparagraph (A) has
				cooperated fully with the United States or has taken adequate steps on its own
				to achieve full compliance with the goals and objectives established by the
				United Nations Convention Against Illicit Traffic in Narcotic Drugs and
				Psychotropic Substances and otherwise has assisted in reducing the supply of
				illicit drugs to the United States; and</text>
								</subparagraph><subparagraph id="IDbc8ea196aa864b3ea1c6876ecb0dbfeb"><enum>(C)</enum><text>provides the Director's
				assessment of whether application of procedures set forth in section 490 of the
				Foreign Assistance Act of 1961 (22 U.S.C. 2291j), as provided in section 706 of
				the Foreign Relations Authorization Act, Fiscal Year 2003 (22 U.S.C. 2291j–1),
				is warranted with respect to countries the Director assesses have not
				cooperated
				fully.</text>
								</subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph></subsection><subsection changed="added" id="id8E9CE58839304C98BEB4BED7B8893458" reported-display-style="italic"><enum>(e)</enum><header>Fund control
			 notices</header><text>Section 704(f) (21 U.S.C. 1703(f)) is amended by adding
			 at the end the following:</text>
					<quoted-block changed="added" display-inline="no-display-inline" id="id63A8FEB573F546318417B2D330389E10" reported-display-style="italic" style="OLC">
						<paragraph id="ID4577437c929d4f70985c9b87d4f43de0"><enum>(4)</enum><header>Congressional
				notice</header><text>A copy of each fund control notice shall be transmitted to
				the appropriate congressional committees.</text>
						</paragraph><paragraph id="IDbffc64e5e44942e5be09731d80da0e78"><enum>(5)</enum><header>Restrictions</header><text>The
				Director shall not issue a fund control notice to direct that all or part of an
				amount appropriated to the National Drug Control Program agency account be
				obligated, modified, or altered in any manner contrary, in whole or in part, to
				a specific appropriation or
				statute.</text>
						</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection></section></title><title changed="added" id="id13791EA37194472B91DD7C48FCF71441" reported-display-style="italic"><enum>II</enum><header>The National Drug
			 Control Strategy</header>
			<section changed="added" id="id909ED037AAC1475C93EF06EECB39CCAA" reported-display-style="italic"><enum>201.</enum><header>Annual preparation and
			 submission of National Drug Control Strategy</header><text display-inline="no-display-inline">Section 706 is amended to read as
			 follows:</text>
				<quoted-block changed="added" id="idC8CBAD0E0A304A07BDDD46CB891FFF66" reported-display-style="italic" style="OLC">
					<section id="id315ABB55B3564DE8A32403945B21F186"><enum>706.</enum><header>Development,
				submission, implementation, and assessment of National Drug Control
				Strategy</header>
						<subsection id="id8BEEABA7DBC140F582C9226C0B0CAEC3"><enum>(a)</enum><header>Timing, contents, and
				process for development and submission of National Drug Control
				Strategy</header>
							<paragraph id="id5D7A0CF1ACA24CA581774363A925CEA1"><enum>(1)</enum><header>Timing</header><text>Not
				later than February 1 of each year, the President shall submit to Congress a
				National Drug Control Strategy, which shall set forth a comprehensive plan for
				the year to reduce drug abuse and the consequences of such drug abuse in the
				United States by limiting the availability of, and reducing the demand for,
				illegal drugs.</text>
							</paragraph><paragraph id="idEAF5E00536EF4805A6F0D129CF65DF86"><enum>(2)</enum><header>Contents</header>
								<subparagraph id="idEBD4A36825E24D1B92A485A487090166"><enum>(A)</enum><header>In
				general</header><text>The National Drug Control Strategy submitted under
				paragraph (1) shall include—</text>
									<clause id="id7BBE70A660814ADFA2B0C6F06DED68C0"><enum>(i)</enum><text>comprehensive,
				research-based, long-range, quantifiable goals for reducing drug abuse and the
				consequences of drug abuse in the United States;</text>
									</clause><clause id="id6EEF3EE3EC034E1DB045B12015C932C0"><enum>(ii)</enum><text>annual quantifiable and
				measurable objectives and specific targets to accomplish long-term quantifiable
				goals that the Director determines may be achieved during each year beginning
				on the date on which the National Drug Control Strategy is submitted;</text>
									</clause><clause id="id959953394A944F77BB879493BC8E6EE3"><enum>(iii)</enum><text>5-year projections for
				program and budget priorities;</text>
									</clause><clause id="id1B054AD369124325BE8D92276DB5D6BA"><enum>(iv)</enum><text>a review of
				international, State, local, and private sector drug control activities to
				ensure that the United States pursues coordinated and effective drug control at
				all levels of government;</text>
									</clause><clause id="id86020ED1D7D84FBA9C5C6D70171B1621"><enum>(v)</enum><text>an assessment of current
				illicit drug use (including inhalants) and availability, impact of illicit drug
				use, and treatment availability, which assessment shall include—</text>
										<subclause id="id9C8A0AA98A2742CF8747FDAC1AE88B08"><enum>(I)</enum><text>estimates of drug
				prevalence and frequency of use as measured by national, State, and local
				surveys of illicit drug use and by other special studies of nondependent and
				dependent illicit drug use;</text>
										</subclause><subclause id="id2F3B4FAF621D4A288874ED72F9692202"><enum>(II)</enum><text>illicit drug use in the
				workplace and the productivity lost by such use; and</text>
										</subclause><subclause id="id9C3EF6E07E5F46F9A8D86FBDF7CEAEDA"><enum>(III)</enum><text>illicit drug use by
				arrestees, probationers, and parolees;</text>
										</subclause></clause><clause id="id707F989607C44BF2B7AA95F5E3DE47BD"><enum>(vi)</enum><text>an assessment of the
				reduction of illicit drug availability, as measured by—</text>
										<subclause id="id142392CA01224FC8ACE1B49380D553DD"><enum>(I)</enum><text>the quantities of
				cocaine, heroin, marijuana, methamphetamine, ecstasy, and other drugs available
				for consumption in the United States;</text>
										</subclause><subclause id="idEEAE0F75825A4A338422C753CAB8FBB8"><enum>(II)</enum><text>the amount of marijuana,
				cocaine, heroin, methamphetamine, ecstasy, and precursor chemicals and other
				drugs entering the United States;</text>
										</subclause><subclause id="id58333F96A7594107BF91C9D4D7AE848F"><enum>(III)</enum><text>the number of illicit
				drug manufacturing laboratories seized and destroyed and the number of hectares
				of marijuana, poppy, and coca cultivated and destroyed domestically and in
				other countries;</text>
										</subclause><subclause id="id5D3C7BB76A014EC28F40D71E74D719B7"><enum>(IV)</enum><text>the number of metric
				tons of marijuana, heroin, cocaine, and methamphetamine seized and other drugs;
				and</text>
										</subclause><subclause id="id6473F4DC8BD94052B46AB0EF31FDC92F"><enum>(V)</enum><text>changes in the price and
				purity of heroin, methamphetamine, and cocaine, changes in the price of
				ecstasy, and changes in tetrahydrocannabinol level of marijuana and other
				drugs;</text>
										</subclause></clause><clause id="id3F67505E2B6C4F38ACA40198D03C1A3B"><enum>(vii)</enum><text>an assessment of the
				reduction of the consequences of illicit drug use and availability, which shall
				include—</text>
										<subclause id="idBD1EBB3FEA03447397E05D077007BEDF"><enum>(I)</enum><text>the burden illicit drug
				users placed on hospital emergency departments in the United States, such as
				the quantity of illicit drug-related services provided;</text>
										</subclause><subclause id="idAC5DD3623E4D4704B72ACBC9508F191B"><enum>(II)</enum><text>the annual national
				health care cost of illicit drug use; and</text>
										</subclause><subclause id="id09FE9C4850A54A5292CC6D16CC4C7138"><enum>(III)</enum><text>the extent of illicit
				drug-related crime and criminal activity;</text>
										</subclause></clause><clause id="idA81FC26211924C59A4DCF39AB951F311"><enum>(viii)</enum><text>a determination of the
				status of drug treatment in the United States, by assessing—</text>
										<subclause id="id590B73EDA0754192BEEBA0E097D01DB7"><enum>(I)</enum><text>public and private
				treatment utilization; and</text>
										</subclause><subclause id="id114F4E8501F34F62B129F46D732AAC73"><enum>(II)</enum><text>the number of illicit
				drug users the Director estimates meet diagnostic criteria for
				treatment;</text>
										</subclause></clause><clause id="id88C32904A37F4E81BE6BC163C53E0A20"><enum>(ix)</enum><text>a review of the research
				agenda of the Counterdrug Technology Assessment Center to reduce the
				availability and abuse of drugs; and</text>
									</clause><clause id="id552E4FD811314E2893E9216F9EEFB778"><enum>(x)</enum><text>a summary of the efforts
				made to coordinate with private sector entities to conduct private research and
				development of medications to treat addiction by—</text>
										<subclause id="id6E070385CC464BF19BC9A744BE751D84"><enum>(I)</enum><text>screening chemicals for
				potential therapeutic value;</text>
										</subclause><subclause id="id7BD72F64D0D44372B1F9BE86B8C82101"><enum>(II)</enum><text>developing promising
				compounds;</text>
										</subclause><subclause id="id1986760BD9D742E2B3FB7EFFEFB05D7B"><enum>(III)</enum><text>conducting clinical
				trials;</text>
										</subclause><subclause id="id7C86C19FDD4245B3A9C8B65E459A947A"><enum>(IV)</enum><text>seeking Food and Drug
				Administration approval for drugs to treat addiction;</text>
										</subclause><subclause id="idCD682FE2A6124C55B4E5C8C2278E365B"><enum>(V)</enum><text>marketing the drug for
				the treatment of addiction;</text>
										</subclause><subclause id="id646A046BFB6946709585E04AFA035A88"><enum>(VI)</enum><text>urging physicians to use
				the drug in the treatment of addiction; and</text>
										</subclause><subclause id="id7416B3192D3444CA86FD2B53B8FE0031"><enum>(VII)</enum><text>encouraging insurance
				companies to reimburse the cost of the drug for the treatment of
				addiction.</text>
										</subclause></clause></subparagraph><subparagraph id="id7DC18F48D1D74A18B6948147D4BE72DC"><enum>(B)</enum><header>Classified
				information</header><text>Any contents of the National Drug Control Strategy
				that involve information properly classified under criteria established by an
				Executive order shall be presented to Congress separately from the rest of the
				National Drug Control Strategy.</text>
								</subparagraph></paragraph><paragraph id="id32D74FBCB92F4624A7C9E61141D7DB46"><enum>(3)</enum><header>Process for development
				and submission</header><text>In developing and effectively implementing the
				National Drug Control Strategy, the Director—</text>
								<subparagraph id="idC25C431CDCE244588EFEB0EA15FD1A60"><enum>(A)</enum><text>shall consult
				with—</text>
									<clause id="idAE9BAA81BEDE419A819FAC024A701728"><enum>(i)</enum><text>the heads of the National
				Drug Control Program agencies;</text>
									</clause><clause id="id9167C1432EF740B2A82C1A398544715B"><enum>(ii)</enum><text>Congress;</text>
									</clause><clause id="id47E9F4007D414B008310ADF35A4A7A16"><enum>(iii)</enum><text>State and local
				officials;</text>
									</clause><clause id="id3E0B0634A4A1419185751D492867147C"><enum>(iv)</enum><text>private citizens and
				organizations with experience and expertise in demand reduction;</text>
									</clause><clause id="idA6376959881C437EB6E606C76193C967"><enum>(v)</enum><text>private citizens and
				organizations with experience and expertise in supply reduction; and</text>
									</clause><clause id="idB09180D8166C433A9FBE489BB3D681B0"><enum>(vi)</enum><text>appropriate
				representatives of foreign governments;</text>
									</clause></subparagraph><subparagraph id="idF841BB9336FC44DEB74556EC1C94DCAB"><enum>(B)</enum><text>in satisfying the
				requirements of subparagraph (A), shall ensure, to the maximum extent possible,
				that State and local officials and relevant private organizations commit to
				support and take steps to achieve the goals and objectives of the National Drug
				Control Strategy;</text>
								</subparagraph><subparagraph id="id82DCB58910E84759B04C6032A4E0751C"><enum>(C)</enum><text>with the concurrence of
				the Attorney General, may require the El Paso Intelligence Center to undertake
				specific tasks or projects to support or implement the National Drug Control
				Strategy; and</text>
								</subparagraph><subparagraph id="idFF28E820870E43BB8D74EAE7DD30369D"><enum>(D)</enum><text>with the concurrence of
				the Director of National Intelligence and the Attorney General, may request
				that the National Drug Intelligence Center undertake specific tasks or projects
				to support or implement the National Drug Control Strategy.</text>
								</subparagraph></paragraph></subsection><subsection id="id14975106FBCE45CBA49E45DDA961616C"><enum>(b)</enum><header>Submission of revised
				strategy</header><text>The President may submit to Congress a revised National
				Drug Control Strategy that meets the requirements of this section—</text>
							<paragraph id="id38AD1F30AADA497DBCEF7D87A92F8114"><enum>(1)</enum><text>at any time, upon a
				determination of the President, in consultation with the Director, that the
				National Drug Control Strategy in effect is not sufficiently effective;
				or</text>
							</paragraph><paragraph id="id55C7CF45D8574341A6616BD0B5662E05"><enum>(2)</enum><text>if a new President or
				Director takes
				office.</text>
							</paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
			</section><section changed="added" id="idC3FC69BDF3B2401C85050AC8F218920B" reported-display-style="italic"><enum>202.</enum><header>Performance
			 measurements</header><text display-inline="no-display-inline">Section 706 is
			 amended by adding at the end the following:</text>
				<quoted-block changed="added" id="id3A9454B523354348B804CDFE647DF909" reported-display-style="italic" style="OLC">
					<subsection id="id146F72D4A91B4762BF5636C9BC088DF3"><enum>(c)</enum><header>Performance measurement
				system</header><text>Not later than February 1 of each year, the Director shall
				submit to Congress as part of the National Drug Control Strategy, a description
				of a national drug control performance measurement system, that—</text>
						<paragraph id="id2FE2F9488D7241749A2E58D892CDD96F"><enum>(1)</enum><text>develops 2-year and
				5-year performance measures and targets for each National Drug Control Strategy
				goal and objective established for reducing drug use, availability, and the
				consequences of drug use;</text>
						</paragraph><paragraph id="idAC3DC28B6A924610A3E26473A24EFC03"><enum>(2)</enum><text>describes the sources of
				information and data that will be used for each performance measure
				incorporated into the performance measurement system;</text>
						</paragraph><paragraph id="id40FE80CF3EC04436910C231B4ADCC807"><enum>(3)</enum><text>identifies major programs
				and activities of the National Drug Control Program agencies that support the
				goals and annual objectives of the National Drug Control Strategy;</text>
						</paragraph><paragraph id="id97F3B6791084442B9CC6A34B904B1DE3"><enum>(4)</enum><text>evaluates the
				contribution of demand reduction and supply reduction activities as defined in
				section 702 implemented by each National Drug Control Program agency in support
				of the National Drug Control Strategy;</text>
						</paragraph><paragraph id="id522EB909A0204A8DA8716815322BF0CD"><enum>(5)</enum><text>monitors consistency
				between the drug-related goals and objectives of the National Drug Control
				Program agencies and ensures that each agency’s goals and budgets support and
				are fully consistent with the National Drug Control Strategy; and</text>
						</paragraph><paragraph id="id153648DF33D64355A83CED000C61D4FD"><enum>(6)</enum><text>coordinates the
				development and implementation of national drug control data collection and
				reporting systems to support policy formulation and performance measurement,
				including an assessment of—</text>
							<subparagraph id="id1385A5EA2D924F2FACAAEF4F56CB7783"><enum>(A)</enum><text>the quality of current
				drug use measurement instruments and techniques to measure supply reduction and
				demand reduction activities;</text>
							</subparagraph><subparagraph id="idCC1D84A444884547B2E3FEB79E80EEB9"><enum>(B)</enum><text>the adequacy of the
				coverage of existing national drug use measurement instruments and techniques
				to measure the casual drug use population, the addicted drug user population,
				and groups that are at risk for drug use;</text>
							</subparagraph><subparagraph id="id70DDB26D76EE47379351C69322E876E0"><enum>(C)</enum><text>the adequacy of the
				coverage of existing national treatment outcome monitoring systems to measure
				the effectiveness of drug abuse treatment in reducing drug use and criminal
				behavior during and after the completion of substance abuse treatment;
				and</text>
							</subparagraph><subparagraph id="id18FA577B9BEF4717AB2FCB8389973092"><enum>(D)</enum><text>the actions the Director
				shall take to correct any deficiencies and limitations identified pursuant to
				subparagraphs (A) and (B) of this subsection.</text>
							</subparagraph></paragraph></subsection><subsection id="id95B850BABA3D48ACA99585E785829BA1"><enum>(d)</enum><header>Modifications</header><text>A
				description of any modifications made during the preceding year to the national
				drug performance measurement system described in subsection (c) shall be
				included in each report submitted under subsection
				(b).</text>
					</subsection><after-quoted-block>.</after-quoted-block></quoted-block>
			</section><section changed="added" id="id6D5020F5B60A466AAE5B9AAE79A33766" reported-display-style="italic"><enum>203.</enum><header>Annual report
			 requirement</header>
				<subsection changed="added" id="idBE3B5CB3139B410DB8C5EF914063BFC0" reported-display-style="italic"><enum>(a)</enum><header>In
			 general</header><text>On or before February 1 of each year, the Director shall
			 submit a report to Congress that describes—</text>
					<paragraph changed="added" id="idE9429541228C48D6B90948EDC38522FA" reported-display-style="italic"><enum>(1)</enum><text>the strategy of the
			 national media campaign and whether specific objectives of the campaign were
			 accomplished;</text>
					</paragraph><paragraph changed="added" id="id5634B506E4BF416294E201675770021F" reported-display-style="italic"><enum>(2)</enum><text>steps taken to ensure
			 that the national media campaign operates in an effective and efficient manner
			 consistent with the overall strategy and focus of the campaign;</text>
					</paragraph><paragraph changed="added" id="id0F346F8AD4054F33AF5E505AD6BF47F4" reported-display-style="italic"><enum>(3)</enum><text>plans to purchase
			 advertising time and space;</text>
					</paragraph><paragraph changed="added" id="id4268F7C9A6764CE189A15678D2DF4AA6" reported-display-style="italic"><enum>(4)</enum><text>policies and practices
			 implemented to ensure that Federal funds are used responsibly to purchase
			 advertising time and space and eliminate the potential for waste, fraud, and
			 abuse;</text>
					</paragraph><paragraph changed="added" id="id324F5B2341004AA4A7601A19B656EFAA" reported-display-style="italic"><enum>(5)</enum><text>all contracts entered
			 into with a corporation, partnership, or individual working on behalf of the
			 national media campaign;</text>
					</paragraph><paragraph changed="added" id="idCAB232B9848749F58A1D4FA10C84742D" reported-display-style="italic"><enum>(6)</enum><text>specific policies and
			 steps implemented to ensure compliance with title IV of this Act;</text>
					</paragraph><paragraph changed="added" id="idD6C9738EF30A440DA358FA315A04F28E" reported-display-style="italic"><enum>(7)</enum><text>steps taken to ensure
			 that the national media campaign will secure, to the maximum extent possible,
			 no cost matches of advertising time and space or in-kind contributions that are
			 directly related to the campaign in accordance with title IV of this Act;
			 and</text>
					</paragraph><paragraph changed="added" id="idB4410109EEE9457990DBDE55D29E6D2D" reported-display-style="italic"><enum>(8)</enum><text>a review and evaluation
			 of the effectiveness of the national media campaign strategy for the past
			 year.</text>
					</paragraph></subsection><subsection changed="added" id="idDF786EABBB56453F8A17120C60A59633" reported-display-style="italic"><enum>(b)</enum><header>Audit</header><text>The
			 Government Accountability Office shall, at a frequency of not less than once
			 per year—</text>
					<paragraph changed="added" id="id1C294251BC58473D9E75AD864EB37508" reported-display-style="italic"><enum>(1)</enum><text>conduct and supervise an
			 audit and investigation relating to the programs and operations of the—</text>
						<subparagraph changed="added" id="id650EF43A13064729BB3276BABC0F1A86" reported-display-style="italic"><enum>(A)</enum><text>Office; or</text>
						</subparagraph><subparagraph changed="added" id="idE4E6A56810C1471DA30B8BEC88B57DAC" reported-display-style="italic"><enum>(B)</enum><text>certain programs within
			 the Office, including—</text>
							<clause changed="added" id="id48BAF1304E084442954FBE8AE2764EBE" reported-display-style="italic"><enum>(i)</enum><text>the High Intensity Drug
			 Trafficking Areas Program;</text>
							</clause><clause changed="added" id="idA4B59A06FD0440ABA3F654AB450138D6" reported-display-style="italic"><enum>(ii)</enum><text>the Counterdrug
			 Technology Assessment Center; or</text>
							</clause><clause changed="added" id="id7E24A4F4E59D4B8EB5CA40B6A434631E" reported-display-style="italic"><enum>(iii)</enum><text>the National Youth
			 Anti-drug Media Campaign; and</text>
							</clause></subparagraph></paragraph><paragraph changed="added" id="idFD8568D3F9874121BBCD56BA2EFC65A9" reported-display-style="italic"><enum>(2)</enum><text>provide the Director and
			 the appropriate congressional committees with a report containing an evaluation
			 of and recommendations on the—</text>
						<subparagraph changed="added" id="id01CB40DDB5504260ACBFEC01B34FC0FF" reported-display-style="italic"><enum>(A)</enum><text>policies and activities
			 of the programs and operations subject to the audit and investigation;</text>
						</subparagraph><subparagraph changed="added" id="id2C978A7EF7B9465499437CDCFDFFC228" reported-display-style="italic"><enum>(B)</enum><text>economy, efficiency, and
			 effectiveness in the administration of the reviewed programs and operations;
			 and</text>
						</subparagraph><subparagraph changed="added" id="id9EBE50BA68374C879C03EB7D61586802" reported-display-style="italic"><enum>(C)</enum><text>policy or management
			 changes needed to prevent and detect fraud and abuse in such programs and
			 operations.</text>
						</subparagraph></paragraph></subsection></section></title><title changed="added" id="idDF2DC72778CA4AEE8EB496A8A583AE62" reported-display-style="italic"><enum>III</enum><header>High intensity drug
			 trafficking areas </header>
			<section changed="added" id="id56005F25986B4DEA97874EBD096A5125" reported-display-style="italic"><enum>301.</enum><header>High Intensity Drug
			 Trafficking Areas Program</header><text display-inline="no-display-inline">Section 707 is amended to read as
			 follows:</text>
				<quoted-block changed="added" id="id738C6CF1035E4D768B7D2B7C8EB21442" reported-display-style="italic" style="OLC">
					<section id="id178287D80BF349AB8EAF3833C01D95CD"><enum>707.</enum><header>High Intensity Drug
				Trafficking Areas Program</header>
						<subsection id="id41BEF4CBC4784F4989591643F5502F13"><enum>(a)</enum><header>Establishment</header>
							<paragraph id="id23C485EFE3894E81A58608E5968B3990"><enum>(1)</enum><header>In
				general</header><text>There is established in the Office a program to be known
				as the High Intensity Drug Trafficking Areas Program (in this section referred
				to as the <quote>Program</quote>).</text>
							</paragraph><paragraph id="id1E48D3D7B5F54026AD5A68516297DE59"><enum>(2)</enum><header>Purpose</header><text>The
				purpose of the Program is to reduce drug trafficking and drug production in the
				United States by—</text>
								<subparagraph id="idED7CC8B0178F4C55BA646A9E36132A27"><enum>(A)</enum><text>facilitating cooperation
				among Federal, State, and local law enforcement agencies to share information
				and implement coordinated enforcement activities;</text>
								</subparagraph><subparagraph id="idFA5416ADAE834D3D8DB85ABB74FB10F1"><enum>(B)</enum><text>enhancing intelligence
				sharing among Federal, State, and local law enforcement agencies;</text>
								</subparagraph><subparagraph id="id345058DDEAD641299F7C1A46D11A4B25"><enum>(C)</enum><text>providing reliable
				intelligence to law enforcement agencies needed to design effective enforcement
				strategies and operations; and</text>
								</subparagraph><subparagraph id="id5C39A225CA6047119F70A829537753BB"><enum>(D)</enum><text>supporting coordinated
				law enforcement strategies which maximize use of available resources to reduce
				the supply of illegal drugs in designated areas and in the United States as a
				whole.</text>
								</subparagraph></paragraph></subsection><subsection id="idF7B94BB17CEB4997BE26C769C0641D7C"><enum>(b)</enum><header>Designation</header>
							<paragraph id="id8A7B08E8FD9A4F2389C98D9785CB7336"><enum>(1)</enum><header>In
				general</header><text>The Director, in consultation with the Attorney General,
				the Secretary of the Treasury, the Secretary of Homeland Security, heads of the
				National Drug Control Program agencies, and the Governor of each applicable
				State, may designate any specified area of the United States as a high
				intensity drug trafficking area.</text>
							</paragraph><paragraph id="id07E4331402554C619690548F9F540DFF"><enum>(2)</enum><header>Activities</header><text>After
				making a designation under paragraph (1) and in order to provide Federal
				assistance to the area so designated, the Director may—</text>
								<subparagraph id="idF07A8AFA72A54BAAAA488A526A0BFDF3"><enum>(A)</enum><text>obligate such sums as are
				appropriated for the Program;</text>
								</subparagraph><subparagraph id="id16620CA57BD04F0BB9A21670A2C90A0A"><enum>(B)</enum><text>direct the temporary
				reassignment of Federal personnel to such area, subject to the approval of the
				head of the department or agency that employs such personnel;</text>
								</subparagraph><subparagraph id="idEE5887E75DCB403FA6BA8B5F24EF8931"><enum>(C)</enum><text>take any other action
				authorized under section 704 to provide increased Federal assistance to those
				areas; and</text>
								</subparagraph><subparagraph id="id93F824E6DE7447D79E41F727EBCD9D66"><enum>(D)</enum><text>coordinate activities
				under this section (specifically administrative, recordkeeping, and funds
				management activities) with State and local officials.</text>
								</subparagraph></paragraph></subsection><subsection id="id94665533792147AD9374D0060FF68CAE"><enum>(c)</enum><header>Petitions for
				designation</header><text>The Director shall establish regulations under which
				a coalition of interested law enforcement agencies from an area may petition
				for designation as a high intensity drug trafficking area. Such regulations
				shall provide for a regular review by the Director of the petition, including a
				recommendation regarding the merit of the petition to the Director by a panel
				of qualified, independent experts.</text>
						</subsection><subsection id="id0032DA46799B439683B7FA3F03FE0CB1"><enum>(d)</enum><header>Factors for
				consideration</header><text>In considering whether to designate an area under
				this section as a high intensity drug trafficking area, the Director shall
				consider, in addition to such other criteria as the Director considers to be
				appropriate, the extent to which—</text>
							<paragraph id="idFB88E0B273E74E07963AF9F8E1C2C69A"><enum>(1)</enum><text>the area is a significant
				center of illegal drug production, manufacturing, importation, or
				distribution;</text>
							</paragraph><paragraph id="idF37AD1A3829946A19DB6801FE9DE15DD"><enum>(2)</enum><text>State and local law
				enforcement agencies have committed resources to respond to the drug
				trafficking problem in the area, thereby indicating a determination to respond
				aggressively to the problem;</text>
							</paragraph><paragraph id="idAF6147F1207A4FD4B79DF4DD8894F835"><enum>(3)</enum><text>drug-related activities
				in the area are having a significant harmful impact in the area, and in other
				areas of the country; and</text>
							</paragraph><paragraph id="id305FE4D99DA34005BCA3C11DDA0FFF27"><enum>(4)</enum><text>a significant increase in
				allocation of Federal resources is necessary to respond adequately to
				drug-related activities in the area.</text>
							</paragraph></subsection><subsection id="id14EF13BE44DB492CAB1BDAFAC4CD0CCB"><enum>(e)</enum><header>Organization of high
				intensity drug trafficking areas</header>
							<paragraph id="id9B76F88BF5834D8CAC3E5D8489FA37AA"><enum>(1)</enum><header>Executive Board and
				officers</header><text>To be eligible for funds appropriated under this
				section, each high intensity drug trafficking area shall be governed by an
				Executive Board. The Executive Board shall designate a chairman, vice chairman,
				and any other officers to the Executive Board that it determines are
				necessary.</text>
							</paragraph><paragraph id="idB334DFD32FE54273A326DFF474D7BC0B"><enum>(2)</enum><header>Responsibilities</header><text>The
				Executive Board of a high intensity drug trafficking area shall be responsible
				for—</text>
								<subparagraph id="id452CE38F4C46408281BDE7D0DD9C64F7"><enum>(A)</enum><text>providing direction and
				oversight in establishing and achieving the goals of the high intensity drug
				trafficking area;</text>
								</subparagraph><subparagraph id="id2D54F3E897EC4686949E044DB40D60CE"><enum>(B)</enum><text>managing the funds of the
				high intensity drug trafficking area;</text>
								</subparagraph><subparagraph id="idFB5827F78D2C421985725EBD4867AE55"><enum>(C)</enum><text>reviewing and approving
				all funding proposals consistent with the overall objective of the high
				intensity drug trafficking area; and</text>
								</subparagraph><subparagraph id="id4CA774F0DC344B8ABC40406F19927B09"><enum>(D)</enum><text>reviewing and approving
				all reports to the Director on the activities of the high intensity drug
				trafficking area.</text>
								</subparagraph></paragraph><paragraph id="id19E18D44D5E540508FA32D5C3AA20A01"><enum>(3)</enum><header>Board
				representation</header><text>None of the funds appropriated under this section
				may be expended for any high intensity drug trafficking area, or for a
				partnership or region of a high intensity drug trafficking area, if the
				Executive Board for such area, region, or partnership, does not apportion an
				equal number of votes between representatives of participating Federal agencies
				and representatives of participating State and local agencies. Where it is
				impractical for an equal number of representatives of Federal agencies and
				State and local agencies to attend a meeting of an Executive Board in person,
				the Executive Board may use a system of proxy votes or weighted votes to
				achieve the voting balance required by this paragraph.</text>
							</paragraph><paragraph id="idA936D0FCEBC147EDA0A81A2843D73E0B"><enum>(4)</enum><header>No agency
				relationship</header><text>The eligibility requirements of this section are
				intended to ensure the responsible use of Federal funds. Nothing in this
				section is intended to create an agency relationship between individual high
				intensity drug trafficking areas and the Federal Government.</text>
							</paragraph></subsection><subsection id="id8657891F2828497BAFE8A5D8ED3C72E0"><enum>(f)</enum><header>Use of
				funds</header><text>The Director shall ensure that no Federal funds
				appropriated for the Program are expended for the establishment or expansion of
				drug treatment programs, and shall ensure that not more than 5 percent of the
				Federal funds appropriated for the Program are expended for the establishment
				of drug prevention programs.</text>
						</subsection><subsection id="idB82E14F6B4D1408FAF9CFA7D2CE759B0"><enum>(g)</enum><header>Counterterrorism
				activities</header>
							<paragraph id="id88DD868F53D14A50AE863684ED14C61A"><enum>(1)</enum><header>Assistance
				authorized</header><text>The Director may authorize use of resources available
				for the Program to assist Federal, State, and local law enforcement agencies in
				investigations and activities related to terrorism and prevention of terrorism,
				especially but not exclusively with respect to such investigations and
				activities that are also related to drug trafficking.</text>
							</paragraph><paragraph id="id1EAA78C75781498E806F5C83BAD89B34"><enum>(2)</enum><header>Limitation</header><text>The
				Director shall ensure—</text>
								<subparagraph id="id9C24C01FAC6E40909AB184D13349AB00"><enum>(A)</enum><text>that assistance provided
				under paragraph (1) remains incidental to the purpose of the Program to reduce
				drug availability and carry out drug-related law enforcement activities;
				and</text>
								</subparagraph><subparagraph id="id2DD8866394B841A0B2844FD5D9F16176"><enum>(B)</enum><text>that significant
				resources of the Program are not redirected to activities exclusively related
				to terrorism, except on a temporary basis under extraordinary circumstances, as
				determined by the Director.</text>
								</subparagraph></paragraph></subsection><subsection id="id92600E0218FB4DF8BA859EC690B3E55E"><enum>(h)</enum><header>Role of Drug
				Enforcement Administration</header><text>The Director, in consultation with the
				Attorney General, shall ensure that a representative of the Drug Enforcement
				Administration is included in the Intelligence Support Center for each high
				intensity drug trafficking area.</text>
						</subsection><subsection id="idF43E5A7107714CF4BABC7D11088E6503"><enum>(i)</enum><header>Annual HIDTA program
				budget submissions</header><text>As part of the documentation that supports the
				President’s annual budget request for the Office, the Director shall submit to
				Congress a budget justification that includes—</text>
							<paragraph id="id14BA70C809B44F21B6D98942E1D9EB51"><enum>(1)</enum><text>the amount requested for
				each high intensity drug trafficking area, with supporting narrative
				descriptions and rationale for each request; and</text>
							</paragraph><paragraph id="idD840586DAC374DCBACF9CEA55A8AEFB4"><enum>(2)</enum><text>a detailed justification
				for each funding request that explains—</text>
								<subparagraph id="id16B70F26BF0C4251BD81E4FB6A106425"><enum>(A)</enum><text>the reasons for the
				requested funding level; how such funding level was determined based on a
				current assessment of the drug trafficking threat in each high intensity drug
				trafficking area;</text>
								</subparagraph><subparagraph id="id4971C91EAA064E4493B0E95643D24DEF"><enum>(B)</enum><text>how such funding will
				ensure that the goals and objectives of each such area will be achieved;
				and</text>
								</subparagraph><subparagraph id="id409929D05347440D9D3139BF0B3A9C03"><enum>(C)</enum><text>how such funding supports
				the National Drug Control Strategy.</text>
								</subparagraph></paragraph></subsection><subsection id="idB0B62B57EFB34B7E939E0129347167D0"><enum>(j)</enum><header>Emerging threat
				response fund</header>
							<paragraph id="idFD0F2469233D452D8143347141EABC8C"><enum>(1)</enum><header>In
				general</header><text>Subject to the availability of appropriations, the
				Director may expend up to 10 percent of the amounts appropriated under this
				section on a discretionary basis, to respond to any emerging drug trafficking
				threat in an existing high intensity drug trafficking area, or to establish a
				new high intensity drug trafficking area or expand an existing high intensity
				drug trafficking area, in accordance with the criteria established under
				paragraph (2).</text>
							</paragraph><paragraph id="idE08FED23C4EE430896DCFCE968BB71FD"><enum>(2)</enum><header>Consideration of
				impact</header><text>In allocating funds under this subsection, the Director
				shall consider—</text>
								<subparagraph id="id87FCFFB0E7FE4BC09EDFA884FE3BCF9F"><enum>(A)</enum><text>the impact of activities
				funded on reducing overall drug traffic in the United States, or minimizing the
				probability that an emerging drug trafficking threat will spread to other areas
				of the United States; and</text>
								</subparagraph><subparagraph id="idB5466B43E13340AB8EBB97A0655EE241"><enum>(B)</enum><text>such other criteria as
				the Director considers appropriate.</text>
								</subparagraph></paragraph></subsection><subsection id="id50AEF1DD074B433BBF9BF937EA516185"><enum>(k)</enum><header>Evaluation</header>
							<paragraph id="idB52C84254E214D50A5A7BCF185875C38"><enum>(1)</enum><header>Initial
				report</header><text>Not later than 90 days after the date of the enactment of
				this section, the Director shall, after consulting with the Executive Boards of
				each designated high intensity drug trafficking area, submit a report to
				Congress that describes, for each designated high intensity drug trafficking
				area—</text>
								<subparagraph id="id3AA112C01A6C4010B848030F7E009AA2"><enum>(A)</enum><text>the specific purposes for
				the high intensity drug trafficking area;</text>
								</subparagraph><subparagraph id="id6B5FC6D7308942EB976F2865158B353D"><enum>(B)</enum><text>the specific long-term
				and short-term goals and objectives for the high intensity drug trafficking
				area;</text>
								</subparagraph><subparagraph id="id66599B5DA6574BDEA1D5586745527884"><enum>(C)</enum><text>the measurements that
				will be used to evaluate the performance of the high intensity drug trafficking
				area in achieving the long-term and short-term goals; and</text>
								</subparagraph><subparagraph id="idA23B2CEC298C4582ADA6C07F315834EA"><enum>(D)</enum><text>the reporting
				requirements needed to evaluate the performance of the high intensity drug
				trafficking area in achieving the long-term and short-term goals.</text>
								</subparagraph></paragraph><paragraph id="idFA673F2496454559879A8E9EAA431C4F"><enum>(2)</enum><header>Evaluation of HIDTA
				program as part of national drug control strategy</header><text>For each
				designated high intensity drug trafficking area, the Director shall submit, as
				part of the annual National Drug Control Strategy report, a report that—</text>
								<subparagraph id="id361AA24E914E44A3ABB770FC0C28B43D"><enum>(A)</enum><text>describes—</text>
									<clause id="idE629D7A3D6CB475680A57253ADA34752"><enum>(i)</enum><text>the specific purposes for
				the high intensity drug trafficking area; and</text>
									</clause><clause id="id771AC34ED8C0489DAD86F4CA74591E88"><enum>(ii)</enum><text>the specific long-term
				and short-term goals and objectives for the high intensity drug trafficking
				area; and</text>
									</clause></subparagraph><subparagraph id="idB46AB9006114461F8DA7923F6A0A09DB"><enum>(B)</enum><text>includes an evaluation of
				the performance of the high intensity drug trafficking area in accomplishing
				the specific long-term and short-term goals and objectives identified under
				paragraph (1)(B).</text>
								</subparagraph></paragraph></subsection><subsection id="id74BB1CDD11324D75927F425AF3769FD9"><enum>(l)</enum><header>Assessment of drug
				enforcement task forces in high intensity drug trafficking
				areas</header><text>Not later than 180 days after the date of enactment of this
				subsection, and as part of each subsequent annual National Drug Control
				Strategy report, the Director shall submit to Congress a report—</text>
							<paragraph id="id829E017964E44E29931237BAE8166974"><enum>(1)</enum><text>assessing the number and
				operation of all federally funded drug enforcement task forces within each high
				intensity drug trafficking area; and</text>
							</paragraph><paragraph id="idCE3F26CDE686415289A23DC6ABA281B0"><enum>(2)</enum><text>describing—</text>
								<subparagraph id="id6766A6427A3E44709EAA8D13B68D10D0"><enum>(A)</enum><text>each Federal, State, and
				local drug enforcement task force operating in the high intensity drug
				trafficking area;</text>
								</subparagraph><subparagraph id="idD1D81BDE38ED416AAD297F91A77DE4A1"><enum>(B)</enum><text>how such task forces
				coordinate with each other, with any high intensity drug trafficking area task
				force, and with investigations receiving funds from the Organized Crime and
				Drug Enforcement Task Force;</text>
								</subparagraph><subparagraph id="id7CA804E4AF2E40BCA451F075899DC543"><enum>(C)</enum><text>what steps, if any, each
				such task force takes to share information regarding drug trafficking and drug
				production with other federally funded drug enforcement task forces in the high
				intensity drug trafficking area;</text>
								</subparagraph><subparagraph id="idE61F7DB1E54C464CA744650AF11EB82A"><enum>(D)</enum><text>the role of the high
				intensity drug trafficking area in coordinating the sharing of such information
				among task forces;</text>
								</subparagraph><subparagraph id="id4D3F8A2ACA434296BD3F3BCB09724F7B"><enum>(E)</enum><text>the nature and extent of
				cooperation by each Federal, State, and local participant in ensuring that such
				information is shared among law enforcement agencies and with the high
				intensity drug trafficking area;</text>
								</subparagraph><subparagraph id="idED3A10063138406B98EE21C0C8C2736C"><enum>(F)</enum><text>the nature and extent to
				which information sharing and enforcement activities are coordinated with joint
				terrorism task forces in the high intensity drug trafficking area; and</text>
								</subparagraph><subparagraph id="id89E1CF5765C843318D0255CC9C22D503"><enum>(G)</enum><text>any recommendations for
				measures needed to ensure that task force resources are utilized efficiently
				and effectively to reduce the availability of illegal drugs in the high
				intensity drug trafficking areas.</text>
								</subparagraph></paragraph></subsection><subsection id="id1299C247D9AC45E392F9E7685671E990"><enum>(m)</enum><header>Assessment of
				Intelligence Sharing in High Intensity Drug Trafficking Areas
				program</header><text>Not later than 180 days after the date of the enactment
				of this section, and as part of each subsequent annual National Drug Control
				Strategy report, the Director, in consultation with the Director of National
				Intelligence, shall submit to Congress a report—</text>
							<paragraph id="idE9ADBEB883D94235BD52AE7E44D3401B"><enum>(1)</enum><text>evaluating existing and
				planned intelligence systems supported by each high intensity drug trafficking
				area, or utilized by task forces receiving any funding under the Program,
				including the extent to which such systems ensure access and availability of
				intelligence to Federal, State, and local law enforcement agencies within the
				high intensity drug trafficking area and outside of it;</text>
							</paragraph><paragraph id="idDAB734588E7F497D856A7C28FD99133C"><enum>(2)</enum><text>the extent to which
				Federal, State, and local law enforcement agencies participating in each high
				intensity drug trafficking area are sharing intelligence information to assess
				current drug trafficking threats and design appropriate enforcement strategies;
				and</text>
							</paragraph><paragraph id="idD9E1E0539BE94B97A56B97EE402A381E"><enum>(3)</enum><text>the measures needed to
				improve effective sharing of information and intelligence regarding drug
				trafficking and drug production among Federal, State, and local law enforcement
				participating in a high intensity drug trafficking area, and between such
				agencies and similar agencies outside the high intensity drug trafficking
				area.</text>
							</paragraph></subsection><subsection id="idCA82147624CD4B50B4F49CCB21805E15"><enum>(n)</enum><header>Coordination of
				intelligence sharing with Organized Crime Drug Enforcement Task Force
				program</header><text>The Director, in consultation with the Attorney General,
				shall ensure that any drug enforcement intelligence obtained by the
				Intelligence Support Center for each high intensity drug trafficking area is
				shared, on a timely basis, with the drug intelligence fusion center operated by
				the Organized Crime Drug Enforcement Task Force of the Department of
				Justice.</text>
						</subsection><subsection id="idBDB5F5B44B6A4B30A79058FCA787F3AA"><enum>(o)</enum><header>Use of funds To combat
				methamphetamine trafficking</header>
							<paragraph id="id30B912CD5D2340F88DB571711FF2EEF0"><enum>(1)</enum><header>In general</header>
								<subparagraph id="id5CF00F4848EE46D2AE61DCCC80A4846F"><enum>(A)</enum><header>Requirement</header><text>The
				Director shall ensure that, of the amounts appropriated for a fiscal year for
				the Program, at least $15,000,000 is allocated to combat the trafficking of
				methamphetamine in areas designated by the Director as high intensity drug
				trafficking areas.</text>
								</subparagraph><subparagraph id="idB5C9753242B5448AA452A20D66596C0E"><enum>(B)</enum><header>Activities</header><text>In
				meeting the requirement in subparagraph (A), the Director shall transfer funds
				to appropriate Federal, State, and local governmental agencies for employing
				additional Federal law enforcement personnel, or facilitating the employment of
				additional State and local law enforcement personnel, including agents,
				investigators, prosecutors, laboratory technicians, chemists, investigative
				assistants, and drug prevention specialists.</text>
								</subparagraph></paragraph><paragraph id="id12EB00E8DDC54D9AB133B4A2EA4397F8"><enum>(2)</enum><header>Apportionment of
				funds</header>
								<subparagraph id="id3B8BC2635AD547EC9C5C73B7AAAD15EC"><enum>(A)</enum><header>Factors in
				apportionment</header><text>The Director shall apportion amounts allocated
				under paragraph (1) among areas designated by the Director as high intensity
				drug trafficking areas based on the following factors:</text>
									<clause id="id36457259CEF74DD0856D8C0F7D719F82"><enum>(i)</enum><text>The number of
				methamphetamine manufacturing facilities discovered by Federal, State, or local
				law enforcement officials in the area during the previous fiscal year.</text>
									</clause><clause id="id20A9D7E8383E4EB68C6BFF896D1CEA44"><enum>(ii)</enum><text>The number of
				methamphetamine prosecutions in Federal, State, or local courts in the area
				during the previous fiscal year.</text>
									</clause><clause id="idFEE4AE653E7E41DE851F74D4CE45ED58"><enum>(iii)</enum><text>The number of
				methamphetamine arrests by Federal, State, or local law enforcement officials
				in the area during the previous fiscal year.</text>
									</clause><clause id="id604CC83019644B558096D8DD2C2BDC6A"><enum>(iv)</enum><text>The amounts of
				methamphetamine or listed chemicals (as that term is defined in section 102(33)
				of the <act-name parsable-cite="CSA">Controlled Substances Act</act-name> (21
				U.S.C. 802(33)) seized by Federal, State, or local law enforcement officials in
				the area during the previous fiscal year.</text>
									</clause><clause id="id23EE0CC125D64284A4E6781763ECB66C"><enum>(v)</enum><text>Intelligence and
				predictive data from the Drug Enforcement Administration showing patterns and
				trends in abuse, trafficking, and transportation in methamphetamine and listed
				chemicals (as that term is so defined).</text>
									</clause></subparagraph><subparagraph id="id4CDE2E9E4A40406B8A8AC00BB2E1C1CA"><enum>(B)</enum><header>Certification</header><text>Before
				the Director apportions any funds under this paragraph to a high intensity drug
				trafficking area, the Director shall certify that the law enforcement entities
				responsible for clandestine methamphetamine laboratory seizures in that area
				are providing laboratory seizure data to the national clandestine laboratory
				database at the El Paso Intelligence Center.</text>
								</subparagraph></paragraph></subsection><subsection id="id33A86430C3754F37ACAA40FA56498910"><enum>(p)</enum><header>Authorization of
				appropriations</header><text>There is authorized to be appropriated to the
				Office of National Drug Control Policy to carry out this section—</text>
							<paragraph id="id620431DF375B48979555CE8F9D096AFE"><enum>(1)</enum><text>$280,000,000 for fiscal
				year 2007;</text>
							</paragraph><paragraph id="idC07D7C55E43F48F4A97B5254CEF24E6D"><enum>(2)</enum><text>$290,000,000 for each of
				fiscal years 2008 and 2009; and</text>
							</paragraph><paragraph id="id3E35F4BF3EB147ECA5C8E34C592EAE0C"><enum>(3)</enum><text>$300,000,000 for each of
				fiscal years 2010 and
				2011.</text>
							</paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
			</section><section changed="added" id="id49B5EF5896554A509165B2BC156D3D1D" reported-display-style="italic"><enum>302.</enum><header>Funding for certain
			 high intensity drug trafficking areas</header>
				<subsection changed="added" id="id8FD2D87A279642DFAECE1D0A82520EEF" reported-display-style="italic"><enum>(a)</enum><header>Short
			 Title</header><text>This section may be cited as the <quote>Dawson Family
			 Community Protection Act</quote>.</text>
				</subsection><subsection changed="added" id="id7698FFDCB5D64885B1651D5FF3E9294F" reported-display-style="italic"><enum>(b)</enum><header>Findings</header><text>Congress
			 finds the following:</text>
					<paragraph changed="added" id="id5EE91C7B6AD4400CA08C00E5DDE85C3D" reported-display-style="italic"><enum>(1)</enum><text>In the early morning
			 hours of October 16, 2002, the home of Carnell and Angela Dawson was firebombed
			 in apparent retaliation for Mrs. Dawson’s notification to police about
			 persistent drug distribution activity in their East Baltimore City
			 neighborhood.</text>
					</paragraph><paragraph changed="added" id="id372A990E6A6546D6846AC54986052F0F" reported-display-style="italic"><enum>(2)</enum><text>The arson claimed the
			 lives of Mr. and Mrs. Dawson and their 5 young children, aged 9 to 14.</text>
					</paragraph><paragraph changed="added" id="idC0853B5760584580A77CAB4E29B48DEB" reported-display-style="italic"><enum>(3)</enum><text>The horrific murder of
			 the Dawson family is a stark example of domestic narco-terrorism.</text>
					</paragraph><paragraph changed="added" id="idB7E7F021220D4207A844A97497A03379" reported-display-style="italic"><enum>(4)</enum><text>In all phases of
			 counternarcotics law enforcement—from prevention to investigation to
			 prosecution to reentry—the voluntary cooperation of ordinary citizens is a
			 critical component.</text>
					</paragraph><paragraph changed="added" id="id922DB09172584065B05B1C75D2EB5646" reported-display-style="italic"><enum>(5)</enum><text>Voluntary cooperation is
			 difficult for law enforcement officials to obtain when citizens feel that
			 cooperation carries the risk of violent retaliation by illegal drug trafficking
			 organizations and their affiliates.</text>
					</paragraph><paragraph changed="added" id="id84FFBDEFD8D7468293FE4644877F087C" reported-display-style="italic"><enum>(6)</enum><text>Public confidence that
			 law enforcement is doing all it can to make communities safe is a prerequisite
			 for voluntary cooperation among people who may be subject to intimidation or
			 reprisal (or both).</text>
					</paragraph><paragraph changed="added" id="idA9492E835B7C40F1BB0748907C10A725" reported-display-style="italic"><enum>(7)</enum><text>Witness protection
			 programs are insufficient on their own to provide security because many
			 individuals and families who strive every day to make distressed neighborhoods
			 livable for their children, other relatives, and neighbors will resist or
			 refuse offers of relocation by local, State, and Federal prosecutorial agencies
			 and because, moreover, the continued presence of strong individuals and
			 families is critical to preserving and strengthening the social fabric in such
			 communities.</text>
					</paragraph><paragraph changed="added" id="id8EFB61658B364199B7D50AA0316334B3" reported-display-style="italic"><enum>(8)</enum><text>Where (as in certain
			 sections of Baltimore City) interstate trafficking of illegal drugs has severe
			 ancillary local consequences within areas designated as high intensity drug
			 trafficking areas, it is important that supplementary High Intensity Drug
			 Trafficking Areas Program funds be committed to support initiatives aimed at
			 making the affected communities safe for the residents of those communities and
			 encouraging their cooperation with local, State, and Federal law enforcement
			 efforts to combat illegal drug trafficking.</text>
					</paragraph></subsection><subsection changed="added" id="idF496030BA9AD4B6388BD259B06842559" reported-display-style="italic"><enum>(c)</enum><header>Funding for Certain
			 High Intensity Drug Trafficking Areas</header><text>Section 707, as amended by
			 section 301, is amended by adding at the end the following:</text>
					<quoted-block changed="added" display-inline="no-display-inline" id="id7E5BCDD4E13B48079B596A6C621A1248" reported-display-style="italic" style="OLC">
						<subsection id="id9FEACB41BAB242278273B1F46946F48B"><enum>(q)</enum><header>Specific
				Purposes</header>
							<paragraph id="idC9DA2F1DCD3D49B29C78658E714DBBE2"><enum>(1)</enum><header>In
				general</header><text>The Director shall ensure that, of the amounts
				appropriated for a fiscal year for the Program, at least $7,000,000 is used in
				high intensity drug trafficking areas with severe neighborhood safety and
				illegal drug distribution problems.</text>
							</paragraph><paragraph id="id5CA65D2DBC3842BD96655E4EE15ED787"><enum>(2)</enum><header>Required
				uses</header><text>The funds used under paragraph (1) shall be used—</text>
								<subparagraph id="id82E7D86FC23549DA9722FE1820F20D6F"><enum>(A)</enum><text>to ensure the safety of
				neighborhoods and the protection of communities, including the prevention of
				the intimidation of potential witnesses of illegal drug distribution and
				related activities; and</text>
								</subparagraph><subparagraph commented="no" display-inline="no-display-inline" id="idD987676A10474E2CA991760F5195D979"><enum>(B)</enum><text>to combat illegal drug
				trafficking through such methods as the Director considers appropriate, such as
				establishing or operating (or both) a toll-free telephone hotline for use by
				the public to provide information about illegal drug-related
				activities.</text>
								</subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection></section><section changed="added" id="id9A53505E1B1E46D48AE66FFEC5010FF0" reported-display-style="italic"><enum>303.</enum><header>Assessment</header><text display-inline="no-display-inline">The Director shall assess the ability of the
			 HIDTA Program to respond to the so-called <quote>balloon effect</quote>,
			 whereby urban drug traffickers facing intensive law enforcement efforts expand
			 and spread their trafficking and distribution into rural, suburban, and smaller
			 urban areas by conducting a demonstration project examining the ability of the
			 New York/New Jersey HIDTA, with its new single colocated Organized Crime and
			 Drug Enforcement Task Force/High Intensity Drug Trafficking Area Strike Force
			 and HIDTA Regional Intelligence Center, to address the movement of drug
			 traffickers into the more rural, suburban, and smaller areas encompassed by the
			 counties of Albany, Onondaga, Monroe, and Erie in New York State and by
			 annexing these counties into the existing New York/New Jersey HIDTA.</text>
			</section></title><title changed="added" id="idA35FAEAEAB8B4B4596F3A45D9566C9A5" reported-display-style="italic"><enum>IV</enum><header>Technology</header>
			<section changed="added" id="idC1FCFAE579B041D1A521B3C86D947ED9" reported-display-style="italic"><enum>401.</enum><header>Counterdrug Technology
			 Assessment Center</header>
				<subsection changed="added" id="id6083F04F1D1349D187BA553A7DF5797E" reported-display-style="italic"><enum>(a)</enum><header>Chief
			 Scientist</header><text>Section 708(b) is amended to read as follows:</text>
					<quoted-block changed="added" id="idD2DD70DC349140819A3B3465BA1A994A" reported-display-style="italic" style="OLC">
						<subsection id="id708A4DE8F2A44969AA4C523E1777A54F"><enum>(b)</enum><header>Chief
				Scientist</header><text>There shall be at the head of the Center the Chief
				Scientist, who shall be appointed by the Director from among individuals
				qualified and distinguished in the area of science, medicine, engineering, or
				technology.</text>
						</subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection><subsection changed="added" id="idF495627B6B1F4CC685A8CFBC56B99DF6" reported-display-style="italic"><enum>(b)</enum><header>Responsibilities</header>
					<paragraph changed="added" id="id0E1F8C6C20C748EAB022673CBB4B60ED" reported-display-style="italic"><enum>(1)</enum><header>Research and
			 development</header><text>Section 708 is amended by—</text>
						<subparagraph changed="added" id="id1D56FC9C65CB4AB986F08BE3E06B4FD8" reported-display-style="italic"><enum>(A)</enum><text>redesignating subsection
			 (d) as subsection (e); and</text>
						</subparagraph><subparagraph changed="added" id="idC61DB8069BF64CFBA94CB980112FF23B" reported-display-style="italic"><enum>(B)</enum><text>striking subsection (c)
			 and inserting the following:</text>
							<quoted-block changed="added" id="idEC85D72680FA4FFFBFCEA0B26124F8C7" reported-display-style="italic" style="OLC">
								<subsection id="id24B493BB1D9442948E983167FC3B8CD6"><enum>(c)</enum><header>Research and
				Development Responsibilities</header><text>The Chief Scientist shall be
				responsible to the Director for—</text>
									<paragraph id="idB6C8101DC55E4A639CCE44C68DB51892"><enum>(1)</enum><text>identifying and defining
				the short-, medium-, and long-term scientific and technological needs of
				Federal, State, and local drug supply reduction agencies, including—</text>
										<subparagraph id="id7C98E4F13E664B2EBF1957976AF4180F"><enum>(A)</enum><text>advanced surveillance,
				tracking, and radar imaging;</text>
										</subparagraph><subparagraph id="id4F69AB02C1F34CF5932E7195DC2A4A64"><enum>(B)</enum><text>electronic support
				measures;</text>
										</subparagraph><subparagraph id="idCE8C90E98E7A4D9EBDF2AB99FF6325DE"><enum>(C)</enum><text>communications;</text>
										</subparagraph><subparagraph id="idF32BCCFD5EFC405ABEFB60DFF2EFDA8F"><enum>(D)</enum><text>data fusion, advanced
				computer systems, and artificial intelligence; and</text>
										</subparagraph><subparagraph id="idEFC379175FDA4173922A602FFE6602B3"><enum>(E)</enum><text>chemical, biological,
				radiological (including neutron and electron), and other means of
				detection;</text>
										</subparagraph></paragraph><paragraph id="idC0428E4FB1B3475889C6515EC0218B14"><enum>(2)</enum><text>identifying demand
				reduction basic and applied research needs and initiatives, in consultation
				with affected National Drug Control Program agencies, including—</text>
										<subparagraph id="id0CBD6D0C716B4DA39756A338AB152060"><enum>(A)</enum><text>improving treatment
				through neuroscientific advances;</text>
										</subparagraph><subparagraph id="id1E7AFD24651640E4BD2C463FC5EAFDD1"><enum>(B)</enum><text>improving the transfer of
				biomedical research to the clinical setting; and</text>
										</subparagraph><subparagraph id="idCFF1F374F0E84F109F822A45993CBFFD"><enum>(C)</enum><text>in consultation with the
				National Institute of Drug Abuse, and through interagency agreements or grants,
				examining addiction and rehabilitation research and the application of
				technology to expanding the effectiveness and availability of drug
				treatment;</text>
										</subparagraph></paragraph><paragraph id="idB79585FC16944AB0ADD3336230B7C185"><enum>(3)</enum><text>making a priority ranking
				of such needs identified in paragraphs (1) and (2) according to fiscal and
				technological feasibility, as part of a National Counterdrug Research and
				Development Program;</text>
									</paragraph><paragraph id="id5433DEEF398A49C29096329DFE56D24C"><enum>(4)</enum><text>overseeing and
				coordinating counterdrug technology initiatives with related activities of
				other Federal civilian and military departments;</text>
									</paragraph><paragraph id="id9DD0F7FBDEB543E4A73E51D16FF8533E"><enum>(5)</enum><text>providing support to the
				development and implementation of the national drug control performance
				measurement system established under subsection (c) of section 706; and</text>
									</paragraph><paragraph id="id20C7BD1DA6D746F1A820230793021546"><enum>(6)</enum><text>transferring funds made
				available to a National Drug Control Program Agency for counterdrug technology
				research and development to another account within such agency or to another
				National Drug Control Program Agency for counterdrug technology research and
				development, pursuant to the authority of the Director under section
				704.</text>
									</paragraph></subsection><subsection id="idCC1BB6352E204426803EBFBA44B030B9"><enum>(d)</enum><header>Limitation on
				Authority</header><text>The authority granted to the Director under this
				section shall not extend to the awarding of contracts, management of individual
				projects, or other operational
				activities.</text>
								</subsection><after-quoted-block>.</after-quoted-block></quoted-block>
						</subparagraph></paragraph><paragraph changed="added" id="id70B673A124C64ABD8250A53359023897" reported-display-style="italic"><enum>(2)</enum><header>Assistance and
			 support</header><text>Subsection (e) of section 708, as redesignated by this
			 section, is amended to read as follows:</text>
						<quoted-block changed="added" id="id926FB3D5EF1740BAA4E6EF4E1211D0C9" reported-display-style="italic" style="OLC">
							<subsection id="id194716522A5248F382D4D59B656E0E60"><enum>(e)</enum><header>Assistance and Support
				to the Office of National Drug Control Policy</header><text>The Secretary of
				Defense, the Secretary of Homeland Security, and the Secretary of Health and
				Human Services shall, to the maximum extent practicable, render assistance and
				support to the Office and to the Director in the conduct of counterdrug
				technology
				assessment.</text>
							</subsection><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph><paragraph changed="added" id="idAEA7AA3C88CB40A6B25F3E417D3B0629" reported-display-style="italic"><enum>(3)</enum><header>Technology transfer
			 program</header><text>Section 708 is amended by adding at the end the
			 following:</text>
						<quoted-block changed="added" id="idE7BE520A71FA4D4690C1A68C1FCF0CB9" reported-display-style="italic" style="OLC">
							<subsection id="idDB7D1ACD64FB438484EA0CA03958C3A0"><enum>(f)</enum><header>Technology Transfer
				Program</header>
								<paragraph id="idC690321B3F7D46BB9D2E6661623C849F"><enum>(1)</enum><header>Program</header><text>The
				Chief Scientist, with the advice and counsel of experts from State and local
				law enforcement agencies, shall be responsible to the Director for coordination
				and implementation of a counterdrug technology transfer program.</text>
								</paragraph><paragraph id="id120FDFB496474B338DD6B2AAD2BCCAE2"><enum>(2)</enum><header>Purpose</header><text>The
				purpose of the Technology Transfer Program shall be for the Counterdrug
				Technology Assessment Center to transfer technology and associated training
				directly to State and local law enforcement agencies.</text>
								</paragraph><paragraph id="id21683E5623334658B6818AE53191A89E"><enum>(3)</enum><header>Priority of
				receipts</header><text>Transfers shall be made in priority order based
				on—</text>
									<subparagraph id="id228E0DE490EA4085ABCAA610C32DA9B4"><enum>(A)</enum><text>the need of potential
				recipients for such technology;</text>
									</subparagraph><subparagraph id="id428AE97B2E0240219E2ACD008F6486AC"><enum>(B)</enum><text>the effectiveness of the
				technology to enhance current counterdrug activities of potential recipients;
				and</text>
									</subparagraph><subparagraph id="id34D9BF14CA6E4BF29C3A1941C4A4959B"><enum>(C)</enum><text>the ability and
				willingness of potential recipients to evaluate transferred technology.</text>
									</subparagraph></paragraph><paragraph id="id84DA1617C8A04E00A665BF01BAA6C0BD"><enum>(4)</enum><header>Agreement
				authority</header><text>The Director may enter into an agreement with the
				Secretary of Homeland Security to transfer technology with both counterdrug and
				homeland security applications to State and local law enforcement agencies on a
				reimbursable basis.</text>
								</paragraph><paragraph id="id009CC5A66D244EC2839DC51B7B1AC18B"><enum>(5)</enum><header>Report</header><text>On
				or before July 1 of each year, the Director shall submit a report to the
				appropriate congressional committees which addresses the following:</text>
									<subparagraph id="idEE71F1936AEC44B3AD9E88C7B6BB2590"><enum>(A)</enum><text>The number of requests
				received during the previous 12 months.</text>
									</subparagraph><subparagraph id="idD86781B391994FD699EE2F4A569E35F9"><enum>(B)</enum><text>The number of requests
				fulfilled during the previous 12 months.</text>
									</subparagraph><subparagraph id="idF4288F2A28E94F4CA2A9D766B98A2DD1"><enum>(C)</enum><text>A summary of the criteria
				used in making the determination on what requests were funded and what requests
				were not funded.</text>
									</subparagraph><subparagraph id="idD9BF12971CD34B82BB7CD628C090A277"><enum>(D)</enum><text>A general assessment of
				the future needs of the program, based on expected changes in threats, expected
				technologies, and likely need from potential recipients.</text>
									</subparagraph><subparagraph id="idE38D9C417F8A431B834F9F527BF52109"><enum>(E)</enum><text>An assessment of the
				effectiveness of the technologies transferred, based in part on the evaluations
				provided by the recipients, with a recommendation whether the technology should
				continue to be offered through the
				program.</text>
									</subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
					</paragraph></subsection></section></title><title changed="added" id="id86112F362DF9414E8BA7192596A2F12C" reported-display-style="italic"><enum>V</enum><header>Reauthorization and
			 improvement of the National Anti-Drug Media Campaign</header>
			<section changed="added" id="id9AB0D974391B4B82ACA19C71191F9DC9" reported-display-style="italic"><enum>501.</enum><header>Short
			 title</header><text display-inline="no-display-inline">This title may be cited
			 as the <quote><short-title>National Youth Anti-Drug Media
			 Campaign Reauthorization Act of 2006</short-title></quote>.</text>
			</section><section changed="added" id="idBBDAA472B52842AD9F73DDD2A25E4526" reported-display-style="italic"><enum>502.</enum><header>Purposes of the
			 National Youth Anti-Drug Media Campaign</header><text display-inline="no-display-inline">The Drug-Free Media Campaign Act of 1998 (21
			 U.S.C. 1801 et seq.) is amended—</text>
				<paragraph changed="added" id="id278351315B484FA687009CEA9BC3F6F0" reported-display-style="italic"><enum>(1)</enum><text>in section 101, by
			 striking <quote>Drug-Free Media Campaign Act of 1998</quote> and inserting
			 <quote>National Youth Anti-Drug Media Campaign Act</quote>; and</text>
				</paragraph><paragraph changed="added" id="id525124C31C5E48138CE417079769B5E2" reported-display-style="italic"><enum>(2)</enum><text>in section 102—</text>
					<subparagraph changed="added" id="id0A34AB40247A4DDBB081A13C0C065B4C" reported-display-style="italic"><enum>(A)</enum><text>in subsection (a), by
			 striking “national media campaign” and all that follows through the period and
			 inserting the following: “national youth anti-drug media campaign (referred to
			 in this subtitle as the ‘national media campaign’) in accordance with this
			 subtitle for the purposes of—</text>
						<quoted-block changed="added" id="id184615BA3C0F49959287858394CE256E" reported-display-style="italic" style="OLC">
							<paragraph id="idBEC3D10F2AB041ECBF58AD0216EDAD39"><enum>(1)</enum><text>preventing drug abuse
				among young people in the United States;</text>
							</paragraph><paragraph id="id610E1411F2974BF39C525D626BB163A5"><enum>(2)</enum><text>increasing awareness of
				adults of the impact of drug abuse on young people; and</text>
							</paragraph><paragraph id="id659B357CDFFE4079B237C0DBFED0BE4B"><enum>(3)</enum><text>encouraging parents and
				other interested adults to discuss with young people the dangers of illegal
				drug use.</text>
							</paragraph><after-quoted-block>;
				and</after-quoted-block></quoted-block>
					</subparagraph><subparagraph changed="added" id="id1BE7F36BC6AC4342A3981C55F82B8F49" reported-display-style="italic"><enum>(B)</enum><text>in subsection (b), by
			 striking <quote>105</quote> and inserting <quote>104</quote>.</text>
					</subparagraph></paragraph></section><section changed="added" id="id19D6995E2D3D459DAE6F31559FE7C0A1" reported-display-style="italic"><enum>503.</enum><header>Roles and
			 responsibilities of the Director, the Partnership for a Drug-Free America, and
			 a media buying contractor</header><text display-inline="no-display-inline">The
			 Drug-Free Media Campaign Act of 1998 (21 U.S.C. 1801 et seq.) is
			 amended—</text>
				<paragraph changed="added" id="id6B0F521170164BA88DE033C512A8708D" reported-display-style="italic"><enum>(1)</enum><text>by adding at the end the
			 following:</text>
					<quoted-block changed="added" id="id98D58A73950147BE8BE4C0D4EFAE6977" reported-display-style="italic" style="OLC">
						<subsection id="id93D1F99CDF0041CBAC167AE021A109F6"><enum>(c)</enum><header>Division of
				Responsibilities and Functions Under the Program</header>
							<paragraph id="idD42C0EE9D31F43E38A1E3FFEDA06556F"><enum>(1)</enum><header>In
				general</header><text>The Director, in consultation with the Partnership for a
				Drug-Free America, shall determine the overall purposes and strategy of the
				national media campaign.</text>
							</paragraph><paragraph id="idE4BD45182CE445D5B179AD7DCA653A07"><enum>(2)</enum><header>Responsibilities</header>
								<subparagraph id="id5861D3FED4194C04A64E68D579D59D76"><enum>(A)</enum><header>Director</header><text>The
				Director shall be responsible for implementing a focused national media
				campaign to meet the purposes set forth in section 102(a), and shall
				approve—</text>
									<clause id="idE389C0A4949146ADAD2D698BF9A9170E"><enum>(i)</enum><text>the strategy of the
				national media campaign;</text>
									</clause><clause id="id4EE9471F8FAD439491EA3AC641EAD8D0"><enum>(ii)</enum><text>all advertising and
				promotional material used in the national media campaign; and</text>
									</clause><clause id="id1187CF32ACCE4E339C409A4C6465C9C0"><enum>(iii)</enum><text>the plan for the
				purchase of advertising time and space for the national media campaign.</text>
									</clause></subparagraph><subparagraph id="idE858CFB3398E4205AD1866F1F76BAF3D"><enum>(B)</enum><header>The partnership for a
				drug-free america</header><text>The Director shall request that the Partnership
				for a Drug-Free America—</text>
									<clause id="id99D65828A0B04D728A16FBEBF87892F5"><enum>(i)</enum><text>develop and recommend
				strategies to achieve the goals of the national media campaign, including
				addressing national and local drug threats in specific regions or States, such
				as methamphetamine and ecstasy;</text>
									</clause><clause id="id4D0D35EA8320434DAAC2600A99C51603"><enum>(ii)</enum><text>create all advertising
				to be used in the national media campaign, except advertisements that
				are—</text>
										<subclause id="id9CE4055F4AFD4D0ABDE3E4A5104ACEB6"><enum>(I)</enum><text>provided by other
				nonprofit entities pursuant to section 103(c);</text>
										</subclause><subclause id="id249E205730DB46149AAF2E460B7A3E6A"><enum>(II)</enum><text>intended to reach a
				minority, ethnic, or other special audience that cannot be obtained at no cost
				(not including production costs and talent reuse payments), provided that any
				such advertising material is reviewed by the Partnership for a Drug-Free
				America; or</text>
										</subclause><subclause id="idA987BD999DCD4565BB704B5E3640BD64"><enum>(III)</enum><text>any other
				advertisements that the Partnership for a Drug-Free America determines it is
				unable to provide.</text>
										</subclause></clause></subparagraph><subparagraph id="id062EA796154A403D9A2B14C1E51A1AEB"><enum>(C)</enum><header>Media buying
				contractor</header><text>The Director shall enter into a contract with a media
				buying contractor to plan and purchase advertising time and space for the
				national media campaign. The media buying contractor shall not provide any
				service or material, or conduct any function or activity which can be provided
				by the Partnership for a Drug-Free America, as defined in section
				403(2)(B)</text>
								</subparagraph></paragraph></subsection><after-quoted-block>;
				and</after-quoted-block></quoted-block>
				</paragraph><paragraph changed="added" id="id6B910169DE6549C4AB90CB3727738E09" reported-display-style="italic"><enum>(2)</enum><text>in section 103—</text>
					<subparagraph changed="added" id="idFF1315FAC7C642C9B27DB03D5805EF2C" reported-display-style="italic"><enum>(A)</enum><text>in subparagraph (A), by
			 inserting <quote>, including the strategic planning for, and accounting of,
			 such purchases</quote> after <quote>space</quote>;</text>
					</subparagraph><subparagraph changed="added" id="idE7063AA5D1084C2D95FB4D14D9F97D2D" reported-display-style="italic"><enum>(B)</enum><text>in subparagraph (C), by
			 striking <quote>out-of-pocket</quote>; and</text>
					</subparagraph><subparagraph changed="added" id="id99CEC355132A44A3B9D988F2264ECF76" reported-display-style="italic"><enum>(C)</enum><text>in subparagraph (F), by
			 striking <quote>the Office of National Drug Control Policy</quote> and
			 inserting <quote>either the Office of National Drug Control Policy or the
			 designee of the Office</quote>.</text>
					</subparagraph></paragraph></section><section changed="added" id="id673895749B084DA78298320DC0E3864C" reported-display-style="italic"><enum>504.</enum><header>Responsible use of
			 Federal funds for the National Youth Anti-Drug Media Campaign</header><text display-inline="no-display-inline">The Drug-Free Media Campaign Act of 1998 (21
			 U.S.C. 1801 et seq.) is amended—</text>
				<paragraph changed="added" id="idEB747E601D194AE79ADFFF8AA3E88AB7" reported-display-style="italic"><enum>(1)</enum><text>in section 103, by
			 striking paragraph (2) and inserting the following:</text>
					<quoted-block changed="added" id="id4EB2BA3E8B254D6AAC2493A844F72A73" reported-display-style="italic" style="OLC">
						<paragraph id="idF15CA0E2619646879A62B00C8017024E"><enum>(2)</enum><header>Advertising</header>
							<subparagraph id="id91927D7DCD834BAEBF3FB714A8B010A2"><enum>(A)</enum><header>In
				general</header><text>Except as provided in subparagraph (B), in carrying out
				this subtitle, the Director shall ensure that sufficient funds are allocated to
				meet the stated goals of the national media campaign.</text>
							</subparagraph><subparagraph id="idFB89B01D6721463A8FDCF3B841B74184"><enum>(B)</enum><header>Exception</header><text>No
				funds shall be used for the creative development of advertisements (not
				including out-of-pocket production costs and talent reuse payments) except
				when—</text>
								<clause id="id0959521270B14FF2A7D6335839652565"><enum>(i)</enum><text>the advertisements are
				intended to reach a minority, ethnic, or other special audience that cannot be
				obtained at no cost (not including production costs and talent reuse payments);
				or</text>
								</clause><clause id="id5D021716607D4341A0350FB5D9D22EEE"><enum>(ii)</enum><text>the Partnership for a
				Drug-Free America, determines that it is unable to provide such
				advertisements.</text>
								</clause></subparagraph></paragraph><after-quoted-block>;</after-quoted-block></quoted-block>
				</paragraph><paragraph changed="added" id="id654EF9A303904ED4B4E40F2FCEA5CEAF" reported-display-style="italic"><enum>(2)</enum><text>in subsection (b), by
			 striking <quote>105</quote> and inserting <quote>104</quote>;</text>
				</paragraph><paragraph changed="added" id="id57303858CE124209B99C568146C432A0" reported-display-style="italic"><enum>(3)</enum><text>by striking subsection
			 (c) and inserting the following:</text>
					<quoted-block changed="added" id="id127951E6CF7B4BBEA301E1F28C66F095" reported-display-style="italic" style="OLC">
						<subsection id="idAE9FF6754D6D45FC9E3393815038DA1B"><enum>(c)</enum><header>Matching
				Requirement</header>
							<paragraph id="id716D86B89AB34DDB8B7DD83DCA6D8B13"><enum>(1)</enum><header>No cost match</header>
								<subparagraph id="idFB1B8C10D77A4442950966A4B63BF637"><enum>(A)</enum><header>In
				general</header><text>Except as provided in subparagraph (B), amounts made
				available for the national media campaign under section 106 shall be used to
				require a no cost match of equivalent value of advertising broadcast time,
				print space, or in-kind contributions to the national media campaign.</text>
								</subparagraph><subparagraph id="idF111A97B9BC34E01897ABF6DE56FB3F8"><enum>(B)</enum><header>Exception</header><text>The
				Director shall ensure that all no cost matches of advertising material, time,
				space, or in-kind contributions provided pursuant to subparagraph (A) directly
				relate to substance abuse prevention and specifically promote 1 or more of the
				specific purposes set forth in section 102(a). This may include antismoking
				messages that are produced by nonprofit organizations and are targeted toward
				minors.</text>
								</subparagraph></paragraph><paragraph id="idD7204C20E2BE461EB6E58B224E62326E"><enum>(2)</enum><header>Sponsorship
				identification</header><text>Any advertising material donated to the national
				media campaign at no cost shall not be subject to the sponsorship
				identification provisions in section 317 of the <act-name parsable-cite="CA34">Communications Act of 1934</act-name> (47 U.S.C.
				317).</text>
							</paragraph></subsection><after-quoted-block>;</after-quoted-block></quoted-block>
				</paragraph><paragraph changed="added" id="idF61AD533B7424018A899EB2653F25C59" reported-display-style="italic"><enum>(4)</enum><text>by adding at the end the
			 following:</text>
					<quoted-block changed="added" display-inline="no-display-inline" id="idF1F43766DBD545599497CA833C334476" reported-display-style="italic" style="OLC">
						<subsection id="id57D1EDE94BA54030AE06D78563F1BB47"><enum>(d)</enum><header>Responsible Use of
				Federal Funds</header>
							<paragraph id="id329F7FA2C11A49E0BDC6E407CC00DA87"><enum>(1)</enum><header>In
				general</header><text>The Director shall ensure that—</text>
								<subparagraph id="id3DCB167C488542D682F312AC57EF0293"><enum>(A)</enum><text>for each fiscal year, not
				less than 77 percent of the amounts appropriated under this subtitle shall be
				used for the activities allowed under section 103(a)(1)(A);</text>
								</subparagraph><subparagraph id="id2318375BFF3844A19F08855BE3105115"><enum>(B)</enum><text>no Federal funds provided
				under this subtitle are used to pay any entity for any activity or service that
				duplicates, in whole or in part, any material, function, activity, or service
				provided by the Partnership for a Drug-Free America, as defined in section
				403(2)(B); and</text>
								</subparagraph><subparagraph id="id286EF188A9044F4EB7663EAB45B603EA"><enum>(C)</enum><text>no more than $5,000,000
				is used in each fiscal year to develop advertising material pursuant to
				subsection
				(a)(2)(B)(ii).</text>
								</subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block>
				</paragraph></section><section changed="added" id="id3644D261C4A84183ACF704380D867F64" reported-display-style="italic"><enum>505.</enum><header>Authorization for
			 National Youth Anti-Drug Media Campaign</header><text display-inline="no-display-inline">The Drug-Free Media Campaign Act of 1998 (21
			 U.S.C. 1801 et seq.) is amended by striking sections 104 and 105 and inserting
			 the following:</text>
				<quoted-block changed="added" display-inline="no-display-inline" id="id684CFEF90EEC4DD18678DBD3759A3D39" reported-display-style="italic" style="OLC">
					<section id="id6DF6829C52FD40018DC6ED3E5FE7F6A6"><enum>104.</enum><header>Authorization of
				appropriations</header><text display-inline="no-display-inline">There is
				authorized to be appropriated to the Office of National Drug Control Policy to
				carry out this subtitle, $195,000,000 for each of the fiscal years 2006 through
				2010.</text>
					</section><after-quoted-block>.</after-quoted-block></quoted-block>
			</section></title><title changed="added" id="idBAF3DE3B0D0B40E3BFEEDA5F183436C7" reported-display-style="italic"><enum>VI</enum><header>Authorizations and
			 extension of termination date</header>
			<section changed="added" id="idEC7D6415432048E1A1A1A60B583675AC" reported-display-style="italic"><enum>601.</enum><header>Authorization of
			 appropriations</header><text display-inline="no-display-inline">Section 714 is
			 amended—</text>
				<paragraph changed="added" id="id989BF4E9F4EC4B71AB8BD5DC1BE4B5A4" reported-display-style="italic"><enum>(1)</enum><text>by striking
			 <quote>title,</quote> and inserting <quote>title except activities otherwise
			 specified,</quote>; and</text>
				</paragraph><paragraph changed="added" id="id48D8898A79A346FFBCBDBC870A3CB713" reported-display-style="italic"><enum>(2)</enum><text>by striking <quote>1999
			 through 2003</quote> and inserting <quote>2006 through 2010</quote>.</text>
				</paragraph></section><section changed="added" id="idB09D703FB7AE400B999D1E99B9C71D56" reported-display-style="italic"><enum>602.</enum><header>Extension of
			 termination date</header><text display-inline="no-display-inline">Section
			 715(a) is amended by striking <quote>September 30, 2003, this title and the
			 amendments made by this title</quote> and inserting <quote>September 30, 2010,
			 this title and the amendments made to this title</quote>.</text>
			</section></title><title changed="added" id="id23E2B0A9733B462BB93F17B90936366D" reported-display-style="italic"><enum>VII</enum><header>Anti-Doping
			 Agency</header>
			<section changed="added" id="id778A69651A68400FA956E0DF967CCB83" reported-display-style="italic"><enum>701.</enum><header>Designation of United
			 States Anti-Doping Agency</header>
				<subsection changed="added" id="id5A11C2EA0E234969AEB11A847E9EF7B2" reported-display-style="italic"><enum>(a)</enum><header>Definitions</header><text>In
			 this title:</text>
					<paragraph changed="added" id="idD1DC913DCDE841398814EFD550A44178" reported-display-style="italic"><enum>(1)</enum><header>United States Olympic
			 Committee</header><text>The term <term>United States Olympic Committee</term>
			 means the organization established by the <quote>Ted Stevens Olympic and
			 Amateur Sports Act</quote> (36 U.S.C. 220501 et seq.).</text>
					</paragraph><paragraph changed="added" id="id9038480E9E6C47169FCE1A145FAE7783" reported-display-style="italic"><enum>(2)</enum><header>Amateur athletic
			 competition</header><text>The term <term>amateur athletic competition</term>
			 means a contest, game, meet, match, tournament, regatta, or other event in
			 which amateur athletes compete (36 U.S.C. 220501(b)(2)).</text>
					</paragraph><paragraph changed="added" id="id43EBA01370FE462C84546810497D6F5B" reported-display-style="italic"><enum>(3)</enum><header>Amateur
			 athlete</header><text>The term <term>amateur athlete</term> means an athlete
			 who meets the eligibility standards established by the national governing body
			 or paralympic sports organization for the sport in which the athlete competes
			 (36 U.S.C. 22501(b)(1)).</text>
					</paragraph></subsection><subsection changed="added" id="id1B3ACFDB210247AFBE18A40A1569204A" reported-display-style="italic"><enum>(b)</enum><header>In
			 general</header><text>The United States Anti-Doping Agency shall—</text>
					<paragraph changed="added" id="idBA4F8B4F933647339EFA85D004A6D1C6" reported-display-style="italic"><enum>(1)</enum><text>serve as the independent
			 anti-doping organization for the amateur athletic competitions recognized by
			 the United States Olympic Committee;</text>
					</paragraph><paragraph changed="added" id="id20CBAA002313435BBF850BC58E4BB89E" reported-display-style="italic"><enum>(2)</enum><text>ensure that athletes
			 participating in amateur athletic activities recognized by the United States
			 Olympic Committee are prevented from using performance-enhancing drugs;</text>
					</paragraph><paragraph changed="added" id="id42FA2DDAF2294463B626B3C2F806C06A" reported-display-style="italic"><enum>(3)</enum><text>implement anti-doping
			 education, research, testing, and adjudication programs to prevent United
			 States Amateur Athletes participating in any activity recognized by the United
			 States Olympic Committee from using performance-enhancing drugs; and</text>
					</paragraph><paragraph changed="added" id="idB6D6A300AF8E47EF93E75363A21DCFCA" reported-display-style="italic"><enum>(4)</enum><text>serve as the United
			 States representative responsible for coordination with other anti-doping
			 organizations coordinating amateur athletic competitions recognized by the
			 United States Olympic Committee to ensure the integrity of athletic
			 competition, the health of the athletes and the prevention of use of
			 performance-enhancing drugs by United States amateur athletes.</text>
					</paragraph></subsection></section><section changed="added" id="id93D32C892FEA41EAAAED6BDBEC67AE4D" reported-display-style="italic"><enum>702.</enum><header>Records, audit, and
			 report</header>
				<subsection changed="added" id="idDB318DECAE28411085CA8DECA07B87D6" reported-display-style="italic"><enum>(a)</enum><header>Records</header><text>The
			 United States Anti-Doping Agency shall keep correct and complete records of
			 account.</text>
				</subsection><subsection changed="added" id="id34F8B8339B474196BB4E0F57A7198FA8" reported-display-style="italic"><enum>(b)</enum><header>Report</header><text>The
			 United States Anti-Doping Agency shall submit an annual report to Congress
			 which shall include—</text>
					<paragraph changed="added" id="id1E555921F8884A84AAB34EBD9A365807" reported-display-style="italic"><enum>(1)</enum><text>an audit conducted and
			 submitted in accordance with section 10101 of title 36, United States Code;
			 and</text>
					</paragraph><paragraph changed="added" id="id77253A50B31942FB8EE2FFF11032C0EA" reported-display-style="italic"><enum>(2)</enum><text>a description of the
			 activities of the agency.</text>
					</paragraph></subsection></section><section changed="added" id="id07CF77B202614121BF74CFE8E780D672" reported-display-style="italic"><enum>703.</enum><header>Authorization of
			 appropriations</header><text display-inline="no-display-inline">There are
			 authorized to be appropriated to the United States Anti-Doping Agency—</text>
				<paragraph changed="added" id="id1F78A487E76B45FEB3FB96242836A2E3" reported-display-style="italic"><enum>(1)</enum><text>for fiscal year 2007,
			 $9,700,000;</text>
				</paragraph><paragraph changed="added" commented="no" display-inline="no-display-inline" id="id15EC2A63D70D442E87B5590996B75254" reported-display-style="italic"><enum>(2)</enum><text>for fiscal year 2008,
			 $10,300,000;</text>
				</paragraph><paragraph changed="added" commented="no" display-inline="no-display-inline" id="idB2A7A959B6BD431189B35008FE5B7F48" reported-display-style="italic"><enum>(3)</enum><text>for fiscal year 2009,
			 $10,600,000;</text>
				</paragraph><paragraph changed="added" commented="no" display-inline="no-display-inline" id="idA95371BAAAB0446AAB0F449B203D89EC" reported-display-style="italic"><enum>(4)</enum><text>for fiscal year 2010,
			 $11,000,000; and</text>
				</paragraph><paragraph changed="added" commented="no" display-inline="no-display-inline" id="id45B03D8AF2074A018BA33A9A7A1060EC" reported-display-style="italic"><enum>(5)</enum><text>for fiscal year 2011,
			 $11,500,000.</text>
				</paragraph></section></title><title changed="added" id="idAE74EB7D644941C4A22F7FB892B7E8D5" reported-display-style="italic"><enum>VIII</enum><header>Drug-free
			 communities</header>
			<section changed="added" id="idCE83103678964AF1AE5DA52F8A1CDC4E" reported-display-style="italic"><enum>801.</enum><header>Reauthorization</header><text display-inline="no-display-inline">Section 1024(a) of the Drug-Free Communities
			 Act of 1997 (21 U.S.C. 1524(a)) is amended—</text>
				<paragraph changed="added" id="idA090E50EDDCC4CCC96D2744D0910B40F" reported-display-style="italic"><enum>(1)</enum><text>in paragraph (9), by
			 striking <quote>and</quote> after the semicolon;</text>
				</paragraph><paragraph changed="added" id="id803306A043FC47319DAF27E578276399" reported-display-style="italic"><enum>(2)</enum><text>in paragraph (10), by
			 striking the period and inserting a semicolon; and</text>
				</paragraph><paragraph changed="added" id="idE4DEDEF0F48D454E8E4C5B2DEE89EFBF" reported-display-style="italic"><enum>(3)</enum><text>by adding at the end the
			 following:</text>
					<quoted-block changed="added" display-inline="no-display-inline" id="id4A7FD302D7714F33A5940CC643C876A8" reported-display-style="italic" style="OLC">
						<paragraph id="idCAFA6BB2799647A69CA881DD63D70F4A"><enum>(11)</enum><text>$109,000,000 for fiscal
				year 2008;</text>
						</paragraph><paragraph id="idC2443B5D8D454B01A2E38F9009314FF1"><enum>(12)</enum><text>$119,000,000 for fiscal
				year 2009;</text>
						</paragraph><paragraph id="idB0381B8223DD40DBA35F950DB04C148E"><enum>(13)</enum><text>$129,000,000 for fiscal
				year 2010;</text>
						</paragraph><paragraph id="idD2C1A24AF0F2453F9A133AECAB0B4772"><enum>(14)</enum><text>$139,000,000 for fiscal
				year 2011; and</text>
						</paragraph><paragraph id="id550B7CD4D3BD41358149FF2CBB842AED"><enum>(15)</enum><text>$149,000,000 for fiscal
				year
				2012.</text>
						</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</paragraph></section><section changed="added" id="id47C2A078B1734D60A9B804904AC71459" reported-display-style="italic"><enum>802.</enum><header>Suspension of
			 grants</header>
				<subsection changed="added" id="id6382485435734A64B22A1802BCF5FAAF" reported-display-style="italic"><enum>(a)</enum><header>In
			 general</header><text>Section 1032(b) of the Drug-Free Communities Act of 1997
			 (21 U.S.C. 1532(b)) is amended by adding at the end the following:</text>
					<quoted-block changed="added" display-inline="no-display-inline" id="idC445F974B8404873ADE53AD1F0660E11" reported-display-style="italic" style="OLC">
						<paragraph id="id6AF5B59925E7467AB731CB17B179DF50"><enum>(4)</enum><header>Process for
				suspension</header><text>A grantee shall not be suspended or terminated under
				paragraph (1)(A)(ii), (2)(A)(iii), or (3)(E) unless that grantee is afforded a
				fair, timely, and independent appeal prior to such suspension or
				termination.</text>
						</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</subsection><subsection changed="added" id="id3C69D3063D3C4B3795C2B07EA79557C9" reported-display-style="italic"><enum>(b)</enum><header>Report to
			 Congress</header><text>Not later than 60 days after the date of enactment of
			 this Act, the Director of the Office of National Drug Control Policy shall
			 submit to Congress a report detailing the appeals process required by section
			 1032 (b)(4) of the Drug-Free Communities Act of 1997, as added by subsection
			 (a).</text>
				</subsection></section><section changed="added" id="id2DC00C8811AB419F8C6AE955EFEF9577" reported-display-style="italic"><enum>803.</enum><header>Grant award
			 increase</header><text display-inline="no-display-inline">Subsections
			 (b)(1)(A)(iv), (b)(2)(C)(i), and (b)(3)(F) of section 1032 of the Drug-Free
			 Communities Act of 1997 (21 U.S.C. 1532) are amended by striking
			 <quote>$100,000</quote> and inserting <quote>$125,000</quote>.</text>
			</section><section changed="added" id="idFEEC0D18515847E19BCD8973DFB207F8" reported-display-style="italic"><enum>804.</enum><header>Prohibition on
			 additional eligibility criteria</header><text display-inline="no-display-inline">Section 1032(a) of the Drug-Free Communities
			 Act of 1997 (21 U.S.C. 1532(a)) is amended by adding at the end the
			 following:</text>
				<quoted-block changed="added" display-inline="no-display-inline" id="id63062FE769DF429DB74C63D8C07A0594" reported-display-style="italic" style="OLC">
					<paragraph id="id234E0EEE3CCB474C8CC81E10E532EB76"><enum>(7)</enum><header>Additional
				criteria</header><text>The Director shall not impose any eligibility criteria
				on new applicants or renewal grantees not provided in this
				chapter.</text>
					</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
			</section><section changed="added" id="idDAD4F9026A7E4B15A826CC6F7D10CC81" reported-display-style="italic"><enum>805.</enum><header>Supplemental grants
			 for coalitions</header><text display-inline="no-display-inline">The Drug-Free
			 Communities Act of 1997 (21 U.S.C. 1521 et seq.) is amended by inserting after
			 section 1035 the following:</text>
				<quoted-block changed="added" display-inline="no-display-inline" id="id93C0996E3C4749D189CB142FCFC4D87C" reported-display-style="italic" style="OLC">
					<section id="id623F6C724F6E41418D901FE70A1F90E8"><enum>1036.</enum><header>Supplemental grants
				for coalitions with a major local drug crisis</header>
						<subsection id="id7D45C1B53B59482886650073BFE7CD9D"><enum>(a)</enum><header>Authority to make
				grants</header><text>As part of the program established under section 1031, the
				Director may award an initial grant under this subsection, and renewal grants
				under subsection (f), to any coalition awarded a grant under section 1032 that
				meets the criteria specified in subsection (d) in order to fund a coalition
				dealing with a major local drug crisis.</text>
						</subsection><subsection id="id617922FF3E65418588287D8F44DA6737"><enum>(b)</enum><header>Treatment with other
				grants</header>
							<paragraph id="id68FB356AB0994303A14195E69E576C9F"><enum>(1)</enum><header>Supplement</header><text>A
				grant awarded to a coalition under this section is in addition to any grant
				awarded to the coalition under section 1032.</text>
							</paragraph><paragraph id="id9966A03AD2B740978407183373C4DAFA"><enum>(2)</enum><header>Requirement for basic
				grant</header><text>A coalition may not be awarded a grant under this section
				for a fiscal year unless the coalition was awarded a grant or renewal grant
				under section 1032(b) for that fiscal year.</text>
							</paragraph></subsection><subsection id="idBF6E3155C7CE4FF69EF9447C843C9A1A"><enum>(c)</enum><header>Application</header><text>A
				coalition seeking a grant under this section shall submit to the Administrator
				an application for the grant in such form and manner as the Administrator may
				require.</text>
						</subsection><subsection id="id86C9059C83C74F06AF230C4DE76E3380"><enum>(d)</enum><header>Criteria</header><text>A
				coalition meets the criteria specified in this subsection if the
				coalition—</text>
							<paragraph id="id180B5869A871414B871AD7CB6130DB04"><enum>(1)</enum><text>has achieved by or
				through it’s own efforts measurable results in the prevention and reduction of
				substance use among youth generally;</text>
							</paragraph><paragraph id="id892A1EA8E9B34B0297C6808F8396773F"><enum>(2)</enum><text>has documented a highly,
				statistically significant increase in a specific drug, from a baseline
				determined by locally collected data, that can be defined as a local drug
				crisis; and</text>
							</paragraph><paragraph id="id9C0ED695E34042C0925647372CB6DBC8"><enum>(3)</enum><text>submits to the
				Administrator a detailed plan for addressing the specific local drug
				crisis.</text>
							</paragraph></subsection><subsection id="idABD1E1E3E85C49BFB2DD096B0A8645C0"><enum>(e)</enum><header>Use of grant
				funds</header><text>A coalition awarded a grant under this section shall use
				the grant amount for implementing comprehensive, community-wide strategies that
				address their local drug crises in accordance with the detailed plan submitted
				to the Administrator under subsection (d)(3).</text>
						</subsection><subsection id="idE0023AFF39524F93ADD2FEE262F3915C"><enum>(f)</enum><header>Renewal
				grants</header><text>The Administrator may make a renewal grant to any
				coalition awarded a grant under subsection (a), or a previous renewal grant
				under this subsection, if the coalition at the time of the application for such
				renewal grant—</text>
							<paragraph id="idD0F6B81FBB8F4F7D94F49E5BA7A7D844"><enum>(1)</enum><text>continues to meet the
				criteria specified in subsection (d); and</text>
							</paragraph><paragraph id="id43F00AA5BA534D86A0A1B6B90FAB27FA"><enum>(2)</enum><text>has made demonstrable
				progress in addressing the specific local drug crisis.</text>
							</paragraph></subsection><subsection id="idDB8DBEE9D60A40CA9722EBF41D0A355A"><enum>(g)</enum><header>Grant amounts</header>
							<paragraph id="id1117B6A7649B4374BA3F3145A79EF283"><enum>(1)</enum><header>In
				general</header><text>Subject to paragraphs (2) and (3) the total amount of
				grants awarded to a coalition under this section for a fiscal year may not
				exceed the amount of non-Federal funds raised by the coalition, including in
				kind contributions, for that fiscal year.</text>
							</paragraph><paragraph id="id6AE04DE6E8354A1C811AE4B20E03E583"><enum>(2)</enum><header>Initial
				grants</header><text>The amount of the initial grant awarded to a coalition
				under subsection (a) may not exceed $50,000.</text>
							</paragraph><paragraph id="id27F7A577F11C4B8ABDC9B3763D2FE55C"><enum>(3)</enum><header>Renewal
				grants</header><text>The total amount of renewal grants awarded to a coalition
				under subsection (f) for any fiscal year may not exceed $50,000.</text>
							</paragraph></subsection><subsection id="idE9BE1691AE56485D8B2BC9004092DE82"><enum>(h)</enum><header>Fiscal year limitation
				on the amount available for grants</header><text>The total amount available for
				grants under this section, including renewal grants under subsection (f), in
				any fiscal year may not exceed the amount equal to 5 percent of the actual
				amount appropriated for that fiscal
				year.</text>
						</subsection></section><after-quoted-block>.</after-quoted-block></quoted-block>
			</section><section changed="added" id="id46665E61EC3144459ECE4664C9A3F06F" reported-display-style="italic"><enum>806.</enum><header>National Community
			 Anti-Drug Coalition Institute</header><text display-inline="no-display-inline">Section 4 of Public Law 107–82 (21 U.S.C.
			 1521 note), reauthorizing the Drug-Free Communities Support Program, is
			 amended—</text>
				<paragraph changed="added" id="idF9E1AB687C1C4A1CAF6678FA7A5EFC97" reported-display-style="italic"><enum>(1)</enum><text>by amending subsection
			 (a) to read as follows:</text>
					<quoted-block changed="added" display-inline="no-display-inline" id="id89280DA68C774FC19541E185C82E1617" reported-display-style="italic" style="OLC">
						<subsection id="id0AB2B6C30C7A405A93CF6E22E04F7AD9"><enum>(a)</enum><header>In
				general</header><text>The Director of the Office of National Drug Control
				Policy shall, using amounts authorized to be appropriated by subsection (d),
				make a directed grant to Community Anti-Drug Coalitions of America to provide
				for the continuation of the National Community Antidrug Coalition
				Institute.</text>
						</subsection><after-quoted-block>;</after-quoted-block></quoted-block>
				</paragraph><paragraph changed="added" id="idAB55366A94E04644A19953F21ADB91DF" reported-display-style="italic"><enum>(2)</enum><text>by striking subsection
			 (b) and redesignating subsections (c) and (d) as (b) and (c), respectively;
			 and</text>
				</paragraph><paragraph changed="added" id="id599DB8F07511440FB41F488A9B32A1CF" reported-display-style="italic"><enum>(3)</enum><text>in subsection (c), as
			 redesignated by paragraph (2), by adding at the end the following:</text>
					<quoted-block changed="added" display-inline="no-display-inline" id="id38A04850608B43B29E35F741FC4BDEC1" reported-display-style="italic" style="OLC">
						<paragraph id="id8D4C9B99729D418987B550115854B4D7"><enum>(4)</enum><text>For each of the fiscal
				years 2008 through 2012,
				$2,000,000.</text>
						</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
				</paragraph></section><section changed="added" commented="no" display-inline="no-display-inline" id="idF53696D1A172479785688D001617228E" reported-display-style="italic" section-type="subsequent-section"><enum>807.</enum><header>Contracting
			 requirement</header><text display-inline="no-display-inline">Section 1031(d) of
			 the Drug-Free Communities Act of 1997 (21 U.S.C. 1531(d)) is amended by adding
			 at the end the following: <quote>The Director shall delegate all authority for
			 grant eligibility determinations, review, selection, management, and appeals to
			 another qualified national drug control agency.</quote>.</text>
			</section></title><title changed="added" id="id5F4456C9116046E987238B8002BFE94D" reported-display-style="italic"><enum>IX</enum><header>National Guard
			 counterdrug schools</header>
			<section changed="added" id="idB25F9779F8EB4AE1924603E1E168EBBC" reported-display-style="italic"><enum>901.</enum><header>National Guard
			 counterdrug schools</header>
				<subsection changed="added" id="idD07BD7C4925F45F5996FD73F6C6252E6" reported-display-style="italic"><enum>(a)</enum><header>Authority To
			 Operate</header><text>Under such regulations as the Secretary of Defense may
			 prescribe, the Chief of the National Guard Bureau may establish and operate, or
			 provide financial assistance to the States to establish and operate, not more
			 than five schools (to be known generally as <quote>National Guard counterdrug
			 schools</quote>).</text>
				</subsection><subsection changed="added" id="id759C98CF66F645ED8580733EE46DA767" reported-display-style="italic"><enum>(b)</enum><header>Purpose</header><text>The
			 purpose of the National Guard counterdrug schools shall be the provision by the
			 National Guard of training in drug interdiction and counterdrug activities and
			 drug demand reduction activities to personnel of the following:</text>
					<paragraph changed="added" id="idD83B9D1765274AC8886CB80669E10B2A" reported-display-style="italic"><enum>(1)</enum><text>Federal agencies.</text>
					</paragraph><paragraph changed="added" id="id66D14C450E324E3ABC0462141D481C59" reported-display-style="italic"><enum>(2)</enum><text>State and local law
			 enforcement agencies.</text>
					</paragraph><paragraph changed="added" id="id4A270AAB02F24148AD028587AB4957A7" reported-display-style="italic"><enum>(3)</enum><text>Community-based
			 organizations engaged in such activities.</text>
					</paragraph><paragraph changed="added" id="idE9378F76639643CFA9FA52F4D670FC63" reported-display-style="italic"><enum>(4)</enum><text>Other non-Federal
			 governmental and private entities and organizations engaged in such
			 activities.</text>
					</paragraph></subsection><subsection changed="added" id="id727ACACD8DA646F9BDA45657052AC614" reported-display-style="italic"><enum>(c)</enum><header>Counterdrug Schools
			 Specified</header><text>The National Guard counterdrug schools operated under
			 the authority in subsection (a) are as follows:</text>
					<paragraph changed="added" id="id54A2765D03B543FE84F4492DE61781BA" reported-display-style="italic"><enum>(1)</enum><text>The National Interagency
			 Civil-Military Institute (NICI), San Luis Obispo, California.</text>
					</paragraph><paragraph changed="added" id="id439DA0250F5F477DBAEB5E5E1804F405" reported-display-style="italic"><enum>(2)</enum><text>The Multi-Jurisdictional
			 Counterdrug Task Force Training (MCTFT), St. Petersburg, Florida.</text>
					</paragraph><paragraph changed="added" id="idE942B26CF36C4790A1937967E7881030" reported-display-style="italic"><enum>(3)</enum><text>The Midwest Counterdrug
			 Training Center (MCTC), Johnston, Iowa.</text>
					</paragraph><paragraph changed="added" id="idDA0123FBD9C44211B8B3F1083A781E34" reported-display-style="italic"><enum>(4)</enum><text>The Regional Counterdrug
			 Training Academy (RCTA), Meridian, Mississippi.</text>
					</paragraph><paragraph changed="added" id="id698DF5B05C5E4062A84802020A24F711" reported-display-style="italic"><enum>(5)</enum><text>The Northeast Regional
			 Counterdrug Training Center (NCTC), Fort Indiantown Gap, Pennsylvania.</text>
					</paragraph></subsection><subsection changed="added" id="idC50AEA46901649C8BF1257A42D7C0A41" reported-display-style="italic"><enum>(d)</enum><header>Use of National Guard
			 Personnel</header>
					<paragraph changed="added" id="idF672EED00F904F8DB8BEA1DCA080D8D9" reported-display-style="italic"><enum>(1)</enum><header>In
			 general</header><text>To the extent provided for in the State drug interdiction
			 and counterdrug activities plan of a State in which a National Guard
			 counterdrug school is located, personnel of the National Guard of that State
			 who are ordered to perform full-time National Guard duty authorized under
			 section 112(b) of that title 32, United States Code, may provide training
			 referred to in subsection (b) at that school.</text>
					</paragraph><paragraph changed="added" id="idB61481FB5193477D992DE6D9624237D2" reported-display-style="italic"><enum>(2)</enum><header>Definition</header><text>In
			 this subsection, the term <term>State drug interdiction and counterdrug
			 activities plan</term>, in the case of a State, means the current plan
			 submitted by the Governor of the State to the Secretary of Defense under
			 section 112 of title 32, United States Code.</text>
					</paragraph></subsection><subsection changed="added" id="id2BF1C66D76D948308AB4C81E3D80D72F" reported-display-style="italic"><enum>(e)</enum><header>Treatment Under
			 Authority To Provide Counterdrug Support</header><text>The provisions of
			 section 1004 of the National Defense Authorization Act for Fiscal Year 1991
			 (Public Law 101–510; 10 U.S.C. 374 note) shall apply to any activities of a
			 National Guard counterdrug school under this section that are for an agency
			 referred to in subsection (a) of such section 1004 and for a purpose set forth
			 in subsection (b) of such section 1004.</text>
				</subsection><subsection changed="added" id="idB352168B00C147629E9314790D36AC85" reported-display-style="italic"><enum>(f)</enum><header>Annual Reports on
			 Activities</header>
					<paragraph changed="added" id="id61BB9AD469CF4DA79187AA1381243E03" reported-display-style="italic"><enum>(1)</enum><header>In
			 general</header><text>Not later than February 1 each year, the Secretary of
			 Defense shall submit to Congress a report on the activities of the National
			 Guard counterdrug schools during the preceding year.</text>
					</paragraph><paragraph changed="added" id="idB4887FEAB4064964B80326A2F467425C" reported-display-style="italic"><enum>(2)</enum><header>Contents</header><text>Each
			 report under paragraph (1) shall set forth the following:</text>
						<subparagraph changed="added" id="idC1443C11DE544F69AF32380CA8CB1A3F" reported-display-style="italic"><enum>(A)</enum><header>Funding</header><text>The
			 amount made available for each National Guard counterdrug school during the
			 fiscal year ending in the year preceding the year in which such report is
			 submitted.</text>
						</subparagraph><subparagraph changed="added" id="id7490FEB45DFB475C855C3301D6FB5B88" reported-display-style="italic"><enum>(B)</enum><header>Activities</header><text>A
			 description of the activities of each National Guard counterdrug school during
			 the year preceding the year in which such report is submitted.</text>
						</subparagraph></paragraph></subsection><subsection changed="added" id="idDAC9CA2E4F2846DBB526B7EEC80542DB" reported-display-style="italic"><enum>(g)</enum><header>Authorization of
			 Appropriations</header>
					<paragraph changed="added" id="idBE07EDEBAB5F4CA293F0EE9E621764D1" reported-display-style="italic"><enum>(1)</enum><header>In
			 general</header><text>There is hereby authorized to be appropriated for the
			 Department of Defense for the National Guard for each of fiscal years 2006
			 through 2010, $30,000,000 for purposes of the National Guard counterdrug
			 schools in such fiscal year.</text>
					</paragraph><paragraph changed="added" id="id2729B927714B4678B5701336DC9BB474" reported-display-style="italic"><enum>(2)</enum><header>Construction</header><text>The
			 amount authorized to be appropriated by paragraph (1) for a fiscal year is in
			 addition to any other amount authorized to be appropriated for the Department
			 of Defense for the National Guard for such fiscal year.</text>
					</paragraph></subsection></section></title><title changed="added" id="idEA3FD7EFC244473E95F64CA211C922DB" reported-display-style="italic"><enum>X</enum><header>National Methamphetamine
			 Information Clearinghouse Act of 2006</header>
			<section changed="added" id="S1" reported-display-style="italic"><enum>1001.</enum><header>Short
			 title</header><text display-inline="no-display-inline">This title may be cited
			 as the <quote><short-title>National Methamphetamine
			 Information Clearinghouse Act of 2006</short-title></quote>.</text>
			</section><section changed="added" id="id4259A57EE59645AFAE08C8FD7E0162A8" reported-display-style="italic"><enum>1002.</enum><header>Definitions</header><text display-inline="no-display-inline">In this title—</text>
				<paragraph changed="added" id="id2105623B50774AAA8FC1552175D0C983" reported-display-style="italic"><enum>(1)</enum><text>the term
			 <term>Council</term> means the National Methamphetamine Advisory Council
			 established under section 1003(b)(1);</text>
				</paragraph><paragraph changed="added" id="id99C256E7DB344F538195D7248964D2F2" reported-display-style="italic"><enum>(2)</enum><text>the term <term>drug
			 endangered children</term> means children whose physical, mental, or emotional
			 health are at risk because of the production, use, or other effects of
			 methamphetamine production or use by another person;</text>
				</paragraph><paragraph changed="added" id="idCA55C5AA3F5544B8A5BC0163F5542E5B" reported-display-style="italic"><enum>(3)</enum><text>the term <term>National
			 Methamphetamine Information Clearinghouse</term> or <term>NMIC</term> means the
			 information clearinghouse established under section 1003(a); and</text>
				</paragraph><paragraph changed="added" id="id16BE94CAE38F49A4B71B5985856507FC" reported-display-style="italic"><enum>(4)</enum><text>the term <term>qualified
			 entity</term> means a State or local government, school board, or public
			 health, law enforcement, nonprofit, community antidrug coalition, or other
			 nongovernmental organization providing services related to
			 methamphetamines.</text>
				</paragraph></section><section changed="added" id="id1C8EAE147902412AA42977231EA5FB9B" reported-display-style="italic"><enum>1003.</enum><header>Establishment of
			 clearinghouse and advisory council</header>
				<subsection changed="added" id="id133FB3770BBE4A11BCDAE10B8E03A88D" reported-display-style="italic"><enum>(a)</enum><header>Clearinghouse</header><text>There
			 is established, under the supervision of the Attorney General of the United
			 States, an information clearinghouse to be known as the National
			 Methamphetamine Information Clearinghouse.</text>
				</subsection><subsection changed="added" id="id37459BBE94274596BC6A42D839250566" reported-display-style="italic"><enum>(b)</enum><header>Advisory
			 Council</header>
					<paragraph changed="added" id="idEE1685C4EEA54CC19B77E8CA9526EC8D" reported-display-style="italic"><enum>(1)</enum><header>In
			 general</header><text>There is established an advisory council to be known as
			 the National Methamphetamine Advisory Council.</text>
					</paragraph><paragraph changed="added" id="id6CD044539925425F9BEC0D17D2D5AF52" reported-display-style="italic"><enum>(2)</enum><header>Membership</header><text>The
			 Council shall consist of 10 members appointed by the Attorney General—</text>
						<subparagraph changed="added" id="id7219A65B6FF14ED2A63A9AF84FBB006B" reported-display-style="italic"><enum>(A)</enum><text>not fewer than 3 of whom
			 shall be representatives of law enforcement agencies;</text>
						</subparagraph><subparagraph changed="added" id="id5FEC20B42C994769B04EB321386D3FDF" reported-display-style="italic"><enum>(B)</enum><text>not fewer than 4 of whom
			 shall be representatives of nongovernmental and nonprofit organizations
			 providing services or training and implementing programs or strategies related
			 to methamphetamines; and</text>
						</subparagraph><subparagraph changed="added" id="idB2D7A3219DE940B98AEA5B241E05AE2B" reported-display-style="italic"><enum>(C)</enum><text>1 of whom shall be a
			 representative of the Department of Health and Human Services.</text>
						</subparagraph></paragraph><paragraph changed="added" id="id7664036DD1F149CCABB82E7378BF299F" reported-display-style="italic"><enum>(3)</enum><header>Period of appointment;
			 vacancies</header><text>Members shall be appointed for 3 years. Any vacancy in
			 the Council shall not affect its powers, but shall be filled in the same manner
			 as the original appointment.</text>
					</paragraph><paragraph changed="added" id="id2331810D7D23479EA1E9D577EDD0B931" reported-display-style="italic"><enum>(4)</enum><header>Personnel
			 matters</header>
						<subparagraph changed="added" id="id37B7D23E6FFD460E9FDFE6045A3DE986" reported-display-style="italic"><enum>(A)</enum><header>Travel
			 expenses</header><text>The members of the Council shall be allowed travel
			 expenses, including per diem in lieu of subsistence, at rates authorized for
			 employees of agencies under subchapter I of chapter 57 of title 5, United
			 States Code, while away from their homes or regular places of business in the
			 performance of services for the Council.</text>
						</subparagraph><subparagraph changed="added" id="idFC25339ED85A45478D0E54FB59A5E156" reported-display-style="italic"><enum>(B)</enum><header>No
			 compensation</header><text>The members of the Council shall not receive
			 compensation for the performance of the duties of a member of the
			 Council.</text>
						</subparagraph></paragraph></subsection></section><section changed="added" id="idAF750BD07433427EAD5C1F07B8F0B88D" reported-display-style="italic"><enum>1004.</enum><header>NMIC requirements and
			 review</header>
				<subsection changed="added" id="id49264EC034624943914731A68B0C2CC6" reported-display-style="italic"><enum>(a)</enum><header>In
			 general</header><text>The NMIC shall promote sharing information regarding
			 successful law enforcement, treatment, environmental, prevention, social
			 services, and other programs related to the production, use, or effects of
			 methamphetamine and grants available for such programs.</text>
				</subsection><subsection changed="added" id="id0C80C0A834B242A28B6A463CBFA49E62" reported-display-style="italic"><enum>(b)</enum><header>Components</header><text>The
			 NMIC shall include—</text>
					<paragraph changed="added" id="ID078f4366208d4ed58c836ca78c9a01c0" reported-display-style="italic"><enum>(1)</enum><text>a toll-free number;
			 and</text>
					</paragraph><paragraph changed="added" id="id4CD4E25A146B445489F3F7B91F40738E" reported-display-style="italic"><enum>(2)</enum><text>a website that provides a
			 searchable database, which—</text>
						<subparagraph changed="added" id="idF6D4C6BC53284678B2A9CFA484F19216" reported-display-style="italic"><enum>(A)</enum><text>provides information on
			 the short-term and long-term effects of methamphetamine use;</text>
						</subparagraph><subparagraph changed="added" id="idA7839351AABD40A29FC4A9BCFFFC8F05" reported-display-style="italic"><enum>(B)</enum><text>provides information
			 regarding methamphetamine treatment and prevention programs and strategies and
			 programs for drug endangered children, including descriptions of successful
			 programs and strategies and contact information for such programs and
			 strategies;</text>
						</subparagraph><subparagraph changed="added" id="IDb1bbbb25488c4d849d1b1d23de3026ab" reported-display-style="italic"><enum>(C)</enum><text>provides information
			 regarding grants for methamphetamine-related programs, including contact
			 information and links to websites;</text>
						</subparagraph><subparagraph changed="added" id="id3A0040D0C39245DEB060F5F74A685753" reported-display-style="italic"><enum>(D)</enum><text>allows a qualified entity
			 to submit items to be posted on the website regarding successful public or
			 private programs or other useful information related to the production, use, or
			 effects of methamphetamine;</text>
						</subparagraph><subparagraph changed="added" id="id8F58392C717449F98DBEBE68DDAC401C" reported-display-style="italic"><enum>(E)</enum><text>includes a restricted
			 section that may only be accessed by a law enforcement organization that
			 contains successful strategies, training techniques, and other information that
			 the Council determines helpful to law enforcement agency efforts to identify or
			 combat the production, use or effects of methamphetamine;</text>
						</subparagraph><subparagraph changed="added" id="idECB7FE5157C34529A7B60C415536DC81" reported-display-style="italic"><enum>(F)</enum><text>allows public access to
			 all information not in a restricted section; and</text>
						</subparagraph><subparagraph changed="added" id="IDff7936a885c64b5cab18d1f01ccbbf17" reported-display-style="italic"><enum>(G)</enum><text>contains any additional
			 information the Council determines may be useful in identifying or combating
			 the production, use, or effects of methamphetamine.</text>
						</subparagraph></paragraph></subsection><subsection changed="added" id="id00889DC7D88A491F867756ECCFCA6838" reported-display-style="italic"><enum>(c)</enum><header>Review of posted
			 information</header>
					<paragraph changed="added" id="id3A517D7FCF4644D482FDE2D26BC78613" reported-display-style="italic"><enum>(1)</enum><header>In
			 general</header><text>Not later than 30 days after the date of submission of an
			 item by a qualified entity, the Council shall review an item submitted for
			 posting on the website described in subsection (b)(2)—</text>
						<subparagraph changed="added" id="idAB47F8671C1E4E44BE42C34AD3C815F1" reported-display-style="italic"><enum>(A)</enum><text>to evaluate and determine
			 whether the item, as submitted or as modified, meets the requirements for
			 posting; and</text>
						</subparagraph><subparagraph changed="added" commented="no" display-inline="no-display-inline" id="idA545FE30CB37405BB6529F3E91007597" reported-display-style="italic"><enum>(B)</enum><text>in consultation with the
			 Attorney General, to determine whether the item should be posted in a
			 restricted section of the website.</text>
						</subparagraph></paragraph><paragraph changed="added" id="id02EE1077F91B48D29F4F6E6B929F0C4C" reported-display-style="italic"><enum>(2)</enum><header>Determination</header><text>Not
			 later than 45 days after the date of submission of an item, the Council
			 shall—</text>
						<subparagraph changed="added" id="idA4C4E86B89EB4E07B58554465143C019" reported-display-style="italic"><enum>(A)</enum><text>post the item on the
			 website described in subsection (b)(2); or</text>
						</subparagraph><subparagraph changed="added" id="id651DF2333078494EB3E620C40BB7CB20" reported-display-style="italic"><enum>(B)</enum><text>notify the qualified
			 entity that submitted the item regarding the reason such item shall not be
			 posted and modifications, if any, that the qualified entity may make to allow
			 the item to be posted.</text>
						</subparagraph></paragraph></subsection></section><section changed="added" id="id10275FE4DCA64BCDB56DA7C796E89150" reported-display-style="italic"><enum>1005.</enum><header>Authorization of
			 appropriations</header><text display-inline="no-display-inline">There are
			 authorized to be appropriated—</text>
				<paragraph changed="added" id="idDB237A63E7534A8D82F52AB57D40C0D4" reported-display-style="italic"><enum>(1)</enum><text>for fiscal year
			 2006—</text>
					<subparagraph changed="added" id="idEE54D7F68D874CECA1538DA946F31E06" reported-display-style="italic"><enum>(A)</enum><text>$2,000,000 to establish
			 the NMIC and Council; and</text>
					</subparagraph><subparagraph changed="added" id="id2C5B268007DA425893C6ECBE30255A17" reported-display-style="italic"><enum>(B)</enum><text>such sums as are
			 necessary for the operation of the NMIC and Council; and</text>
					</subparagraph></paragraph><paragraph changed="added" id="idB46F05D87F9F49C39632F3092D355030" reported-display-style="italic"><enum>(2)</enum><text>for each of fiscal years
			 2007 through 2010, such sums as are necessary for the operation of the NMIC and
			 Council.</text>
				</paragraph></section></title><title changed="added" id="idCDD86DFE344A43099977B363289DEBE1" reported-display-style="italic"><enum>XI</enum><header>Miscellaneous
			 provisions</header>
			<section changed="added" id="id8185C957F50F408EA60136397B76A154" reported-display-style="italic"><enum>1101.</enum><header>Repeals</header>
				<subsection changed="added" id="idD472878A64264C0C88FD2EE11934B3FA" reported-display-style="italic"><enum>(a)</enum><header>Act</header><text>Sections
			 709, 710, and 711 are repealed.</text>
				</subsection><subsection changed="added" id="idA409816B4C564C2A95EF04B74257BBB3" reported-display-style="italic"><enum>(b)</enum><header>Forfeiture
			 assets</header><text>Section 6073 of the Assets Forfeiture Amendments Act of
			 1988 (21 U.S.C. 1509) is repealed.</text>
				</subsection></section><section changed="added" id="idB9A5CF4A1B2544BE98BCC94CF7BF0CA4" reported-display-style="italic"><enum>1102.</enum><header><act-name parsable-cite="CSA">Controlled Substances Act</act-name>
			 amendments</header><text display-inline="no-display-inline">Section
			 303(g)(2)(B)(iii) of the Controlled Substances Act (21 U.S.C.
			 823(g)(2)(B)(iii)) is amended by striking <quote>except that the
			 Secretary</quote> and inserting the following: <quote>unless, not sooner than 1
			 year after the date on which the practitioner submitted the initial
			 notification, the practitioner submits a second notification to the Secretary
			 of the need and intent of the practitioner to treat more than such applicable
			 number of patients. A second notification under this clause shall contain the
			 certifications required by clauses (i) and (ii) of this subparagraph. The
			 Secretary</quote>.</text>
			</section><section changed="added" id="id80FD782160884CAB8DF999C76497A813" reported-display-style="italic"><enum>1103.</enum><header>Report on
			 intelligence sharing</header><text display-inline="no-display-inline">Not later
			 than 180 days after the date of enactment of this Act, the Director shall
			 submit to Congress a report—</text>
				<paragraph changed="added" id="id7F4AB6DFFA134BB48A9BC8A0FA181DE1" reported-display-style="italic"><enum>(1)</enum><text>evaluating existing and
			 planned intelligence systems used by Federal, State, and local law enforcement
			 agencies responsible for drug trafficking and drug production enforcement;
			 and</text>
				</paragraph><paragraph changed="added" id="idAD8850DE7DFA4BE39B3A4AAE886D0A9C" reported-display-style="italic"><enum>(2)</enum><text>addressing—</text>
					<subparagraph changed="added" id="id7A81CA3B6476443AB020FE48701D44B5" reported-display-style="italic"><enum>(A)</enum><text>the current intelligence
			 systems used by Federal, State, and local law enforcement agencies;</text>
					</subparagraph><subparagraph changed="added" id="idB9A94AFEDB02414FB43C3B2F5CCAC4A5" reported-display-style="italic"><enum>(B)</enum><text>the compatibility of such
			 systems in ensuring access and availability of intelligence to Federal, State,
			 and local law enforcement;</text>
					</subparagraph><subparagraph changed="added" id="idAE26F9340C2B4500B37A3BF0DE5E69C4" reported-display-style="italic"><enum>(C)</enum><text>the extent to which
			 Federal, State, and local law enforcement are sharing intelligence information
			 to assess current threats and design appropriate enforcement strategies;
			 and</text>
					</subparagraph><subparagraph changed="added" commented="no" display-inline="no-display-inline" id="id672497A35974443480F8E1350F31A01B" reported-display-style="italic"><enum>(D)</enum><text>the measures needed to
			 ensure and to promote effective information sharing among intelligence systems
			 operated by Federal, State, and local law enforcement agencies responsible for
			 drug trafficking and drug production enforcement.</text>
					</subparagraph></paragraph></section><section changed="added" id="id5302D96684B6431283F4DE4F8F31DB6F" reported-display-style="italic"><enum>1104.</enum><header>Requirement for South
			 American heroin strategy</header>
				<subsection changed="added" id="idA09C7B1FE97D4AEEA4398F7F77A1DDCB" reported-display-style="italic"><enum>(a)</enum><header>In
			 general</header><text>Not later than 90 days after the date of enactment of
			 this Act, the Director shall submit to Congress a comprehensive strategy that
			 addresses the increased threat from South American heroin, and in particular
			 Colombian heroin, and the emerging threat from opium poppy grown in Peru and
			 often intended for transit to Columbia for processing into heroin.</text>
				</subsection><subsection changed="added" id="idB7FA432A04BE4BCCBA3A725F0D77B04C" reported-display-style="italic"><enum>(b)</enum><header>Contents</header><text>The
			 strategy submitted under subsection (a) shall include—</text>
					<paragraph changed="added" id="idE4B5BB83D2EA4602843BBDB47B6D27D4" reported-display-style="italic"><enum>(1)</enum><text>opium eradication efforts
			 to eliminate the problem at the source to prevent heroin from entering the
			 stream of commerce;</text>
					</paragraph><paragraph changed="added" id="id7E06D34D06C64C9395FDF356A763A272" reported-display-style="italic"><enum>(2)</enum><text>interdiction and
			 precursor chemical controls;</text>
					</paragraph><paragraph changed="added" id="idD0326384EA5446AAAECBD37BD11CD2F2" reported-display-style="italic"><enum>(3)</enum><text>demand reduction and
			 treatment;</text>
					</paragraph><paragraph changed="added" id="id9C9274B89B85475CA85763E5C3D422C8" reported-display-style="italic"><enum>(4)</enum><text>alternative development
			 programs, including direct assistance to regional governments to demobilize and
			 provide alternative livelihoods to former members of insurgent or other groups
			 engaged in heroin, cocoa, or other illicit drug production or
			 trafficking;</text>
					</paragraph><paragraph changed="added" id="id2CBAB5017FDA44C79AECDF3D707810FA" reported-display-style="italic"><enum>(5)</enum><text>efforts to inform and
			 involve local citizens in the programs described in paragraphs (1) through (4),
			 such as through leaflets advertising rewards for information;</text>
					</paragraph><paragraph changed="added" id="idF2D832FA05474F87BDF06260E1EED2D1" reported-display-style="italic"><enum>(6)</enum><text>provisions that ensure
			 the maintenance at current levels of efforts to eradicate coca in Colombia;
			 and</text>
					</paragraph><paragraph changed="added" id="idA5E8F433B7014BA8B814E619B650CAB4" reported-display-style="italic"><enum>(7)</enum><text>an assessment of the
			 specific level of funding and resources necessary to simultaneously address the
			 threat from South American heroin and the threat from Colombian and Peruvian
			 coca.</text>
					</paragraph></subsection><subsection changed="added" id="idF7D7AE91E71D4AD59C4BC8303398AD1D" reported-display-style="italic"><enum>(c)</enum><header>Treatment of classified
			 or law enforcement sensitive information</header><text>Any content of the
			 strategy submitted under subsection (a) that involves information classified
			 under criteria established by an Executive order, or whose public disclosure,
			 as determined by the Director or the head of any relevant Federal agency, would
			 be detrimental to the law enforcement of national security activities of any
			 Federal, foreign, or international agency, shall be presented to Congress
			 separately from the rest of the strategy.</text>
				</subsection></section><section changed="added" id="id945E827BB86F4FD78FEA921FF0E27CC3" reported-display-style="italic"><enum>1105.</enum><header>Model acts</header>
				<subsection changed="added" id="idDD676DAEB88C46658A321907FF049718" reported-display-style="italic"><enum>(a)</enum><header>In
			 general</header><text>The Director shall enter into an agreement with a
			 nonprofit corporation that works with States on laws and policies to address
			 alcohol and other drug issues, under which the corporation shall revise the
			 model State drug laws developed by the President's Commission on Model State
			 Drug Laws and draft supplementary model acts to meet changes in States'
			 substance abuse issues.</text>
				</subsection><subsection changed="added" id="id294233FA88424544ADB13E67377FF175" reported-display-style="italic"><enum>(b)</enum><header>Authorization of
			 appropriations</header><text>There are authorized to be appropriated $1,500,000
			 to carry out this section.</text>
				</subsection></section><section changed="added" id="id67ABAEF699CA41E4B7285D97E6312628" reported-display-style="italic"><enum>1106.</enum><header>Study on iatrogenic
			 addiction associated with prescription opioid analgesic drugs</header>
				<subsection changed="added" id="ID7ffa95b2d5d8444da9e1dafb31d4d36b" reported-display-style="italic"><enum>(a)</enum><header>In general</header>
					<paragraph changed="added" id="idB518F4B3663B4797AE1A3CD97A928470" reported-display-style="italic"><enum>(1)</enum><header>Study</header><text>The
			 Director of the Office of National Drug Control Policy shall request the
			 Institute of Medicine of the National Academy of Sciences to enter into an
			 agreement under which the Institute agrees to study certain aspects of
			 iatrogenic addiction to prescription opioid analgesics included in schedules II
			 and III of the Controlled Substances Act (21 U.S.C. 812).</text>
					</paragraph><paragraph changed="added" id="id517C2969076A4AE2B6D1F798B69DD0F6" reported-display-style="italic"><enum>(2)</enum><header>Iatrogenic
			 addiction</header><text>In this section, the term <term>iatrogenic
			 addiction</term> means an addiction developed from the use of an opioid
			 analgesic by an individual with no previous history of any addiction, who has
			 lawfully obtained and used the drug for a legitimate medical purpose by
			 administration from, or pursuant to the prescription or order of, an individual
			 practitioner acting in the usual course of professional practice.</text>
					</paragraph></subsection><subsection changed="added" id="ID91d61daa693e424b80bda7f14ae5f830" reported-display-style="italic"><enum>(b)</enum><header>Requirements</header><text>The
			 study conducted pursuant to this section shall assess the current scientific
			 literature to determine, if possible—</text>
					<paragraph changed="added" id="ID59bb1327dff448ac89944dcc2e8ecde7" reported-display-style="italic"><enum>(1)</enum><text>the rate of iatrogenic
			 addiction associated with the appropriate use of prescription drugs described
			 in subsection (a);</text>
					</paragraph><paragraph changed="added" id="ID9c8183a02d564c83890a868225dbb431" reported-display-style="italic"><enum>(2)</enum><text>the impact of iatrogenic
			 addiction associated with the appropriate use of prescription drugs described
			 in subsection (a) on the individual, the prescriber, other patients, and
			 society in general;</text>
					</paragraph><paragraph changed="added" id="IDd8381c541b434f04ae71f194b424a33e" reported-display-style="italic"><enum>(3)</enum><text>the comparative abuse
			 liability of prescription drugs described in subsection (a) when used properly
			 by the ultimate user for a legitimate medical purpose; and</text>
					</paragraph><paragraph changed="added" id="ID0778e8c70749415ea2a3a47b866c99bb" reported-display-style="italic"><enum>(4)</enum><subparagraph commented="no" display-inline="yes-display-inline" id="id1764CDB260274CE5A981D197C61A99AE"><enum>(A)</enum><text>what types of
			 prospective or retrospective studies should be undertaken to determine the rate
			 of iatrogenic addiction associated with the appropriate use of the prescription
			 drugs described in subsection (a); and</text>
						</subparagraph><subparagraph changed="added" id="id053F6080D6CE48B0B86E7F5884DC11C1" indent="up1" reported-display-style="italic"><enum>(B)</enum><text>a
			 feasible timeline for conducting and reporting such studies, should the current
			 state of the scientific literature be insufficient to determine the rate,
			 impact, and comparative abuse liability of prescription drugs described in
			 subsection (a).</text>
						</subparagraph></paragraph></subsection><subsection changed="added" id="IDefb78087651043d7b10260ae5397064d" reported-display-style="italic"><enum>(c)</enum><header>Report</header><text>Not
			 later than 1 year after the date of enactment of this Act, the Director of the
			 Office of National Drug Control Policy shall ensure that the agreement under
			 subsection (a) provides for the submission of a report to the Congress on the
			 status of the study conducted pursuant to this section.</text>
				</subsection></section><section changed="added" id="IDa69bb8530f9f46ed8d8ab1bcdc5463ec" reported-display-style="italic"><enum>1107.</enum><header>Requirement for
			 strategy to stop Internet advertising of prescription medicines without a
			 prescription</header><text display-inline="no-display-inline">Not later than
			 120 days after the date of the enactment of this Act, the Director of the
			 Office of National Drug Control Policy shall submit to Congress a strategy to
			 stop advertisements that provide information about obtaining over the Internet
			 drugs (as defined in section 702(3) of the Office of National Drug Control
			 Policy Reauthorization Act of 1998) for which a prescription is required
			 without the use of such a lawful prescription.</text>
			</section><section changed="added" id="ID8d0c950d6a224e2eafdd3474a3a0bb38" reported-display-style="italic"><enum>1108.</enum><header>Requirement for study
			 on diversion and inappropriate uses of prescription drugs</header><text display-inline="no-display-inline">Not later than 90 days after the date of
			 enactment of this Act, the Director of the Office of National Drug Control
			 Policy, in consultation with the Secretary of Health and Human Services, shall
			 submit to Congress a report that includes a plan to conduct a study on the
			 illegal diversion and inappropriate uses of prescription drugs, including the
			 following:</text>
				<paragraph changed="added" id="IDc480b9f956d24e2da91ef5aed4339ddf" reported-display-style="italic"><enum>(1)</enum><text>Methods to utilize both
			 public use surveys that are in existence as of the date of enactment of this
			 Act and other surveys to provide appropriate baseline data on the natural
			 history of diversion and abuse of prescription drugs that are included in
			 schedules under the Controlled Substances Act to evaluate the extent and nature
			 of potential problems with such use to guide corrective actions which may
			 reduce such problems without unintentionally hindering access to these drugs
			 for legitimate medical purposes. Specifically, other surveys to be considered
			 are those that address the abuse of these substances on a regional or national
			 basis, and those that address the diversion of these substances on a regional
			 or national basis.</text>
				</paragraph><paragraph changed="added" commented="no" display-inline="no-display-inline" id="ID25efc1b598134bc4bdd3b91d8a276c99" reported-display-style="italic"><enum>(2)</enum><text>A scientifically based
			 analysis of the relative contribution of both innate and acquired genetic
			 factors, environmental factors, psychological factors and drug characteristics
			 that contribute to addiction to prescription drugs.</text>
				</paragraph></section></title></legis-body>
	<endorsement>
		<action-date date="20060525">May 25, 2006</action-date>
		<action-desc>Reported with an amendment</action-desc>
	</endorsement>
</bill>
